Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
114 "Resection"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Display
Original Articles
Colorectal cancer
Margin-driven outcomes prevail over resection planes: multivisceral surgery matches total mesorectal excision in locally advanced rectal cancer
Niyaz Shadmanov, Baris Bakir, Suha Goksel, Oktar Asoglu
Ann Coloproctol. 2026;42(2):226-236.   Published online April 27, 2026
DOI: https://doi.org/10.3393/ac.2025.00920.0131
  • 504 View
  • 21 Download
AbstractAbstract PDF
Purpose
This study compared oncologic and perioperative outcomes between patients with locally advanced rectal cancer (LARC) treated with beyond total mesorectal excision (bTME) and those with pathologic stage III disease undergoing TME.
Methods
A retrospective analysis was conducted using prospectively collected data from 580 LARC patients treated with curative-intent surgery over a 23-year period. Patients were categorized as those with clinical T4b tumors who underwent bTME with multivisceral resection (MVR) and those with pathologic stage III tumors treated with TME. Demographic, surgical, pathological, and oncologic outcomes were compared.
Results
Circumferential resection margin (CRM) positivity was similar between the groups (5.3% vs. 3.6%, P=0.467). Postoperative complications occurred more often in the bTME group (28.9% vs. 16.6%, P=0.004), although major complications were comparable (P=0.812). Five-year local recurrence (10.5% vs. 9.3%, P=0.371), distant metastasis (19.7% vs. 21.4%, P=0.140), disease-free survival (64.4% vs. 66.2%, P=0.326), and overall survival (74.8% vs. 75.5%, P=0.464) demonstrated no significant differences. Within the bTME group, 32 patients (42.1%) underwent major MVR and 44 (57.9%) underwent minor MVR. CRM positivity (6.2% vs. 4.5%, P=0.999), local recurrence (12.5% vs. 9.1%, P=0.714), and distant metastasis (25.0% vs. 15.9%, P=0.388) rates were similar. Five-year disease-free survival (61.5% vs. 72.3%, P=0.454) and overall survival (68.5% vs. 74.8%, P=0.609) favored minor MVR, although the differences were not statistically significant.
Conclusion
When negative circumferential margins are achieved, margin-driven bTME resections provide long-term oncologic outcomes comparable to standard TME in high-risk rectal cancer, although they are associated with higher overall complication rates.
Colorectal cancer
Palliative resection versus palliative stenting for intestinal obstruction in patients with metastatic left-sided colonic cancer: a propensity score–matched analysis
Ruby Siu Ting Lau, Sophie Sok Fei Hon, Man Fung Ho, Simon Chu, Dennis CK Ng, Simon SM Ng
Ann Coloproctol. 2025;41(6):528-536.   Published online December 29, 2025
DOI: https://doi.org/10.3393/ac.2025.00535.0076
  • 1,340 View
  • 63 Download
AbstractAbstract PDF
Purpose
Palliative resection and palliative stenting are established options for managing obstruction in patients with metastatic left-sided colonic cancer. This retrospective study investigated the long-term outcomes and survival associated with each treatment modality.
Methods
Patients with left-sided colon cancer complicated by intestinal obstruction and unresectable metastatic lesions were included. Propensity score matching was conducted to balance demographic characteristics. The primary outcome was long-term survival. Secondary outcomes included short-term morbidity, length of hospital stay, clinical success rate, stoma formation rate, and number of readmissions due to tumor-related complications.
Results
Initially, 131 patients who underwent palliative resection or stenting between 2015 and 2022 were included. After propensity score matching, 98 patients remained (49 in each group). Survival was significantly better among patients receiving palliative resection compared to stenting (median, 19.6 months vs. 9.6 months; P=0.003). However, subgroup analysis for patients older than 70 years demonstrated no statistically significant survival benefit (median, 11.5 months vs. 10.2 months; P=0.240). The resection group experienced significantly higher rates of stoma formation and longer postoperative hospital stays. Readmission rates were similar. Cox regression analysis identified low carcinoembryonic antigen levels, tumor resection, chemotherapy, and targeted therapy as independent predictors of longer survival.
Conclusion
For metastatic colon cancer patients presenting with intestinal obstruction, palliative resection may offer a survival advantage. However, this benefit diminishes in patients over 70 years of age. Additionally, resection is associated with a higher rate of stoma formation. Therefore, individualized treatment decisions are warranted when choosing between palliative resection and palliative stenting in metastatic colonic cancer patients.
Complications
Effects of prune consumption on the incidence of low anterior resection syndrome: a randomized controlled trial
Dae Hee Pyo, Jung Kyong Shin, Jung Wook Huh, Hee Cheol Kim, Seong Hyeon Yun, Woo Yong Lee, Yoonah Park, Yong Beom Cho
Ann Coloproctol. 2025;41(6):510-518.   Published online December 12, 2025
DOI: https://doi.org/10.3393/ac.2025.00514.0073
  • 6,295 View
  • 87 Download
  • 1 Citations
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Purpose
Low anterior resection syndrome (LARS) is common and devastating complication for patients with rectal cancer who have undergone sphincter-sparing surgery. Prunes are a fiber-rich fruit being effective in treating chronic constipation. The aim of this study was to investigate the effect of prune consumption on the incidence of LARS.
Methods
A prospective, double-arm, parallel, nonblinded, randomized controlled trial was conducted from September 2019 to March 2021 at a single tertiary center for patients who underwent low anterior resection. Patients randomized to the prune group consumed prune daily for 2 weeks after surgery, while those in the no-prune group did not. The primary outcome was the incidence of major LARS at 3 weeks after surgery.
Results
A total of 130 patients were randomized and 118 completed the study (81 men, 37 women), including 55 patients (46.6%) in the prune group and 63 patients (53.4%) in the no-prune group. LARS was confirmed in 15 patients (27.3%) in the prune group and 47 patients (74.6%) in the no-prune group (P<0.001). The incidence of major LARS was also significantly lower in the prune group (18.2% vs. 61.9%, P<0.001). Multivariable analysis showed that the level of anastomosis and prune consumption were significantly associated with the incidence of LARS. The prune group had higher emotional scores and lower symptom scores for constipation, sleep disturbance, and loss of appetite in the quality-of-life questionnaire.
Conclusion
Prune consumption significantly reduced the incidence of LARS and improved quality of life after low anterior resection. Trial registration: CRIS identifier: KCT0006085 (registered on September 1, 2019).

Citations

Citations to this article as recorded by  
  • Advances in Diagnosis and Treatment of Low Anterior Resection Syndrome in Chinese and Western Medicine
    小琴 彭
    Advances in Clinical Medicine.2026; 16(02): 2174.     CrossRef
Minimally invasive surgery
Comparative perioperative outcomes of articulated versus conventional straight devices in laparoscopic low anterior resection: a propensity score–matched analysis
Hayoung Lee, Yong Sik Yoon, Young Il Kim, Min Hyun Kim, Jong Lyul Lee, Chan Wook Kim, In Ja Park, Seok-Byung Lim
Ann Coloproctol. 2025;41(5):434-442.   Published online October 16, 2025
DOI: https://doi.org/10.3393/ac.2025.00227.0032
  • 1,378 View
  • 32 Download
  • 1 Citations
AbstractAbstract PDFSupplementary Material
Purpose
Laparoscopic low anterior resection for rectal cancer is technically challenging due to the precision required for mesorectal excision. Articulated instruments were developed to improve precision and oncological safety over conventional instruments. This study compares their perioperative outcomes.
Methods
A retrospective cohort study of 432 patients with colorectal cancer who underwent low anterior resection between August 2022 and February 2024 applied propensity score matching to minimize selection bias. Primary endpoints were circumferential resection margin (CRM), distal resection margin (DRM), and harvested lymph nodes count. Secondary outcomes included postoperative complications.
Results
Following propensity score matching, 84 matched pairs were analyzed. Most patients achieved CRM negativity (>1 mm), with CRM ≥10 mm in 67.9% of the articulated group and 59.5% of the conventional group (P=0.613). Median (interquartile range, IQR) lymph nodes harvests were comparable (20 [14–26] vs. 18 [14–22], P=0.147). The articulated group had a significantly longer DRM (30.0 mm [IQR, 18.0–40.0 mm] vs. 24.0 mm [IQR, 12.0–34.2 mm], P=0.008) and the median operation time (111.0 minutes [IQR, 95.8–125.2 minutes] vs. 99.5 minutes [IQR, 72.0–119.8 minutes], P=0.009). Estimated blood loss, open conversion rates, and postoperative complications, including leakage (7.1% vs. 8.3%, P>0.999) and surgical site infections, (15.5% vs. 9.5%, P=0.383), showed no significant differences.
Conclusion
Articulated laparoscopic instruments demonstrated comparable safety and feasibility to conventional instruments but offered no significant clinical or oncological benefits beyond a longer DRM. Larger studies are needed to evaluate their value in laparoscopic rectal surgery.

Citations

Citations to this article as recorded by  
  • Comparative perioperative outcomes of single-port laparoscopic ArtiSential versus da Vinci SP platform for totally extraperitoneal inguinal hernia repair: a multi-institutional, propensity score-matched analysis in Korea
    In Kyeong Kim, Moonjin Kim, Ji-Yeon Moon, Ri Na Yoo, Jumyeong Song, Chaedong Lim, Choon Sik Chung, Gwan Cheol Lee, Tae Gyu Kim, Young Sun Choi, Dong Geun Lee, Chul Seung Lee
    Journal of Minimally Invasive Surgery.2026; 29(1): 3.     CrossRef
Complications
Prevalence and clinical significance of evacuation disorders in patients with low anterior resection syndrome
Yuko Homma, Toshiki Mimura, Koji Koinuma, Hisanaga Horie, Naohiro Sata
Ann Coloproctol. 2025;41(4):271-278.   Published online August 25, 2025
DOI: https://doi.org/10.3393/ac.2024.00934.0133
  • 1,985 View
  • 58 Download
AbstractAbstract PDF
Purpose
Low anterior resection syndrome (LARS) manifests with evacuation disorder symptoms and continence problems. However, no prior study has focused on evacuation disorders in patients with LARS. This study investigated the prevalence of evacuation disorders and their association with the LARS score.
Methods
This study included patients with defecation per anus at the time of the survey, which was conducted between November 2020 and April 2021. These patients had undergone anus-preserving surgery for rectal tumors between 2014 and 2019 at a tertiary university hospital. The severity of evacuation disorders and LARS was evaluated using the Constipation Scoring System and the LARS score, respectively. The primary endpoint was the prevalence of evacuation disorders, defined as evacuation difficulty, feeling of incomplete evacuation, and abnormally long time on the toilet. The secondary endpoints were the associations between these symptoms and the LARS score.
Results
Of 332 eligible patients, 238 (71.7%) completed the questionnaire. The overall prevalence of evacuation disorders was 48.3%. The rates of feeling incomplete evacuation, evacuation difficulty, and prolonged time on the toilet were 45.6%, 15.5%, and 8.4%, respectively. Patients with minor or major LARS had a significantly higher prevalence of evacuation disorders than those with no LARS, particularly regarding feeling incomplete evacuation.
Conclusion
Evacuation disorders were present in 48.3% of patients following anus-preserving surgery. Greater severity of LARS was associated with a higher prevalence of evacuation disorders, especially a feeling of incomplete evacuation. Patients should be informed about the potential for both evacuation disorders and continence-related symptoms following anus-preserving surgery.
Colonoscopy
Endoscopic treatment of rectal neuroendocrine tumors: a consecutive analysis of multi-institutional data
Jae Won Shin, Eun-Jung Lee, Sung Sil Park, Kyung Su Han, Chang Gyun Kim, Hee Chul Chang, Won Youn Kim, Eui Chul Jeong, Dong Hyun Choi
Ann Coloproctol. 2025;41(3):221-231.   Published online June 30, 2025
DOI: https://doi.org/10.3393/ac.2024.00927.0132
  • 7,141 View
  • 97 Download
  • 3 Web of Science
  • 3 Citations
AbstractAbstract PDF
Purpose
The incidence of rectal neuroendocrine tumors (NETs) is increasing owing to a rise in colonoscopy screening. For the endoscopic removal of NETs, complete resection including the submucosal layer is essential. Therefore, appropriate endoscopic resection techniques are of critical importance. This study aimed to analyze data on rectal NETs and help provide guidance for their endoscopic treatment.
Methods
A retrospective analysis was conducted on data from patients who underwent resection for rectal NETs at 6 institutions between 2010 and 2021.
Results
A total of 1,406 tumors were resected from 1,401 patients. During a mean follow-up period of 55.4 months, there were 8 cases (0.5%) of recurrence. Overall, a complete resection was achieved in 77.6% of the patients, with modified endoscopic mucosal resection (mEMR) and endoscopic submucosal dissection (ESD) showing the highest rate at 86.0% and 84.9%, respectively, followed by conventional EMR (cEMR; 68.7%) and snare polypectomy (59.0%). In the subgroup analysis, statistically significant differences were observed in complete resection rates based on tumor size. ESD and mEMR demonstrated significantly higher complete resection rates compared with cEMR. Univariate and multivariate analyses showed that tumor location of the lower rectum and advanced techniques (mEMR and ESD) were significant prognostic factors for complete resection rates.
Conclusion
When encountering rectal subepithelial lesions on endoscopic examination, endoscopists should consider the possibility of NETs and carefully decide on the endoscopic treatment method. Therefore, it is advisable to perform mEMR or ESD to achieve complete resection, especially for rectal NETs measuring ≤10 mm.

Citations

Citations to this article as recorded by  
  • Defining endoscopic candidacy for intermediate size rectal neuroendocrine tumors
    Yu-Hang Sheng, Qi-Yang Chen, Xiao-Meng Li, Zhi-Xiang Zhou, Tian-Le Xue
    World Journal of Gastroenterology.2026;[Epub]     CrossRef
  • Efficacy, Safety and Oncological Outcomes of Minimally Invasive Approaches (EMR, ESD and TAMIS) for Early Rectal Tumors: A Systematic Review and Meta-Analysis
    Mariam Hussain, Fatima Kayali, Abdelaziz O Surkhi, Roy Shartouni, Thurkga Moothathamby, Ahmed Akmal, Rohan Vyas, Leen Ammari, Ibrahim Sharaf, Mona Jaffar-Karballai, Mohamed Refaie, Yousif Jubouri, Matti Jubouri, Mohamad Bashir, Ali Murtada
    Medical Devices: Evidence and Research.2026; Volume 19: 1.     CrossRef
  • Long-term outcomes of endoscopic resection of 1-1.5 cm sized grade 1 rectal neuroendocrine tumor: A retrospective study
    Minjee Kim, Yuwon Kim, Ji Eun Kim, Sung Noh Hong, Dong Kyung Chang, Young-Ho Kim, Eun Ran Kim
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
ERAS
Early urinary catheter removal in patients undergoing rectal cancer surgery: a randomized controlled trial on silodosin versus no pharmacological treatment on urinary function in the early postoperative period
Žilvinas Gricius, Justas Kuliavas, Eugenijus Stratilatovas, Bronius Buckus, Audrius Dulskas
Ann Coloproctol. 2025;41(3):239-245.   Published online June 20, 2025
DOI: https://doi.org/10.3393/ac.2024.00703.0100
  • 4,413 View
  • 80 Download
  • 1 Web of Science
  • 1 Citations
AbstractAbstract PDF
Purpose
This study aimed to evaluate the efficacy of the α1 adrenergic receptor antagonist silodosin in preventing lower urinary tract symptoms after rectal cancer surgery.
Methods
We conducted a 2-arm, double-blind, single-center randomized controlled trial. The study included 150 patients with rectal cancer who underwent radical surgery between 2019 and 2022. On the first postoperative day, the urinary catheter was removed for all patients. Of these, 100 patients were administered silodosin, while 50 patients (control group) receive placebo (glucose tablet). Urinary dysfunction (urinary retention, infection, dysuria) and other complications were monitored.
Results
Among the 150 patients, 84 (56.0%) were male and 66 (44.0%) were female. Surgical procedures included abdominoperineal resection in 33 patients, partial mesorectal excision in 45, and total mesorectal excision in 72. A laparoscopic approach was used in 69 patients, while the remaining 81 underwent open surgery. Urinary tract symptoms developed in 10 patients (6.7%): 7 (7.0%) in the silodosin group and 3 (6.0%) in the control group (P=0.92). In the silodosin group, there was 1 case (1.0%) of urinary retention, 3 cases (3.0%) of urinary tract infection, and 3 cases (3.0%) of dysuria. In the control group, there was 1 case (2.0%) each of urinary retention, urinary tract infection, and dysuria (all P=0.92).
Conclusion
Early urinary catheter removal on the first postoperative day was safe in both groups. The use of the oral α-antagonist silodosin did not provide additional benefits in preventing lower urinary tract symptoms in patients undergoing rectal cancer surgery. Trial registration: ClinicalTrials.gov identifier: NCT03607370

Citations

Citations to this article as recorded by  
  • Less is more: simplifying patient-centered cancer care
    In Ja Park
    Annals of Coloproctology.2025; 41(3): 173.     CrossRef
Translational/basic research
The effect of tumor resection on intestinal microbiota dysbiosis in patients with right-sided colon cancer
Aldhimas Marthsyal Pratikna, M. Iqbal Rivai, Rini Suswita, Andani Eka Putra, Irwan Abdul Rachman, Avit Suchitra
Ann Coloproctol. 2025;41(1):47-56.   Published online February 26, 2025
DOI: https://doi.org/10.3393/ac.2024.00346.0049
  • 3,878 View
  • 161 Download
  • 2 Citations
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Purpose
This study aimed to determine the effect of tumor resection on dysbiosis of the intestinal microbiota in patients with right-sided colon cancer.
Methods
This study utilized a longitudinal design to explore the outcomes of patients diagnosed with right-sided colon cancer who underwent surgical resection at Dr. M. Djamil General Hospital from July to December 2023. We excluded patients with a documented history of comorbidities, specifically those affecting the digestive system. To compare the microbiota (genus and phylum) between patients with right-sided colon cancer and the control group, we conducted bivariate analyses using the independent t-test or Mann-Whitney test. Furthermore, we employed the dependent t-test or Wilcoxon test to assess changes in the dysbiosis of the microbiota (genus and phylum) before and after resection. A P-value of <0.05 was considered statistically significant.
Results
This study included a total of 21 patients diagnosed with right-sided colon cancer. In the control group, Bacteroidetes constituted the highest proportion of intestinal microbiota, accounting for 56.34%. Prior to tumor resection, the intestinal microbiota of patients exhibited Proteobacteria as the predominant phylum, representing 52.97%. Following tumor resection, Bacteroidetes remained the most prevalent, comprising 50.9% of the intestinal microbiota. Significant variations in the levels of Proteobacteria, Verrucomicrobia, and Cyanobacteria/Chloroplast were observed in the intestinal microbiota of patients with right-sided colorectal cancer before and after tumor excision (all P=0.001).
Conclusion
The microbiome of patients with right-sided colorectal cancer differed significantly from that of the control group. However, following tumor resection, the microbiome composition of these patients became more similar to that observed in the control group.

Citations

Citations to this article as recorded by  
  • Dynamics of the microbiota in right-sided colon cancer patients: pre- and post-tumor resection
    Youn Young Park
    Annals of Coloproctology.2025; 41(1): 1.     CrossRef
  • 大腸癌周術期におけるONSのエビデンスと意義
    岳史 山田, 明久 松田, 圭 上原, 寛 吉田
    The Japanese Journal of SURGICAL METABOLISM and NUTRITION.2025; 59(4): 96.     CrossRef
Review
Colorectal cancer
Beyond survival: a comprehensive review of quality of life in rectal cancer patients
Won Beom Jung
Ann Coloproctol. 2024;40(6):527-537.   Published online December 20, 2024
DOI: https://doi.org/10.3393/ac.2024.00745.0106
  • 11,529 View
  • 200 Download
  • 7 Web of Science
  • 7 Citations
AbstractAbstract PDF
Rectal cancer is one of the most common carcinomas and a leading cause of cancer-related mortality. Although significant advancements have been made in the treatment of rectal cancer, the deterioration of quality of life (QoL) remains a challenging issue. Various tools have been developed to assess QoL, including the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) scale, the QLQ-C30 and QLQ-CR29 by the European Organization for Research and Treatment of Cancer (EORTC), and the 36-Item Short Form Health Survey (SF-36). Factors such as the lower location of the tumor, radiation therapy, chemoradiotherapy, and chemotherapy are associated with a decline in QoL. Furthermore, anastomotic leakage following rectal cancer resection is an important risk factor affecting QoL. With the development of novel treatment approaches, including neoadjuvant therapies such as chemoradiotherapy and total neoadjuvant therapy, the rate of clinical complete remission has increased, leading to the emergence of organ-preserving strategies. Both local excision and the “watch-and-wait” approach following neoadjuvant therapy improved functional outcomes and QoL. Efforts to improve QoL after rectal cancer surgery are ongoing in surgical techniques for rectal cancer. Since QoL is determined by a complex interplay of factors, including the patient's physical condition, surgical techniques, and psychological and social elements, a comprehensive approach is necessary to understand and enhance it. This review aims to describe the methods for measuring QoL in rectal cancer patients after surgery, the key risk factors involved, and various strategies and efforts to improve QoL outcomes.

Citations

Citations to this article as recorded by  
  • Quality of Life and Functional Outcomes After Rectal Cancer Surgery: A Comparative Study Applying EORTC QLQ-C30, QLQ-CR29, and LARS Score at 1–6 Months Postoperatively
    Floris Cristian Stanculea, Claudiu O. Ungureanu, Octav Ginghina, Razvan A. Stoica, Raul Mihailov, Valerii Lutenco, Valentin T. Grigorean, Mircea Litescu, Niculae Iordache
    Healthcare.2026; 14(9): 1203.     CrossRef
  • Watch‑and‑wait in rectal cancer: A critical appraisal of promise, perils and unresolved contours of organ preservation (Review)
    Xinqiang Zhu, Beibei Ge, Linchun Wen, Siwei Shan
    Oncology Letters.2026; 32(1): 1.     CrossRef
  • Meeting report on the 8th Asian Science Editors’ Conference and Workshop 2024
    Eun Jung Park
    Science Editing.2025; 12(1): 66.     CrossRef
  • Editorial: Organ preservation for rectal cancer patients
    Ionut Negoi, John R. T. Monson, Leonardo Bustamante-Lopez, Zoe Garoufalia, Vito D'Andrea, Sameh Hany Emile
    Frontiers in Surgery.2025;[Epub]     CrossRef
  • Sphincter-preserving surgical techniques in low rectal cancer management: A systematic review of contemporary evidence
    Song Wang, A-Jian Li, Hui-Hong Jiang, Yin Lin, Hai-Bo Ding
    World Journal of Gastrointestinal Surgery.2025;[Epub]     CrossRef
  • Non-operative management of locally advanced rectal cancer with an emphasis on outcomes and quality of life: a narrative review
    In Ja Park
    Ewha Medical Journal.2025; 48(3): e40.     CrossRef
  • Strategies to reduce intestinal toxicity in neoadjuvant management of locally advanced rectal cancer
    Hoda Mahdavi, Sahar Dashti, Shima Jafari
    Discover Oncology.2025;[Epub]     CrossRef
Original Articles
Anorectal benign disease
Long-term outcomes of sacral neuromodulation for low anterior resection syndrome after rectal cancer surgery
Mario J. de Miguel Valencia, Gabriel Marin, Ana Acevedo, Ana Hernando, Alfonso Álvarez, Fabiola Oteiza, Mario J. de Miguel Velasco
Ann Coloproctol. 2024;40(3):234-244.   Published online June 25, 2024
DOI: https://doi.org/10.3393/ac.2023.00542.0077
  • 8,410 View
  • 248 Download
  • 2 Web of Science
  • 3 Citations
AbstractAbstract PDF
Purpose
This study assessed the long-term outcomes and quality of life in patients who underwent sacral neuromodulation (SNM) due to low anterior resection syndrome (LARS).
Methods
This single-center retrospective study, conducted from 2005 to 2021, included 30 patients (21 men; median age, 70 years) who had undergone total mesorectal excision with stoma closure and had no recurrence at inclusion. All patients were diagnosed with LARS refractory to conservative treatment. We evaluated clinical and quality-of-life outcomes after SNM through a stool diary, Wexner score, LARS score, the Fecal Incontinence Quality of Life (FIQL) questionnaire, and EuroQol-5D (EQ-5D) questionnaire.
Results
Peripheral nerve stimulation was successful in all but one patient. Of the 29 patients who underwent percutaneous nerve evaluation, 17 (58.62%) responded well to SNM and received permanent implants. The median follow-up period was 48 months (range, 18–153 months). The number of days per week with fecal incontinence episodes decreased from a median of 7 (range, 2–7) to 0.38 (range, 0–1). The median number of bowel movements recorded in patient diaries fell from 5 (range, 4–12) to 2 (range, 1–6). The median Wexner score decreased from 18 (range, 13–20) to 6 (range, 0–16), while the LARS score declined from 38.5 (range, 37–42) to 19 (range, 4–28). The FIQL and EQ-5D questionnaires demonstrated enhanced quality of life.
Conclusion
SNM may benefit patients diagnosed with LARS following rectal cancer surgery when conservative options have failed, and the treatment outcomes may possess long-term sustainability.

Citations

Citations to this article as recorded by  
  • Advances in Diagnosis and Treatment of Low Anterior Resection Syndrome in Chinese and Western Medicine
    小琴 彭
    Advances in Clinical Medicine.2026; 16(02): 2174.     CrossRef
  • Tertiary lymphoid structures guided opportunities and challenges for immunotherapy in early gastroesophageal junction cancer and low rectal cancer
    Qi Zou, Yongjian Zhang, Zhenyu Xian, Zhen Fang, Jizhun Zhang, Liang Shang, Heng Wang, Bang Hu, Zixu Chen
    Human Vaccines & Immunotherapeutics.2026;[Epub]     CrossRef
  • Low Anterior Resection Syndrome (LARS): A Contemporary Surgical Review of Incidence, Pathophysiology, Risk Stratification and Functional Outcomes
    Supreet Kumar, Vivek Tandon, Deepak Govil
    Apollo Medicine.2025;[Epub]     CrossRef
Colorectal cancer
Long-term bowel functional outcomes following anal sphincter-preserving surgery for upper and middle rectal cancer: a single-center longitudinal study
Ahmad Sakr, Seung Yoon Yang, Min Soo Cho, Hyuk Hur, Byung Soh Min, Kang Young Lee, Nam Kyu Kim
Ann Coloproctol. 2024;40(1):27-35.   Published online February 28, 2024
DOI: https://doi.org/10.3393/ac.2022.01067.0152
  • 6,692 View
  • 216 Download
  • 3 Web of Science
  • 3 Citations
AbstractAbstract PDF
Purpose
Despite advances in neoadjuvant chemoradiotherapy and anal sphincter-preserving surgery for rectal cancer, bowel dysfunction is still unavoidable and negatively affects patients’ quality of life. In this longitudinal study, we aimed to investigate the changes in bowel function with follow-up time and the effect of neoadjuvant chemoradiotherapy on bowel function following low anterior resection for rectal cancer.
Methods
In this study, 171 patients with upper or middle rectal cancer who underwent low anterior resection between 2012 and 2018 were included. Bowel function was assessed longitudinally with Memorial Sloan Kettering Cancer Center Bowel Function Instrument and Wexner scores every 6 months after restoration of bowel continuity. Patients with at least 2 follow-up visits were included.
Results
Overall, 100 patients received neoadjuvant chemoradiotherapy. Urgency, soilage, and fecal incontinence were noted within 24 months in the patients treated with neoadjuvant chemoradiotherapy. After 2 years of follow-up, significant bowel dysfunction and fecal incontinence were observed in the neoadjuvant chemoradiotherapy group. Low tumor level and neoadjuvant chemoradiotherapy were associated with delayed bowel dysfunction.
Conclusion
Neoadjuvant chemoradiotherapy in combination with low tumor level was significantly associated with delayed bowel dysfunction even after 2 years of follow-up. Therefore, careful selection and discussion with patients are paramount.

Citations

Citations to this article as recorded by  
  • Funktionelle Folgen von Radiotherapie, Chemotherapie und Operation bei der Behandlung des Rektumkarzinoms
    Philipp Rhode, Matthias Mehdorn, Undine Gabriele Lange, Sebastian Murad Rabe, Johannes Quart, Robert Nowotny, Patrick Sven Plum, Stefan Niebisch, Sigmar Stelzner
    Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie.2025; 150(04): 353.     CrossRef
  • Efficacy of Neoadjuvant Hypofractionated Chemoradiotherapy in Elderly Patients with Locally Advanced Rectal Cancer: A Single-Center Retrospective Analysis
    Jae Seung Kim, Jaram Lee, Hyeung-min Park, Soo Young Lee, Chang Hyun Kim, Hyeong Rok Kim
    Cancers.2024; 16(24): 4280.     CrossRef
  • Beyond survival: a comprehensive review of quality of life in rectal cancer patients
    Won Beom Jung
    Annals of Coloproctology.2024; 40(6): 527.     CrossRef
Colorectal cancer
Impact of consolidation chemotherapy in poor responders to neoadjuvant radiation therapy: magnetic resonance imaging–based clinical-radiological correlation in high-risk rectal cancers
Swapnil Patel, Suman Ankathi, Purvi Haria, Mufaddal Kazi, Ashwin L. Desouza, Avanish Saklani
Ann Coloproctol. 2023;39(6):474-483.   Published online December 21, 2023
DOI: https://doi.org/10.3393/ac.2023.00080.0011
  • 4,325 View
  • 123 Download
  • 4 Web of Science
  • 4 Citations
AbstractAbstract PDF
Purpose
The current study was conducted to examine the role of consolidation chemotherapy after neoadjuvant radiation therapy (NART) in decreasing the involvement of the mesorectal fascia (MRF) in high-risk locally advanced rectal cancers (LARCs).
Methods
In total, 46 patients who received consolidation chemotherapy after NART due to persistent MRF involvement were identified from a database. A team of 2 radiologists, blinded to the clinical data, studied sequential magnetic resonance imaging (MRI) scans to assess the tumor response and then predict a surgical plan. This prediction was then correlated with the actual procedure conducted as well as histopathological details to assess the impact of consolidation chemotherapy.
Results
The comparison of MRI-based parameters of sequential images showed significant downstaging of T2 signal intensity, tumor height, MRF involvement, diffusion restriction, and N category between sequential MRIs (P < 0.05). However, clinically relevant downstaging (standardized mean difference, > 0.3) was observed for only T2 signal intensity and diffusion restriction on diffusion-weighted imaging. No clinically relevant changes occurred in the remaining parameters; thus, no change was noted in the extent of surgery predicted by MRI. Weak agreement (Cohen κ coefficient, 0.375) and correlation (Spearman rank coefficient, 0.231) were found between MRI-predicted surgery and the actual procedure performed. The comparison of MRI-based and pathological tumor response grading also showed a poor correlation.
Conclusion
Evidence is lacking regarding the use of consolidation chemotherapy in reducing MRF involvement in LARCs. The benefit of additional chemotherapy after NART in decreasing the extent of planned surgery by reducing margin involvement requires prospective research.

Citations

Citations to this article as recorded by  
  • Diagnostic accuracy of magnetic resonance imaging for rectal cancer: is it time to reassess the gold standard?
    Tan Jih Huei, Emile John Tan Kwong Wei
    Annals of Coloproctology.2026; 42(2): 256.     CrossRef
  • Survival benefit of adjuvant chemotherapy in high-risk patients with colon cancer regardless of microsatellite instability
    Sung Uk Bae, Jong Lyul Lee, Chun-Seok Yang, Eun Jung Park, Soo Yeun Park, Chang Woo Kim, Woong Bae Ji, Gyung Mo Son, Yoon Dae Han, So Hyun Kim, Min Sung Kim, Youn Young Park, Kyung Ha Lee, Chang Hyun Kim, Gi Won Ha, JaeIm Lee, Kyeong Eui Kim, Woon Kyung J
    European Journal of Surgical Oncology.2025; 51(6): 109674.     CrossRef
  • Non-operative management of locally advanced rectal cancer with an emphasis on outcomes and quality of life: a narrative review
    In Ja Park
    Ewha Medical Journal.2025; 48(3): e40.     CrossRef
  • The conundrum of total neoadjuvant therapy in rectal cancer
    Devesh S. Ballal, Tejas P. Vispute, Avanish P. Saklani
    Colorectal Disease.2024; 26(5): 1068.     CrossRef
Case Report
Colorectal cancer
Treatment of side limb full-thickness prolapse of the side-to-end coloanal anastomosis following intersphincteric resection: a case report and review of literature
Guglielmo Niccolò Piozzi, Krunal Khobragade, Seon Hui Shin, Jeong Min Choo, Seon Hahn Kim
Ann Coloproctol. 2024;40(Suppl 1):S38-S43.   Published online February 8, 2023
DOI: https://doi.org/10.3393/ac.2022.00829.0118
  • 4,669 View
  • 116 Download
  • 1 Citations
AbstractAbstract PDF
Intersphincteric resection (ISR) with coloanal anastomosis is an oncologically safe anus-preserving technique for very low-lying rectal cancers. Most studies focused on oncological and functional outcomes of ISR with very few evaluating long-term postoperative anorectal complications. Full-thickness prolapse of the neorectum is a relatively rare complication. This report presents the case of a 70-year-old woman presenting with full-thickness prolapse of the side limb of the side-to-end coloanal anastomosis occurring 2 weeks after the stoma closure and 2 months after a robotic partial ISR performed with the Da Vinci single-port platform. The anastomosis was revised through resection of the side limb and conversion of the side-to-end anastomosis into an end-to-end handsewn anastomosis with interrupted stitches. This study describes the first case of full-thickness prolapse of the side limb of the side-to-end handsewn coloanal anastomosis following ISR. Moreover, a revision of all reported cases of post-ISR full-thickness and mucosal prolapse was performed.

Citations

Citations to this article as recorded by  
  • International standardization and optimization group for intersphincteric resection (ISOG‐ISR): modified Delphi consensus on anatomy, definition, indication, surgical technique, specimen description and functional outcome
    Guglielmo Niccolò Piozzi, Krunal Khobragade, Vusal Aliyev, Oktar Asoglu, Paolo Pietro Bianchi, Vlad‐Olimpiu Butiurca, William Tzu‐Liang Chen, Ju Yong Cheong, Gyu‐Seog Choi, Andrea Coratti, Quentin Denost, Yosuke Fukunaga, Emre Gorgun, Francesco Guerra, Ma
    Colorectal Disease.2023; 25(9): 1896.     CrossRef
Original Articles
Colorectal cancer
Validation of the Vietnamese version of the low anterior resection syndrome score questionnaire
Tuong-Anh Mai-Phan, Vu Quang Pham
Ann Coloproctol. 2024;40(6):588-593.   Published online November 25, 2022
DOI: https://doi.org/10.3393/ac.2022.00514.0073
  • 6,221 View
  • 103 Download
  • 2 Web of Science
  • 2 Citations
AbstractAbstract PDFSupplementary Material
Purpose
The aim of this study was to validate the low anterior resection syndrome (LARS) score questionnaire in the Vietnamese language among Vietnamese patients who underwent sphincter-preserving surgery for rectal cancer.
Methods
The LARS score questionnaire was translated from English into Vietnamese and then back-translated as recommended internationally. From January 2018 to December 2020, 93 patients who underwent sphincter-preserving surgery completed the Vietnamese version of the LARS score questionnaire together with an anchored question assessing the influence of bowel function on quality of life. To validate test-retest reliability, patients were requested to answer the LARS score questionnaire twice.
Results
Ninety-three patients completed the LARS score questionnaire, of whom 89 responded twice. The patients who responded twice were included in the analysis of test-retest reliability. Fifty-eight patients had a “major” LARS score. The LARS score was able to discriminate between patients who were obese and those who were not (P<0.001) and between the LAR and AR procedures (P<0.001). Age and sex were not associated with higher LARS scores (P=0.975). There was a perfect fit between the quality of life category question and the LARS score in 56.2% of cases, and a moderate fit was found in 42.7% of cases, showing reasonable convergent validity. The test-retest reliability of 89 patients showed a high intraclass correlation coefficient.
Conclusion
The Vietnamese version of the LARS score questionnaire is a valid tool for measuring LARS.

Citations

Citations to this article as recorded by  
  • Longitudinal evolution of low anterior resection syndrome in ultra-low rectal cancer: A trend analysis of a propensity-matched cohort
    Han-Shuo Wang, Yu-Xin Lin, Si-Rui Xu, Li-Ya Wang, Xiao-Dong Wang, Ming-Jun Huang
    World Journal of Gastroenterology.2026;[Epub]     CrossRef
  • Major Low Anterior Resection Syndrome (LARS) and Quality of Life in Patients With Low Rectal Cancer: A Preoperative Survey Using LARS Score and European Organisation for Research and Treatment of Cancer’s 30-Item Core Quality of Life Questionnaire
    Ly Huu Phu, Ho Tat Bang, Nguyen Viet Binh, Hoang Danh Tan, Ung Van Viet, Nguyen Trung Tin
    Cureus.2023;[Epub]     CrossRef
Anorectal physioloy
Risk factors associated with low anterior resection syndrome: a cross-sectional study
See Liang Lim, Wan Zainira Wan Zain, Zalina Zahari, Andee Dzulkarnaen Zakaria, Mohd Nizam Md Hashim, Michael Pak-Kai Wong, Zaidi Zakaria, Rosnelifaizur Ramely, Ahmad Shanwani Mohamed Sidek
Ann Coloproctol. 2023;39(5):427-434.   Published online June 3, 2022
DOI: https://doi.org/10.3393/ac.2022.00227.0032
  • 11,227 View
  • 229 Download
  • 13 Web of Science
  • 9 Citations
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary Material
Purpose
Oncological outcomes following rectal cancer surgery have improved significantly over recent decades with lower recurrences and longer overall survival. However, many of the patients experienced low anterior resection syndrome (LARS). This study identified the prevalence and risk factors associated with the development of LARS.
Methods
This cross-sectional study involved patients who were diagnosed with rectal cancer and had undergone sphincter-preserving low anterior resection from January 2011 to December 2020. Upon clinic follow-up, patients were asked to complete an interviewed based questionnaire (LARS score) designed to assess bowel dysfunction after rectal cancer surgery.
Results
Out of 76 patients, 25 patients (32.9%) had major LARS, 10 patients (13.2%) had minor LARS, and 41 patients (53.9%) had no LARS. The height of tumor from anal verge showed an association with the development of major LARS (P=0.039). Those patients with less than 8 cm tumor from anal verge had an increased risk of LARS by 3 times compared to those with 8 cm and above (adjusted odds ratio, 3.11; 95% confidence interval, 1.06–9.13).
Conclusion
Results from our study show that low tumor height was a significant risk factor that has a negative impact on bowel function after surgery. The high prevalence of LARS emphasizes the need for study regarding risk factors and the importance of understanding the pathophysiology of LARS, in order for us to improve patient bowel function and quality of life after rectal cancer surgery.

Citations

Citations to this article as recorded by  
  • Longitudinal evolution of low anterior resection syndrome in ultra-low rectal cancer: A trend analysis of a propensity-matched cohort
    Han-Shuo Wang, Yu-Xin Lin, Si-Rui Xu, Li-Ya Wang, Xiao-Dong Wang, Ming-Jun Huang
    World Journal of Gastroenterology.2026;[Epub]     CrossRef
  • Score assessment and treatment in patients presenting with low anterior resection syndrome after sphincter-sparing rectal cancer surgery
    R. Sguinzi, J. Fiechter, L. Bafumi, B. Gremaud, B. Geng, P. Janiak, L. Bühler, B. Egger
    International Journal of Colorectal Disease.2025;[Epub]     CrossRef
  • A randomized controlled trial of a digital lifestyle intervention involving postoperative patients with colorectal cancer
    Young Il Kim, In Ja Park, Jun-Soo Ro, Jong Lyul Lee, Chan Wook Kim, Yong Sik Yoon, Seok-Byung Lim, Chang Sik Yu, Yura Lee, Yae Won Tak, Seockhoon Chung, Kyung Won Kim, Yousun Ko, Sung-Cheol Yun, Min-Woo Jo, Jong Won Lee
    npj Digital Medicine.2025;[Epub]     CrossRef
  • Impact of low anterior resection syndrome after rectal surgery on sleep quality
    Akira Toyoshima, Toshihiro Nishizawa, Osamu Toyoshima, Ryuji Akai, Manabu Kaneko, Shin Sasaki
    Surgery Today.2025; 55(12): 1868.     CrossRef
  • Evaluation of the utility of a nomogram for predicting lymph node metastasis in T1 colorectal cancer in shared decision-making in clinical practice: a survey-based study
    Hyeon Seung Kim, Kyung Su Han, Min Wan Lee, Dae Kyung Sohn, Chang Won Hong, Dong Woon Lee, Kiho You, Sung Chan Park, Byung Chang Kim, Bun Kim, Jae Hwan Oh
    Annals of Coloproctology.2025; 41(4): 303.     CrossRef
  • Comparative analysis of organ preservation attempt and radical surgery in clinical T2N0 mid to low rectal cancer
    Hyeung-min Park, Jaram Lee, Soo Young Lee, Chang Hyun Kim, Hyeong Rok Kim
    International Journal of Colorectal Disease.2024;[Epub]     CrossRef
  • Beyond survival: a comprehensive review of quality of life in rectal cancer patients
    Won Beom Jung
    Annals of Coloproctology.2024; 40(6): 527.     CrossRef
  • Organ preservation for early rectal cancer using preoperative chemoradiotherapy
    Gyung Mo Son
    Annals of Coloproctology.2023; 39(3): 191.     CrossRef
  • Low anterior resection syndrome: is it predictable?
    Dong Hyun Kang
    Annals of Coloproctology.2023; 39(5): 373.     CrossRef
Anorectal physioloy
Validation of low anterior resection syndrome score in Brazil with Portuguese
Kelly C.L.R. Buzatti, Andy Petroianu, Søren Laurberg, Rodrigo G. Silva, Beatriz D.S. Rodrigues, Peter Christensen, Antonio Lacerda-Filho, Therese Juul
Ann Coloproctol. 2023;39(5):402-409.   Published online May 13, 2022
DOI: https://doi.org/10.3393/ac.2022.00136.0019
  • 7,445 View
  • 150 Download
  • 6 Web of Science
  • 4 Citations
AbstractAbstract PDF
Purpose
This study was performed to investigate the convergent validity, discriminative validity, and reliability of the Brazilian version of the low anterior resection syndrome (LARS) score in a population with low educational and socioeconomic levels.
Methods
The LARS score was translated into the Portuguese language by forward- and back-translation procedures. In total, 127 patients from a public hospital in Brazil completed the questionnaires. The convergent validity was tested by comparing the LARS score with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core Module 30 (QLQ-C30) and with patients’ self-reported quality of life. For the discriminative validity, we tested the ability of the score to differentiate among subgroups of patients regarding neoadjuvant radiotherapy, type of surgery, and tumor distance from the anal verge. The test-retest reliability was investigated in a subgroup of 36 patients who responded to the survey twice in 2 weeks.
Results
The LARS score demonstrated a strong correlation with 5 of 6 items from the EORTC QLQ-C30 (P<0.05) and good concordance with patients’ self-reported quality of life (95.3%), confirming the convergent validity. The score was able to discriminate between subgroups of patients with different clinical characteristics related to LARS (P<0.001). The agreement between the test and retest showed that 86.1% of the patients remained in the same LARS category, and there was no significant difference between the LARS score numerical values (P=0.80), indicating good reliability overall.
Conclusion
The Brazilian version of the LARS score is a valid and reliable instrument to assess postoperative bowel function in a population with low educational and socioeconomic levels.

Citations

Citations to this article as recorded by  
  • Longitudinal evolution of low anterior resection syndrome in ultra-low rectal cancer: A trend analysis of a propensity-matched cohort
    Han-Shuo Wang, Yu-Xin Lin, Si-Rui Xu, Li-Ya Wang, Xiao-Dong Wang, Ming-Jun Huang
    World Journal of Gastroenterology.2026;[Epub]     CrossRef
  • Effects of low anterior resection syndrome after colorectal cancer resections on health-related quality of life: a systematic review and meta-analysis
    S. Shojaei-Zarghani, K. Gorgi, A. Bananzadeh, A. R. Safarpour, S. V. Hosseini
    Techniques in Coloproctology.2025;[Epub]     CrossRef
  • Validation of the Vietnamese version of the low anterior resection syndrome score questionnaire
    Tuong-Anh Mai-Phan, Vu Quang Pham
    Annals of Coloproctology.2024; 40(6): 588.     CrossRef
  • Beyond survival: a comprehensive review of quality of life in rectal cancer patients
    Won Beom Jung
    Annals of Coloproctology.2024; 40(6): 527.     CrossRef
Review
Malignant disease, Rectal cancer ,Functional outcomes,Colorectal cancer,Minimally invasive surgery
Robotic Intersphincteric Resection for Low Rectal Cancer: Technical Controversies and a Systematic Review on the Perioperative, Oncological, and Functional Outcomes
Guglielmo Niccolò Piozzi, Seon Hahn Kim
Ann Coloproctol. 2021;37(6):351-367.   Published online November 17, 2021
DOI: https://doi.org/10.3393/ac.2021.00836.0119
  • 12,730 View
  • 229 Download
  • 49 Web of Science
  • 51 Citations
AbstractAbstract PDF
Intersphincteric resection (ISR) is the ultimate anus-sparing technique for low rectal cancer and is considered an oncologically safe alternative to abdominoperineal resection. The application of the robotic approach to ISR (RISR) has been described by few specialized surgical teams with several differences regarding approach and technique. This review aims to discuss the technical aspects of RISR by evaluating point by point each surgical controversy. Moreover, a systematic review was performed to report the perioperative, oncological, and functional outcomes of RISR. Postoperative morbidities after RISR are acceptable. RISR allows adequate surgical margins and adequate oncological outcomes. RISR may result in severe bowel and genitourinary dysfunction affecting the quality of life in a portion of patients.

Citations

Citations to this article as recorded by  
  • Clinical progress and technological innovations in sphincter-preserving treatment for ultra-low rectal cancer
    Fan Wu, Xiaojun Shen
    Frontiers in Oncology.2026;[Epub]     CrossRef
  • Chinese expert consensus on robotic surgery for colorectal cancer (2025 edition)
    Xishan Wang, Jianmin Xu, Yanbing Zhou, Hongliang Yao, Dehai Xiong, Junjun She, Wenqi Bai, Guohao Cai, Chuangqi Chen, Gang Chen, Haipeng Chen, Zongyou Chen, Longwei Cheng, Yong Cheng, Pan Chi, Zhaocheng Chi, Binbin Cui, Chengxue Dang, Kefeng Ding, Peirong
    Clinical Cancer Bulletin.2026;[Epub]     CrossRef
  • Comparison of Clinical Outcomes Between Da Vinci Robot-Assisted and Laparoscopic Intersphincteric Resection for Ultra-Low Rectal Cancer
    ChangZhong Fang, Jiming Lian, Nanhui Yu, Shuang Liu
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2026; 36(6): 423.     CrossRef
  • Rectal Eversion as an Anus-sparing Technique in Laparoscopic Low Anterior Resection With Double Stapling Anastomosis: Long-term Functional Results
    Servet Karagul, Serdar Senol, Oktay Karakose, Huseyin Eken, Cuneyt Kayaalp
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2025;[Epub]     CrossRef
  • Robotic surgery versus laparoscopic surgery for rectal cancer: a comparative study on surgical safety and functional outcomes
    Li TengTeng, Fu HaiXiao, Fu Wei, Zhang Xuan
    ANZ Journal of Surgery.2025; 95(1-2): 156.     CrossRef
  • The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer
    Danni Li, Xi Xiong, Pan Diao, Jitao Hu, Wenbo Niu, Guiying Wang, Baokun Li
    Current Treatment Options in Oncology.2025; 26(2): 84.     CrossRef
  • Long-term functional and prognostic outcomes of robotic intersphincteric resection for treating low rectal cancer: a single-center retrospective study
    Yang Bo, Wang Yigao, Zheng Mingye, Jian Zhao, Yongxiang Li
    International Journal of Colorectal Disease.2025;[Epub]     CrossRef
  • Comparison of laparoscopic versus robot-assisted sugery for rectal cancer after neo-adjuvant therapy: a large volume single center experience
    Heyuan Zhu, Jingyu Zou, Hongfeng Pan, Ying Huang, Pan Chi
    BMC Surgery.2025;[Epub]     CrossRef
  • Construction of a risk factor prediction model for postoperative complications in elderly patients with colorectal cancer using machine learning
    Changzhong Fang, Wenbin Shi, Yu Qiao, Shuwen Deng, Gen Liang, Binbin Huang, Wenjuan Gao, Jiming Lian, Nanhui Yu
    Journal of Robotic Surgery.2025;[Epub]     CrossRef
  • Robotic Beyond Total Mesorectal Excision (bTME) for locally advanced and recurrent anorectal cancer: a systematic review
    Joachim Cheng En Ho, Aryan Raj Goel, Muriel Sirgi, Ayan Bin Rafaih, Ayaz Ahmed Memon, Irshad Shaikh, Muhammad Rafaih Iqbal
    Journal of Robotic Surgery.2025;[Epub]     CrossRef
  • Robotic rectal cancer surgery in a medium-volume center: Oncologic and functional outcomes of an 8-year experience
    Teresa Gatto, Igor Monsellato, Marco Palucci, Federico Sangiuolo, Mariantonietta Alagia, Celeste Del Basso, Fabio Giannone, Gianluca Cassese, Fabrizio Panaro
    Journal of Robotic Surgery.2025;[Epub]     CrossRef
  • Learning curve for Da Vinci single–port robotic rectal cancer surgery
    Yong Ki Jeong, Mohammed Ahmed Almalik, In Kyeong Kim, Jung Hoon Bae, In Kyu Lee, Hyeon-Min Cho, Yoon Suk Lee
    Journal of Robotic Surgery.2025;[Epub]     CrossRef
  • Comparing the Surgical Outcomes of Intersphincteric Resection (ISR) and Transanal Total Mesorectal Excision (TATME) in Rectal Cancer: A Meta-Analysis
    Mohsin Farid Sulehri, Mengchuan Wang, Wulikaixi Yagufu, Zhengqi Peng, Yiteng Chen
    Cureus.2025;[Epub]     CrossRef
  • The prognostic value of preoperative Neutrophil-to-Albumin ratio (NPAR) for postoperative complications and survival in colorectal cancer patients undergoing robot-assisted surgery: a retrospective cohort study
    Jing Wang, Fang Chen, Tao Hu, Nanhui Yu
    Journal of Robotic Surgery.2025;[Epub]     CrossRef
  • Robotic Anterior Resection for Rectosigmoid Colon Cancer Using Single-Port Access
    Sung Uk Bae, Woon Kyung Jeong, Seong Kyu Baek
    Diseases of the Colon & Rectum.2024; 67(1): e1.     CrossRef
  • Robotic surgery for bowel endometriosis: a multidisciplinary management of a complex entity
    G. N. Piozzi, V. Burea, R. Duhoky, S. Stefan, C. So, D. Wilby, D. Tsepov, J. S. Khan
    Techniques in Coloproctology.2024;[Epub]     CrossRef
  • Sex Disparities in Rectal Cancer Surgery: An In-Depth Analysis of Surgical Approaches and Outcomes
    Chungyeop Lee, In Ja Park
    The World Journal of Men's Health.2024; 42(2): 304.     CrossRef
  • Robotic beyond total mesorectal excision for locally advanced rectal cancers: Perioperative and oncological outcomes from a multicentre case series
    Jim S. Khan, Guglielmo Niccolò Piozzi, Philippe Rouanet, Avanish Saklani, Volkan Ozben, Paul Neary, Peter Coyne, Seon Hahn Kim, Julio Garcia-Aguilar
    European Journal of Surgical Oncology.2024; 50(6): 108308.     CrossRef
  • Treatment of side limb full-thickness prolapse of the side-to-end coloanal anastomosis following intersphincteric resection: a case report and review of literature
    Guglielmo Niccolò Piozzi, Krunal Khobragade, Seon Hui Shin, Jeong Min Choo, Seon Hahn Kim
    Annals of Coloproctology.2024; 40(Suppl 1): S38.     CrossRef
  • Robotic approach to colonic resection: For some or for all patients?
    Sentilnathan Subramaniam, Guglielmo Niccolò Piozzi, Seon‐Hahn Kim, Jim S. Khan
    Colorectal Disease.2024; 26(7): 1447.     CrossRef
  • The role of robotic-assisted surgery in the management of rectal cancer: a systematic review and meta-analysis
    Chenxiong Zhang, Hao Tan, Han Xu, Jiaming Ding
    International Journal of Surgery.2024; 110(10): 6282.     CrossRef
  • The Impact of a Modular Robotic Total Mesorectal Excision Training Program on Perioperative and Oncological Outcomes in Robotic Rectal Cancer Surgery
    Samuel Stefan, Guglielmo Niccolò Piozzi, Patricia Tejedor, Christopher C.L. Liao, Anwar Ahmad, Nasir Z. Ahmad, Syed A.H. Naqvi, Richard J. Heald, Jim S. Khan
    Diseases of the Colon & Rectum.2024; 67(11): 1485.     CrossRef
  • Suitable T stage for cryosurgery to spare the anus in patients with low rectal cancer
    Xuejun Jiang, Zujin Ji, Xinyi Lei, Cui Liu, Fangjun Yuan
    Cryobiology.2023; 111: 121.     CrossRef
  • Morbidity and oncological outcomes after intersphincteric resection of the rectum for low-lying rectal cancer: experience of a single center in a lower-middle-income country
    Antoinette Afua Asiedua Bediako-Bowan, Narious Naalane, Jonathan C. B. Dakubo
    BMC Surgery.2023;[Epub]     CrossRef
  • Robotic male and laparoscopic female sphincter-preserving total mesorectal excision of mid-low rectal cancer share similar specimen quality, complication rates and long-term oncological outcomes
    Vusal Aliyev, Guglielmo Niccolò Piozzi, Elnur Huseynov, Teuta Zoto Mustafayev, Vildan Kayku, Suha Goksel, Oktar Asoglu
    Journal of Robotic Surgery.2023; 17(4): 1637.     CrossRef
  • International standardization and optimization group for intersphincteric resection (ISOG‐ISR): modified Delphi consensus on anatomy, definition, indication, surgical technique, specimen description and functional outcome
    Guglielmo Niccolò Piozzi, Krunal Khobragade, Vusal Aliyev, Oktar Asoglu, Paolo Pietro Bianchi, Vlad‐Olimpiu Butiurca, William Tzu‐Liang Chen, Ju Yong Cheong, Gyu‐Seog Choi, Andrea Coratti, Quentin Denost, Yosuke Fukunaga, Emre Gorgun, Francesco Guerra, Ma
    Colorectal Disease.2023; 25(9): 1896.     CrossRef
  • International Society of University Colon and Rectal Surgeons survey of surgeons’ preference on rectal cancer treatment
    Audrius Dulskas, Philip F. Caushaj, Domas Grigoravicius, Liu Zheng, Richard Fortunato, Joseph W. Nunoo-Mensah, Narimantas E. Samalavicius
    Annals of Coloproctology.2023; 39(4): 307.     CrossRef
  • Short-term outcomes of da Vinci SP versus Xi for colon cancer surgery: a propensity-score matching analysis of multicenter cohorts
    Jin-Min Jung, Young Il Kim, Yong Sik Yoon, Songsoo Yang, Min Hyun Kim, Jong Lyul Lee, Chan Wook Kim, In Ja Park, Seok-Byung Lim, Chang Sik Yu
    Journal of Robotic Surgery.2023; 17(6): 2911.     CrossRef
  • Low anterior resection syndrome: is it predictable?
    Dong Hyun Kang
    Annals of Coloproctology.2023; 39(5): 373.     CrossRef
  • Fluorescence-guided colorectal surgery: applications, clinical results, and protocols
    Jin-Min Jung, In Ja Park, Eun Jung Park, Gyung Mo Son
    Annals of Surgical Treatment and Research.2023; 105(5): 252.     CrossRef
  • Robotic and laparoscopic sphincter-saving resections have similar peri-operative, oncological and functional outcomes in female patients with rectal cancer
    Vusal Aliyev, Guglielmo Niccolò Piozzi, Niyaz Shadmanov, Koray Guven, Barıs Bakır, Suha Goksel, Oktar Asoglu
    Updates in Surgery.2023; 75(8): 2201.     CrossRef
  • Development of robotic surgical devices and its application in colorectal surgery
    Kamil Erozkan, Emre Gorgun
    Mini-invasive Surgery.2023;[Epub]     CrossRef
  • Unveiling the profound advantages of total neoadjuvant therapy in rectal cancer: a trailblazing exploration
    Kyung Uk Jung, Hyung Ook Kim, Hungdai Kim, Donghyoun Lee, Chinock Cheong
    Annals of Surgical Treatment and Research.2023; 105(6): 341.     CrossRef
  • Preventing Anastomotic Leakage, a Devastating Complication of Colorectal Surgery
    Hyun Gu Lee
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • Surgical Techniques for Transanal Local Excision for Early Rectal Cancer
    Gyoung Tae Noh
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • Influence of the COVID-19 Pandemic on the Treatment Patterns and Outcomes of Colorectal Cancer
    In Ja Park
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Youngbae Jeon, Eun Jung Park
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • How Can We Improve the Tumor Response to Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer?
    Jeonghee Han
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • Clinical Implication of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
    In Ja Park
    The Ewha Medical Journal.2022; 45(1): 3.     CrossRef
  • Current status of robotic surgery for colorectal cancer: A review
    Won Beom Jung
    International Journal of Gastrointestinal Intervention.2022; 11(2): 56.     CrossRef
  • Current status and role of robotic approach in patients with low-lying rectal cancer
    Hyo Seon Ryu, Jin Kim
    Annals of Surgical Treatment and Research.2022; 103(1): 1.     CrossRef
  • Robotic vs. laparoscopic intersphincteric resection for low rectal cancer: a case matched study reporting a median of 7-year long-term oncological and functional outcomes
    Vusal Aliyev, Guglielmo Niccolò Piozzi, Alisina Bulut, Koray Guven, Baris Bakir, Sezer Saglam, Suha Goksel, Oktar Asoglu
    Updates in Surgery.2022; 74(6): 1851.     CrossRef
  • Efficacy of intraoperative fluorescence imaging using indocyanine green‐containing gauze in identifying the appropriate dissection layer in laparoscopic intersphincteric resection: A case report
    Hiroyuki Kumata, Keisuke Onishi, Tetsuro Takayama, Kengo Asami, Noriyuki Obara, Hirofumi Sugawara, Izumi Haga
    Clinical Case Reports.2022;[Epub]     CrossRef
  • Robotic surgery for colorectal cancer
    Sung Uk Bae
    Journal of the Korean Medical Association.2022; 65(9): 577.     CrossRef
  • Direction of diagnosis and treatment improvement in colorectal cancer
    In Ja Park
    Journal of the Korean Medical Association.2022; 65(9): 540.     CrossRef
  • Current Status and Future of Robotic Surgery for Colorectal Cancer-An English Version
    Sung Uk Bae
    Journal of the Anus, Rectum and Colon.2022; 6(4): 221.     CrossRef
  • Update on Diagnosis and Treatment of Colorectal Cancer
    Chan Wook Kim
    The Ewha Medical Journal.2022;[Epub]     CrossRef
  • Low Anterior Resection Syndrome: Pathophysiology, Risk Factors, and Current Management
    Seung Mi Yeo, Gyung Mo Son
    The Ewha Medical Journal.2022;[Epub]     CrossRef
  • Is It a Refractory Disease?- Fecal Incontinence; beyond Medication
    Chungyeop Lee, Jong Lyul Lee
    The Ewha Medical Journal.2022;[Epub]     CrossRef
  • Robot-Assisted Colorectal Surgery
    Young Il Kim
    The Ewha Medical Journal.2022;[Epub]     CrossRef
  • It Is a Pleasure to Announce the Issue Titled “Master Class 2021” in Annals of Coloproctology
    In Ja Park
    Annals of Coloproctology.2021; 37(6): 349.     CrossRef
Original Articles
Malignant disease,Prognosis
Recurrence after endoscopic resection of small rectal neuroendocrine tumors: a retrospective cohort study
Sukit Pattarajierapan, Supakij Khomvilai
Ann Coloproctol. 2022;38(3):216-222.   Published online July 20, 2021
DOI: https://doi.org/10.3393/ac.2021.00017.0002
  • 11,411 View
  • 203 Download
  • 5 Web of Science
  • 4 Citations
AbstractAbstract PDF
Purpose
According to the European Neuroendocrine Tumor Society consensus guidelines, rectal neuroendocrine tumors (NETs) up to 10 mm in size and without poor prognostic factors could be safely removed with endoscopic resection, suggesting omitting surveillance colonoscopy after complete resection. However, the benefit of surveillance colonoscopy is still unknown. In this study, we aimed to report the outcomes after endoscopic resection of small rectal NETs using our surveillance protocol.
Methods
This retrospective cohort study included patients who underwent endoscopic resection for rectal NETs sized up to 10 mm from January 2013 to December 2019 at our center. We excluded patients without surveillance colonoscopy and those lost to follow-up. We strictly performed surveillance colonoscopy 1 year after endoscopic resection, and every 2 to 3 years thereafter. The primary outcomes were tumor recurrence and occurrence of metachronous tumors during followup.
Results
Of the 54 patients who underwent endoscopic resection for rectal NETs during the study period, 46 were enrolled in this study. The complete resection rates by endoscopic mucosal resection, precutting endoscopic mucosal resection, and endoscopic submucosal dissection were 92.3% (12 of 13), 100% (21 of 21), and 100% (12 of 12), respectively. There was no local or distant recurrence during the median follow-up of 39 months. However, we found that 8.7% (4 of 46) of patients developed metachronous NETs. All metachronous lesions were treated with precutting endoscopic mucosal resection.
Conclusion
Surveillance colonoscopy is reasonable after endoscopic resection of small rectal NETs for timely detection and treatment of metachronous lesions. However, larger collaborative studies are needed to influence the guidelines.

Citations

Citations to this article as recorded by  
  • Efficacy, Safety and Oncological Outcomes of Minimally Invasive Approaches (EMR, ESD and TAMIS) for Early Rectal Tumors: A Systematic Review and Meta-Analysis
    Mariam Hussain, Fatima Kayali, Abdelaziz O Surkhi, Roy Shartouni, Thurkga Moothathamby, Ahmed Akmal, Rohan Vyas, Leen Ammari, Ibrahim Sharaf, Mona Jaffar-Karballai, Mohamed Refaie, Yousif Jubouri, Matti Jubouri, Mohamad Bashir, Ali Murtada
    Medical Devices: Evidence and Research.2026; Volume 19: 1.     CrossRef
  • Linked color imaging for detection and characterization of gastrointestinal neuroendocrine tumors
    Xin Pu, Yang Xu, Xueting Zhang, Zijin Yin, Yan Liu, Min Min
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Comparison of the efficacy of endoscopic submucosal dissection and transanal endoscopic microsurgery in the treatment of rectal neuroendocrine tumors ≤ 2 cm
    Rui Jin, Xiaoyin Bai, Tianming Xu, Xi Wu, Qipu Wang, Jingnan Li
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Current status of the role of endoscopy in evaluation and management of gastrointestinal and pancreatic neuroendocrine tumors
    Zaheer Nabi, Sundeep Lakhtakia, D. Nageshwar Reddy
    Indian Journal of Gastroenterology.2023; 42(2): 158.     CrossRef
Malignant disease, Rectal cancer, Functional outcomes,Colorectal cancer
The Effect of Anastomotic Leakage on the Incidence and Severity of Low Anterior Resection Syndrome in Patients Undergoing Proctectomy: A Propensity Score Matching Analysis
Sungjin Kim, Sung Il Kang, So Hyun Kim, Jae-Hwang Kim
Ann Coloproctol. 2021;37(5):281-290.   Published online June 7, 2021
DOI: https://doi.org/10.3393/ac.2021.03.15
  • 7,372 View
  • 75 Download
  • 26 Web of Science
  • 26 Citations
AbstractAbstract PDF
Purpose
Proctectomy for the treatment of rectal cancer results in inevitable changes to bowel habits. Symptoms such as fecal incontinence, constipation, and tenesmus are collectively referred to as low anterior resection syndrome (LARS). Among the several risk factors that cause LARS, anastomotic leakage (AL) is a strong risk factor for permanent stoma formation. Therefore, the purpose of this study was to investigate the relationship between the severity of LARS and AL in patients with rectal cancer based on the LARS score and the Memorial Sloan Kettering Cancer Center (MSKCC) defecation symptom questionnaires.
Methods
We retrospectively analyzed patients who underwent low anterior resection for rectal cancer since January 2010. Patients who completed the questionnaire were classified into the AL group and control group based on medical and imaging records. Major LARS and MSKCC scores were analyzed as primary endpoints.
Results
Among the 179 patients included in this study, 37 were classified into the AL group. After propensity score matching, there were significant differences in the ratio of major LARS and MSKCC scores of the control group and AL group (ratio of major LARS: 11.1% and 37.8%, P<0.001; MSKCC score: 67.29±10.4 and 56.49±7.2, respectively, P<0.001). Univariate and multivariate analyses revealed that AL was an independent factor for major LARS occurrence and MSKCC score.
Conclusion
This study showed that AL was a significant factor in the occurrence of major LARS and defecation symptoms after proctectomy.

Citations

Citations to this article as recorded by  
  • Impact of timing of ileostomy reversal and anastomotic leakage on bowel function and health-related quality of life following rectal cancer surgery: a cross-sectional study
    Ditte Reitz Petersen, Pia Møller Faaborg, Issam Al-Najami, Maja Mi Thygesen, Anna Pilegaard Bjarnesen Mølstrøm, Sören Möller, Mark Bremholm Ellebæk
    Surgical Endoscopy.2026; 40(4): 2848.     CrossRef
  • Pre-stoma closure anastomotic leakage severity: Could it explain why late closure increases LARS risk?
    Yongliang Li, Shenjia Kong
    Updates in Surgery.2026;[Epub]     CrossRef
  • Knowledge, Attitudes, and Practices Toward LARS Prevention in Rectal Cancer Patients With Prophylactic Stomas: A Multicenter Cross‐Sectional Study
    Na Liu, Hong Ying Pi, Yu Ze Sun, Tian Ze Wang
    Nursing Open.2026;[Epub]     CrossRef
  • Repeated Treatments for Chronic Colorectal and Coloanal Anastomotic Leaks are Associated With a Higher Chance of a Permanent Stoma
    Justin Dourado, Sameh Hany Emile, Anjelli Wignakumar, Brett Weiss, Nir Horesh, Victoria DeTrolio, Rachel Gefen, Zoe Garoufalia, Peter Rogers, Victor Strassmann, Steven D. Wexner
    The American Surgeon™.2025; 91(9): 1492.     CrossRef
  • Association between anastomotic leak after rectal resection and bowel dysfunction, a systematic review, meta‐analysis and meta‐regression
    Sameh Hany Emile, Roberta Lynn Oslin, Anjelli Wignakumar, Nir Horesh, Zoe Garoufalia, Steven D. Wexner, Marylise Boutros
    Colorectal Disease.2025;[Epub]     CrossRef
  • Adenoma and carcinoma in the anal transitional zone following hand-sewn versus stapled ileal pouch-anal anastomosis in familial adenomatous polyposis
    Jun Yong Han, Min Jung Kim, Sang Hui Moon, Young Jin Kim, Hyun Tae Lim, Jesung Park, Jae Hyun Park, Hyo Jun Kim, Ji Won Park, Seung-Bum Ryoo, Kyu Joo Park, Seung-Yong Jeong
    Familial Cancer.2025;[Epub]     CrossRef
  • The effect of robotic surgery on low anterior resection syndrome in patients with lower rectal cancer: a propensity score-matched analysis
    Lei Zhang, Chenhao Hu, Jiamian Zhao, Chenxi Wu, Zhe Zhang, Ruizhe Li, Ruihan Liu, Junjun She, Feiyu Shi
    Surgical Endoscopy.2024; 38(4): 1912.     CrossRef
  • Sex Disparities in Rectal Cancer Surgery: An In-Depth Analysis of Surgical Approaches and Outcomes
    Chungyeop Lee, In Ja Park
    The World Journal of Men's Health.2024; 42(2): 304.     CrossRef
  • Innovációk a colorectalis sebészetben
    Balázs Bánky, András Fülöp, Viktória Bencze, Lóránd Lakatos, Petra Rozman, Attila Szijártó
    Orvosi Hetilap.2024; 165(2): 43.     CrossRef
  • Early detection of anastomotic leakage in colon cancer surgery: the role of early warning score and C-reactive protein
    Gyung Mo Son
    Annals of Coloproctology.2024; 40(5): 415.     CrossRef
  • The Diagnosis and Evolution of Patients with LARS Syndrome: A Five-Year Retrospective Study from a Single Surgery Unit
    Cosmin Vasile Obleagă, Sergiu Marian Cazacu, Tiberiu Ștefăniță Țenea Cojan, Cecil Sorin Mirea, Dan Nicolae Florescu, Cristian Constantin, Mircea-Sebastian Șerbănescu, Mirela Marinela Florescu, Liliana Streba, Dragoș Marian Popescu, Ionică Daniel Vîlcea, M
    Cancers.2024; 16(24): 4175.     CrossRef
  • Low anterior resection syndrome after radical surgical treatment of rectal cancer: interim results of a multicenter interuniversity clinical trial
    A. A. Zakharenko, M. A. Belyaev, A. A. Trushin, A. A. Svechkova, I. A. Paltyshev, A. Kh. Khamid, O. A. Ten, T. V. Kupenskaya, M. V. Zavgorodnyaya, I. A. Filatova, F. Ya. Dzhafarzadeh, K. I. Vladimirova, N. M. Guseinova, L. A. Khamid, Ya. O. Baskova, Z. U.
    The Scientific Notes of the Pavlov University.2024; 31(4): 55.     CrossRef
  • Outcomes following anastomotic leak from rectal resections, including bowel function and quality of life
    Angelina Di Re, Salam Tooza, Jason Diab, Charbel Karam, Mina Sarofim, Kevin Ooi, Catherine Turner, Daniel Kozman, David Blomberg, Matthew Morgan
    Annals of Coloproctology.2023; 39(5): 395.     CrossRef
  • The status of low anterior resection syndrome: data from a single-center in China
    Jing Su, Qianhui Liu, Dagui Zhou, Xiaofeng Yang, Guiru Jia, Lijun Huang, Xiao Tang, Jiafeng Fang
    BMC Surgery.2023;[Epub]     CrossRef
  • Low anterior resection syndrome: is it predictable?
    Dong Hyun Kang
    Annals of Coloproctology.2023; 39(5): 373.     CrossRef
  • Validation of low anterior resection syndrome score in Brazil with Portuguese
    Kelly C.L.R. Buzatti, Andy Petroianu, Søren Laurberg, Rodrigo G. Silva, Beatriz D.S. Rodrigues, Peter Christensen, Antonio Lacerda-Filho, Therese Juul
    Annals of Coloproctology.2023; 39(5): 402.     CrossRef
  • Fluorescence-guided colorectal surgery: applications, clinical results, and protocols
    Jin-Min Jung, In Ja Park, Eun Jung Park, Gyung Mo Son
    Annals of Surgical Treatment and Research.2023; 105(5): 252.     CrossRef
  • How Can We Improve the Tumor Response to Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer?
    Jeonghee Han
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • Surgical Techniques for Transanal Local Excision for Early Rectal Cancer
    Gyoung Tae Noh
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • Preventing Anastomotic Leakage, a Devastating Complication of Colorectal Surgery
    Hyun Gu Lee
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • Early vs. standard reversal ileostomy: a systematic review and meta-analysis
    N. J. O’Sullivan, H. C. Temperley, T. S. Nugent, E. Z. Low, D. O. Kavanagh, J. O. Larkin, B. J. Mehigan, P. H. McCormick, M. E. Kelly
    Techniques in Coloproctology.2022; 26(11): 851.     CrossRef
  • A predictive nomogram model for low anterior resection syndrome after rectal cancer resection
    Mingfang Yan, Zhenmeng Lin, Zhiying Wu, Huizhe Zheng, Meiqin Shi
    ANZ Journal of Surgery.2022; 92(12): 3224.     CrossRef
  • Recycling of Iron Slag Waste in the Production of Ceramic Roof Tiles
    M. M. Ahmed, K. A. M. El Naggar, M. F. Abadir, W. Abbas, E. M. Abdel Hamid, Ajaya Kumar Singh
    Journal of Chemistry.2022; 2022: 1.     CrossRef
  • Low Anterior Resection Syndrome: Pathophysiology, Risk Factors, and Current Management
    Seung Mi Yeo, Gyung Mo Son
    The Ewha Medical Journal.2022;[Epub]     CrossRef
  • The watch-and-wait strategy versus radical resection for rectal cancer patients with a good response (≤ycT2) after neoadjuvant chemoradiotherapy
    Chungyeop Lee, In Ja Park, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim
    Annals of Surgical Treatment and Research.2022; 103(6): 350.     CrossRef
  • Functional outcomes after sphincter-preserving surgeries for low-lying rectal cancer: A review
    Eun Jung Park, Seung Hyuk Baik
    Precision and Future Medicine.2021; 5(4): 164.     CrossRef
Case Reports
Malignant disease, Rectal cancer,Colorectal cancer,Complication
Neorectal Mucosal Prolapse After Intersphincteric Resection for Low-Lying Rectal Cancer: A Case Report
Mohammed Alessa, Hyeon Woo Bae, Homoud Alawfi, Ahmad Sakr, Fozan Sauri, Nam Kyu Kim
Ann Coloproctol. 2021;37(Suppl 1):S15-S17.   Published online April 22, 2021
DOI: https://doi.org/10.3393/ac.2020.02.22
  • 6,103 View
  • 94 Download
  • 6 Web of Science
  • 7 Citations
AbstractAbstract PDF
Radical resection for low rectal cancer is the mainstay among the treatment modalities. Intersphincteric resection (ISR) is considered a relatively new but effective surgical treatment for low-lying rectal tumor. As the sphincter preserving techniques get popularized, we notice uncommon complication associated with it in the form of rectal mucosal prolapse. We presented 2 rare cases that developed neorectal mucosa prolapse after ISR a complication following low rectal cancer surgery. Although ISR is a safe and effective surgical technique for low rectal cancer, it should be considered to correct modifiable possible risk factors. Also, Delorme procedure is good option for management of neorectal mucosal prolapse.

Citations

Citations to this article as recorded by  
  • Tailoring rectal cancer surgery: Surgical approaches and anatomical insights during deep pelvic dissection for optimal outcomes in low‐lying rectal cancer
    Youn Young Park, Nam Kyu Kim
    Annals of Gastroenterological Surgery.2024; 8(5): 761.     CrossRef
  • Treatment of side limb full-thickness prolapse of the side-to-end coloanal anastomosis following intersphincteric resection: a case report and review of literature
    Guglielmo Niccolò Piozzi, Krunal Khobragade, Seon Hui Shin, Jeong Min Choo, Seon Hahn Kim
    Annals of Coloproctology.2024; 40(Suppl 1): S38.     CrossRef
  • Surgical Treatment for Mucosal Prolapse after Intersphincteric Resection
    Rina Takahashi, Makoto Takahashi, Yuki Ii, Megumi Kawaguchi, Hirotaka Momose, Shunsuke Motegi, Ryoichi Tsukamoto, Yu Okazawa, Masaya Kawai, Kiichi Sugimoto, Yutaka Kojima, Kazuhiro Sakamoto
    Nippon Daicho Komonbyo Gakkai Zasshi.2023; 76(3): 299.     CrossRef
  • Unveiling the profound advantages of total neoadjuvant therapy in rectal cancer: a trailblazing exploration
    Kyung Uk Jung, Hyung Ook Kim, Hungdai Kim, Donghyoun Lee, Chinock Cheong
    Annals of Surgical Treatment and Research.2023; 105(6): 341.     CrossRef
  • Clinical outcome of the Gant-Miwa-Thiersch procedure for colonic mucosal prolapse after intersphincteric resection—a single-center report from Japan
    Toshikatsu Nitta, Masatsugu Ishii, Jun Kataoka, Sedakatsu Senpuku, Yasuhiko Ueda, Ryo Iida, Ayumi Matsutani, Takashi Ishibashi
    Annals of Medicine and Surgery.2021; 72: 103005.     CrossRef
  • Robotic Intersphincteric Resection for Low Rectal Cancer: Technical Controversies and a Systematic Review on the Perioperative, Oncological, and Functional Outcomes
    Guglielmo Niccolò Piozzi, Seon Hahn Kim
    Annals of Coloproctology.2021; 37(6): 351.     CrossRef
  • Surgical Treatment of Low-Lying Rectal Cancer: Updates
    Cristopher Varela, Nam Kyu Kim
    Annals of Coloproctology.2021; 37(6): 395.     CrossRef
Malignant disease,Rare disease & stoma
Malignant Melanoma of Anorectum: Two Case Reports
Binh Van Pham, Jae Hyun Kang, Huynh Huu Phan, Min Soo Cho, Nam Kyu Kim
Ann Coloproctol. 2021;37(1):65-70.   Published online February 28, 2021
DOI: https://doi.org/10.3393/ac.2020.01.07.1
  • 13,409 View
  • 167 Download
  • 19 Web of Science
  • 15 Citations
AbstractAbstract PDF
Malignant melanoma of the anorectum is a rare disorder. Patients often present with local symptoms similar to benign diseases. The prognosis is very poor, and almost all patients die because of metastases. We report 2 female patients with unremarkable histories. Both of them received previous operations before visiting our center after they were diagnosed with anorectal malignant melanoma. One case underwent abdominoperineal resection and postoperative chemotherapy. The other had been treated with ultralow anterior resection followed by immunotherapy.

Citations

Citations to this article as recorded by  
  • Transanal sphincter-sparing local excision for primary anorectal malignant melanoma: a case report
    Zhiting Wang, Jianwen Hu, Yingfeng Xu, Shiwei Chen
    Frontiers in Oncology.2026;[Epub]     CrossRef
  • Case Report: Surgical management and prognostic factors in primary anorectal melanoma: a retrospective analysis of nine cases
    Xiangxiang Ren, Xiaoshi Jin, Tianhao Xie, Litao Liu, Qiang Wang, Xingli Sun, Meng Zhang
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Malignant melanoma of the anal canal: a case report
    Shubu Parajuli, Shruti Sah, Narendra Pandit
    Journal of Surgical Case Reports.2025;[Epub]     CrossRef
  • A Rare Entity: Primary Malignant Melanoma of the Anorectum
    Jeongmin Choi, Jong Whan Kim
    Journal of Digestive Cancer Research.2024; 12(1): 44.     CrossRef
  • Anorectal Malignant Melanoma Post- Hemorrhoidectomy
    Ramazan Kozan, Ozkan Akpinar, Meral Toker
    Acta Médica Portuguesa.2024; 37(7-8): 556.     CrossRef
  • Immunotherapy for anorectal melanoma: A case report
    Nicholas L. Vitagliano, Muhammad B. Darwish, Roger W. Hsiung
    Current Problems in Cancer: Case Reports.2024; 15: 100302.     CrossRef
  • Amelanotic Malignant Melanoma With Atypical Divergent Neuroendocrine Differentiation: A Report of an Unusual and Rare Case of Anorectal Bleeding
    Shamiliprabha MG, Anand CD, Supriya Verma, Nivethitha S, Jaison J John
    Cureus.2024;[Epub]     CrossRef
  • Anorectal melanoma: systematic review of the current literature of an aggressive type of melanoma
    Giovanni Paolino, Antonio Podo Brunetti, Carolina De Rosa, Carmen Cantisani, Franco Rongioletti, Andrea Carugno, Nicola Zerbinati, Mario Valenti, Domenico Mascagni, Giulio Tosti, Santo Raffaele Mercuri, Riccardo Pampena
    Melanoma Research.2024; 34(6): 487.     CrossRef
  • A rare account of incidentally discovered anal melanoma
    Nawal Khan, Dondre Irving, Lynn O’Connor
    Journal of Surgical Case Reports.2024;[Epub]     CrossRef
  • Prolapsed anorectal malignant melanoma presenting as hemorrhoids
    Busara Songtanin, Kenneth Nugent, Sameer Islam
    Baylor University Medical Center Proceedings.2023; 36(1): 89.     CrossRef
  • Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report
    Othmane Bourouail, Noureddine Njoumi, Youssef Elmahdaouy, Mohamed Fahssi, Mbarek Yaka, Abderrahmane Hejjouji, Abdelmounaim Ait Ali
    JRSM Open.2023;[Epub]     CrossRef
  • Challenges in managing anorectal melanoma, a rare malignancy
    Jyotirmoy Biswas, Lakshmi Deepak Bethineedi, Arkadeep Dhali, Jamal Miah, Sukanta Ray, Gopal Krishna Dhali
    International Journal of Surgery Case Reports.2023;[Epub]     CrossRef
  • Organ preservation in anorectal melanoma: A tempting challenge—a case report
    Mohamed Mehdi Trabelsi, Neirouz Kammoun, Marwa Inoubli, Mohamed Ali Chaouch, Haifa Ben Romdhane, Wafa Koubaa, Hichem Jerraya
    SAGE Open Medical Case Reports.2023;[Epub]     CrossRef
  • Primary anorectal amelanotic melanoma with liver, lungs and lymph nodal metastases
    James R Marak, Gaurav Raj, Shivam Dwivedi, Ariba Zaidi
    BMJ Case Reports.2023; 16(11): e257510.     CrossRef
  • Treatment of Hemorrhoid in Unusual Condition-Pregnancy
    Hyo Seon Ryu
    The Ewha Medical Journal.2022;[Epub]     CrossRef
Original Articles
Malignant disease,Prognosis and adjuvant therapy,Colorectal cancer
Feasibility and Outcomes of Multivisceral Resection in Locally Advanced Colorectal Cancer: Experience of a Tertiary Cancer Center in North-East India
Joydeep Purkayastha, Pritesh Rajeev Singh, Abhijit Talukdar, Gaurav Das, Jitin Yadav, Srinivas Bannoth
Ann Coloproctol. 2021;37(3):174-178.   Published online July 3, 2020
DOI: https://doi.org/10.3393/ac.2020.06.03
  • 6,717 View
  • 100 Download
  • 8 Web of Science
  • 10 Citations
AbstractAbstract PDF
Purpose
Locally advanced colorectal cancer may require an en bloc resection of surrounding organs or structures to achieve complete tumor removal. This decision must weigh the risk of complications of multivisceral resection against the potential survival benefit. The purpose of this study is to review a single-center experience of feasibility of en bloc multivisceral resections for locally advanced colorectal carcinoma and to examine the effect of surgical experience on immediate outcome and rate of R0 resections.
Methods
This is a study of 27 patients who underwent multivisceral resection for locally advanced colorectal carcinoma which was performed at our institute from January 2016 to December 2019. Among the 27 patients aged between 21 and 76 years (mean age, 48.67±7.3 years), 13 were males and 14 were females. Overall 18 patients had primary colon carcinoma and 9 had primary rectal carcinoma. All rectal cancer patients received neoadjuvant chemoradiation. All patients underwent surgery with curative intent. All patients underwent open surgery of which 66.7% underwent colectomy, 14.8% underwent anterior resection, 11.1% underwent Miles procedure, and 7.4% underwent pelvic exenteration.
Results
The mean operative time was 268.14±72.2 minutes and the median amount of blood units transfused was 2.07 units. The mean hospital stay was 13.67±3.4 days. Histologically, 44.4% of patients had well-differentiated adenocarcinoma and 55.6% had moderately differentiated adenocarcinoma. The final histopathological examinatio n revealed malignant infiltration of the adjacent organs in 19/27 patients (70.4%). Pathological complete response was seen in 2 patients. R0 resection rate achieved was 96.3%. Lymph node metastasis was seen in 66.7% of patients with colon cancer and 11.1% with rectal cancer with overall mean number of harvested lymph nodes being 12.44±3.01. Postoperative complications were identified in 7 patients (25.9%), while mortality was seen in 2 (7.4%).
Conclusion
Multivisceral resection for advanced colorectal cancer invading into the adjacent organ may be performed with acceptable morbidity and mortality.

Citations

Citations to this article as recorded by  
  • Ureteral Resections in Non-urological Cancer Surgeries: Experience from a Tertiary Cancer Center
    Abhiram Gatty, Prasanth Poolakkil, Nizamuddeen Pareekkutty, Bonny Alloissius, Satheesan Balasubramanian
    Indian Journal of Surgical Oncology.2026;[Epub]     CrossRef
  • En bloc Right Hemicolectomy with Pancreaticoduodenectomy for Advanced Ascending Colon Cancer
    Hiroyuki Takeda, Tetsuo Ishizaki, Ryutaro Udo, Tomoya Tago, Kenta Kasahara, Junichi Mazaki, Keiichiro Inoue, Yuichi Nagakawa
    Surgical Case Reports.2025; 11(1): n/a.     CrossRef
  • Multivisceral Resections in GI Oncology: Where to Draw the Line?
    Supreet Kumar, Sonam Gupta, Vivek Tandon, Deepak Govil
    Apollo Medicine.2025;[Epub]     CrossRef
  • The impact of tumor-associated inflammatory adhesions on survival and treatment strategies in patients with colon cancer
    Jinzhu Zhang, Jichuan Quan, Shucheng Liu, Zhixun Zhao, Hengchang Liu, Jianqiang Tang, Haipeng Chen, Xishan Wang
    Discover Oncology.2025;[Epub]     CrossRef
  • Oncologic outcomes of multivisceral resection for locally advanced colorectal cancer: a single-center retrospective cohort study
    Jaram Lee, Hyeung-min Park, Soo Young Lee, Chang Hyun Kim, Hyeong Rok Kim
    BMC Surgery.2025;[Epub]     CrossRef
  • Comparison of short- and long-term outcomes between laparoscopic and open multivisceral resection for clinical T4b colorectal cancer: A multicentre retrospective cohort study in China
    Jinzhu Zhang, Jinfeng Sun, Junguang Liu, Shiwen Mei, Jichuan Quan, Gang Hu, Bo Li, Meng Zhuang, Xishan Wang, Jianqiang Tang
    European Journal of Surgical Oncology.2024; 50(1): 107316.     CrossRef
  • Analysis of Patient Outcomes following Curative R0 Multiorgan Resections for Locally Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
    Viorel Dejeu, Paula Dejeu, Anita Muresan, Paula Bradea, Danut Dejeu
    Journal of Clinical Medicine.2024; 13(10): 3010.     CrossRef
  • Prognostic stratification of patients with pT4bN0M0 colorectal cancer following multivisceral resection: a multi-institutional case series analysis
    Jichuan Quan, Kai Zuo, Guoli Li, Junguang Liu, Shiwen Mei, Gang Hu, Wenlong Qiu, Meng Zhuang, Ling Meng, Xishan Wang, Hu Chang, Jianqiang Tang
    International Journal of Surgery.2024; 110(9): 5323.     CrossRef
  • Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Youngbae Jeon, Eun Jung Park
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • Low Anterior Resection Syndrome: Pathophysiology, Risk Factors, and Current Management
    Seung Mi Yeo, Gyung Mo Son
    The Ewha Medical Journal.2022;[Epub]     CrossRef
Malignant disease, Rectal cancer, Functional outcomes
Validation of Korean Version of Low Anterior Resection Syndrome Score Questionnaire
Chang Woo Kim, Woon Kyung Jeong, Gyung Mo Son, Ik Yong Kim, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park, Suk-Hwan Lee
Ann Coloproctol. 2020;36(2):83-87.   Published online February 11, 2020
DOI: https://doi.org/10.3393/ac.2019.08.01
  • 8,581 View
  • 230 Download
  • 24 Web of Science
  • 21 Citations
AbstractAbstract PDF
Purpose
Patients who undergo radical surgery for rectal cancer often experience low anterior resection syndrome (LARS). Symptoms of this syndrome include frequent bowel movements, gas incontinence, fecal incontinence, fragmentation, and urgency. The aim of this study was to investigate the convergent validity, discriminative validity, and reliability of the Korean version of the LARS score questionnaire.
Methods
The English LARS score questionnaire was translated into Korean using the forward-and-back translation method. A total of 146 patients who underwent radical surgery for rectal cancer answered the Korean version of the LARS score questionnaire including an anchor question assessing the impact of bowel function. Participants answered the questionnaire once more after 2 weeks.
Results
The Korean LARS score questionnaire showed high convergent validity in terms of high correlation between the LARS score and quality of life (perfect fit 55.5% vs. moderate fit 37.6% vs. no fit 6.8%, respectively; P < 0.001). The LARS score also showed good discriminative validity between groups of patients differing by sex (29 for males vs. 25 for females; P = 0.014), tumor level (29 for ≤8 cm vs. 24 for >8 cm; P = 0.021), and radiotherapy (32 for yes vs. 24 for no; P = 0.001). The LARS score also demonstrated high reliability at test-retest with no difference between scores at the first and second tests (intraclass correlation coefficient: Q1 = 0.932; Q2 = 0.909, Q3 = 0.944, Q4 = 0.931, and Q5 = 0.942; P < 0.001, respectively).
Conclusion
The Korean version of the LARS score questionnaire has proven to be a valid and reliable tool for measuring LARS in Korean patients with rectal cancer.

Citations

Citations to this article as recorded by  
  • Longitudinal evolution of low anterior resection syndrome in ultra-low rectal cancer: A trend analysis of a propensity-matched cohort
    Han-Shuo Wang, Yu-Xin Lin, Si-Rui Xu, Li-Ya Wang, Xiao-Dong Wang, Ming-Jun Huang
    World Journal of Gastroenterology.2026;[Epub]     CrossRef
  • Impact of sleep disturbances due to low anterior resection syndrome on the quality of life of patients with rectal cancer
    Do Kyoon Moon, Seung-Bum Ryoo, Mi Suk Kim, Jae Hyun Park, Jesung Park, Jong Sung Ahn, Hyo Jun Kim, Minjung Kim, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park
    The American Journal of Surgery.2025; 246: 116399.     CrossRef
  • Effects of prune consumption on the incidence of low anterior resection syndrome: a randomized controlled trial
    Dae Hee Pyo, Jung Kyong Shin, Jung Wook Huh, Hee Cheol Kim, Seong Hyeon Yun, Woo Yong Lee, Yoonah Park, Yong Beom Cho
    Annals of Coloproctology.2025; 41(6): 510.     CrossRef
  • K-LARS trial: protocol for a multicentre randomised controlled trial evaluating a knowledge-enhanced digital intervention to prevent low anterior resection syndrome in Korea
    Seung-Bum Ryoo, Hong-Min Ahn, Byung-Ho Nam, Young Min Song, Dae Kyung Sohn
    BMJ Open.2025; 15(11): e107819.     CrossRef
  • Validation of the Vietnamese version of the low anterior resection syndrome score questionnaire
    Tuong-Anh Mai-Phan, Vu Quang Pham
    Annals of Coloproctology.2024; 40(6): 588.     CrossRef
  • Bowel dysfunction and lower urinary tract symptoms on quality of life after sphincter-preserving surgery for rectal cancer: A cross-sectional study
    Hyekyung Kim, Hyedan Kim, Ok-Hee Cho
    European Journal of Oncology Nursing.2024; 69: 102524.     CrossRef
  • Effectiveness of personalized treatment stage-adjusted digital therapeutics in colorectal cancer: a randomized controlled trial
    Inah Kim, Ji Young Lim, Sun Woo Kim, Dong Wook Shin, Hee Cheol Kim, Yoon Ah Park, Yoon Suk Lee, Jung-Myun Kwak, Seok Ho Kang, Ji Youl Lee, Ji Hye Hwang
    BMC Cancer.2023;[Epub]     CrossRef
  • Low anterior resection syndrome
    Seung‐Bum Ryoo
    Annals of Gastroenterological Surgery.2023; 7(5): 719.     CrossRef
  • Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial
    Min Jung Kim, Dae Won Lee, Hyun-Cheol Kang, Ji Won Park, Seung-Bum Ryoo, Sae-Won Han, Kyung Su Kim, Eui Kyu Chie, Jae Hwan Oh, Woon Kyung Jeong, Byoung Hyuck Kim, Eun Mi Nam, Seung-Yong Jeong
    BMC Cancer.2023;[Epub]     CrossRef
  • Validation of low anterior resection syndrome score in Brazil with Portuguese
    Kelly C.L.R. Buzatti, Andy Petroianu, Søren Laurberg, Rodrigo G. Silva, Beatriz D.S. Rodrigues, Peter Christensen, Antonio Lacerda-Filho, Therese Juul
    Annals of Coloproctology.2023; 39(5): 402.     CrossRef
  • Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: a multicenter, randomized controlled trial (SOLAR trial)
    Min Kyu Kang, Soo Yeun Park, Jun Seok Park, Hye Jin Kim, Jong Gwang Kim, Byung Woog Kang, Jin Ho Baek, Seung Hyun Cho, An Na Seo, Duck-Woo Kim, Jin Kim, Se Jin Baek, Ji Hoon Kim, Ji Yeon Kim, Gi Won Ha, Eun Jung Park, In Ja Park, Chang Hyun Kim, Hyun Kang
    BMC Cancer.2023;[Epub]     CrossRef
  • Clinical Implication of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
    In Ja Park
    The Ewha Medical Journal.2022; 45(1): 3.     CrossRef
  • Low Anterior Resection Syndrome: Pathophysiology, Risk Factors, and Current Management
    Seung Mi Yeo, Gyung Mo Son
    The Ewha Medical Journal.2022;[Epub]     CrossRef
  • Analgesic effect of structured anal skin care for perianal dermatitis after low anterior resection in the rectal cancer patients: prospective, single-center, open-label, therapeutic confirmatory, randomized clinical trial
    Gyung Mo Son, In Young Lee, Mi Sook Yun, Jung-Hea Youn, Hong Min An, Kyung Hee Kim, Seung Mi Yeo, Bokyung Ku, Myeong Suk Kwon, Kun Hyung Kim
    Annals of Surgical Treatment and Research.2022; 103(6): 360.     CrossRef
  • Two dominant patterns of low anterior resection syndrome and their effects on patients’ quality of life
    Min Jung Kim, Ji Won Park, Mi Ae Lee, Han-Ki Lim, Yoon-Hye Kwon, Seung-Bum Ryoo, Kyu Joo Park, Seung-Yong Jeong
    Scientific Reports.2021;[Epub]     CrossRef
  • Anterior resection syndrome: a randomized clinical trial of a 5-HT3 receptor antagonist (ramosetron) in male patients with rectal cancer
    S -B Ryoo, J W Park, D W Lee, M A Lee, Y -H Kwon, M J Kim, S H Moon, S -Y Jeong, K J Park
    British Journal of Surgery.2021; 108(6): 644.     CrossRef
  • The incidence and risk factors of low anterior resection syndrome (LARS) after sphincter-preserving surgery of rectal cancer: a systematic review and meta-analysis
    Rui Sun, Ziyi Dai, Yin Zhang, Junyang Lu, Yuelun Zhang, Yi Xiao
    Supportive Care in Cancer.2021; 29(12): 7249.     CrossRef
  • Defining low anterior resection syndrome (LARS): Scoring tools and patient-reported outcomes
    Dr Rebekka Troller, Dr Jeremy Meyer, Mr Justin Davies
    Seminars in Colon and Rectal Surgery.2021; 32(4): 100847.     CrossRef
  • The Effect of Anastomotic Leakage on the Incidence and Severity of Low Anterior Resection Syndrome in Patients Undergoing Proctectomy: A Propensity Score Matching Analysis
    Sungjin Kim, Sung Il Kang, So Hyun Kim, Jae-Hwang Kim
    Annals of Coloproctology.2021; 37(5): 281.     CrossRef
  • Robotic Intersphincteric Resection for Low Rectal Cancer: Technical Controversies and a Systematic Review on the Perioperative, Oncological, and Functional Outcomes
    Guglielmo Niccolò Piozzi, Seon Hahn Kim
    Annals of Coloproctology.2021; 37(6): 351.     CrossRef
  • Functional outcomes after sphincter-preserving surgeries for low-lying rectal cancer: A review
    Eun Jung Park, Seung Hyuk Baik
    Precision and Future Medicine.2021; 5(4): 164.     CrossRef
Benign GI diease,Benign diesease & IBD,Complication,Surgical technique
Triple-Staple Technique Effectively Reduces Operating Time for Rectal Anastomosis
Marie Shella De Robles, Christopher John Young
Ann Coloproctol. 2021;37(1):16-20.   Published online February 5, 2020
DOI: https://doi.org/10.3393/ac.2019.06.30
  • 7,852 View
  • 172 Download
  • 11 Web of Science
  • 11 Citations
AbstractAbstract PDF
Purpose
Stapled anastomotic techniques to the distal rectum have gained widespread acceptance due to their procedural advantages. Various modifications in the stapling techniques have evolved since their inception. The triple-staple technique utilizing stapled closure of both the proximal colon and distal rectal stump provides a rapid and secure colorectal anastomosis. The aims of this study were to determine the safety and efficacy of the triple-staple technique and to compare the clinical outcomes with a historical control group for which the conventional double-staple technique had been performed.
Methods
One hundred consecutive patients operated on by a single surgeon were included in the study; 50 patients who underwent a double-staple (DSA) procedure and 50 patients undergoing triple-staple anastomosis (TSA).
Results
The most common indication for surgery in both groups was rectal cancer followed by diverticular disease and distal sigmoid cancer. There was no significant difference in number of patients requiring loop ileostomy formation in the groups (TSA, 56.0% vs. DSA, 68.0%; P = 0.621). The mean operating time for the TSA group was significantly shorter compared to that of the DSA group (TSA, 242.8 minutes vs. DSA, 306.1 minutes; P = 0.001). There was no significant difference in complication rate (TSA, 40% vs. DSA, 50%; P = 0.315) or length of hospital stay between the two groups (TSA, 11.3 days vs. DSA, 13.0 days; P = 0.246). Postoperative complications included anastomotic leak, prolonged ileus, bleeding, wound infection, and pelvic collection.
Conclusion
The triple-staple technique is a safe alternative to double-staple anastomosis after anterior resection and effectively shortens operating time.

Citations

Citations to this article as recorded by  
  • Single versus double stapled anastomosis in natural orifice specimen extraction (NOSE) laparoscopic anterior resection
    Abdus Salam Raju, Seyed Mohammad Javad Taghavi, Andrew James Gilmore
    ANZ Journal of Surgery.2025; 95(6): 1198.     CrossRef
  • Sphincter-preserving surgical techniques in low rectal cancer management: A systematic review of contemporary evidence
    Song Wang, A-Jian Li, Hui-Hong Jiang, Yin Lin, Hai-Bo Ding
    World Journal of Gastrointestinal Surgery.2025;[Epub]     CrossRef
  • Utility of Artificial Intelligence-Driven Chatbots in Suggesting Solutions to Stapling Misadventures in Colorectal Surgery
    Sameh Hany Emile, Preeti Singh, Nir Horesh, Lucia Oliveira, Julio Mayol, Steven D. Wexner
    Surgical Innovation.2025;[Epub]     CrossRef
  • Sex Disparities in Rectal Cancer Surgery: An In-Depth Analysis of Surgical Approaches and Outcomes
    Chungyeop Lee, In Ja Park
    The World Journal of Men's Health.2024; 42(2): 304.     CrossRef
  • Double-row staple technology versus triple-row staple technology for colorectal surgery: A systematic review and meta-analysis
    Tyler McKechnie, Victoria Shi, Elena Huang, Bright Huo, Aristithes Doumouras, Nalin Amin, Cagla Eskicioglu, Dennis Hong
    Surgery.2024; 176(3): 633.     CrossRef
  • The Colorectal Anastomosis: A Timeless Challenge
    Alexander A. Gaidarski III, Marco Ferrara
    Clinics in Colon and Rectal Surgery.2023; 36(01): 011.     CrossRef
  • Fluorescence-guided colorectal surgery: applications, clinical results, and protocols
    Jin-Min Jung, In Ja Park, Eun Jung Park, Gyung Mo Son
    Annals of Surgical Treatment and Research.2023; 105(5): 252.     CrossRef
  • Preventing Anastomotic Leakage, a Devastating Complication of Colorectal Surgery
    Hyun Gu Lee
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • Robotic surgery for colorectal cancer
    Sung Uk Bae
    Journal of the Korean Medical Association.2022; 65(9): 577.     CrossRef
  • Current Status and Future of Robotic Surgery for Colorectal Cancer-An English Version
    Sung Uk Bae
    Journal of the Anus, Rectum and Colon.2022; 6(4): 221.     CrossRef
  • Effort to Improve Rectal Anastomosis: the Triple-Stapled Technique for Rectal Anastomosis
    Sung Il Kang
    Annals of Coloproctology.2021; 37(1): 1.     CrossRef
Clinical Outcomes of Patients With Locally Advanced Rectal Cancer With Persistent Circumferential Resection Margin Invasion After Preoperative Chemoradiotherapy
Chang Hyun Kim, Seung-Seop Yeom, Hand-Duk Kwak, Soo Young Lee, Jae Kyun Ju, Young Jin Kim, Hyeong Rok Kim
Ann Coloproctol. 2019;35(2):72-82.   Published online April 30, 2019
DOI: https://doi.org/10.3393/ac.2019.04.22
  • 6,846 View
  • 121 Download
  • 14 Web of Science
  • 14 Citations
AbstractAbstract PDF
Purpose
Treatment after failure of circumferential resection margin (CRM) conversion after preoperative chemoradiotherapy (pCRT) for locally advanced rectal cancer (LARC) has not been evaluated well. We conducted a single‐center, retrospective analysis to fill this information gap.
Methods
From 2008 to 2016, we included 112 patients who had predictive CRM involvement on baseline magnetic resonance imaging (MRI) and who underwent surgery following pCRT for LARC. Baseline and posttreatment radiologic and clinical factors were analyzed.
Results
Of 493 patients with LARC, 112 had CRM involvement by baseline MRI (mrCRM). In 40 patients (35.7%), mrCRM involvement was converted as negative posttreatment CRM (ymrCRM−). Multivariate analysis showed the risk factors for persistent CRM involvement (ymrCRM+) after pCRT were extramural venous invasion (mrEMVI+) (P = 0.030) and lower tumor location (P = 0.007). In addition, persistent CRM involvement after pCRT was an independent risk factor for predicting pathologic CRM involvement. The Cox proportional hazard model showed baseline positive mrEMVI remained significant for disease-free survival (DFS) (P < 0.001). On posttreatment MRI, abdominoperineal resection (P = 0.031), intersphincteric resection (P = 0.006), and persistent CRM involvement (P = 0.001) remained significant for local recurrence-free survival. With regard to DFS, persistent CRM involvement (P = 0.048) and positive EMVI on posttreatment MRI (ymrEMVI) (P = 0.014) were significant. In the patient subgroup with persistent CRM involvement, 5-year DFS in patients with mrEMVI and ymrEMVI was 29.8% and 21.2%, respectively.
Conclusion
Patients who fail to convert to negative CRM have extremely poor oncologic outcomes. Lower tumor height and negative mrEMVI status were good responders to ymrCRM conversion. Our results suggest that these patients require a more intensive treatment modality.

Citations

Citations to this article as recorded by  
  • Post‐diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis
    Nerea Becerra‐Tomás, Georgios Markozannes, Margarita Cariolou, Katia Balducci, Rita Vieira, Sonia Kiss, Dagfinn Aune, Darren C. Greenwood, Laure Dossus, Ellen Copson, Andrew G. Renehan, Martijn Bours, Wendy Demark‐Wahnefried, Melissa M. Hudson, Anne M. Ma
    International Journal of Cancer.2024; 155(3): 400.     CrossRef
  • A Review of Neoadjuvant Therapy and the Watch-and-Wait Protocol in Rectal Cancer: Current Evidence and Future Directions
    Iulian M Slavu, Octavian Munteanu, Florin Filipoiu, Raluca Tulin, Anca Monica Macovei Oprescu , Ileana Dima, Iulian A Dogaru, Adrian Tulin
    Cureus.2024;[Epub]     CrossRef
  • A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma
    Shuiwang Qing, Lei Gu, Tingting Du, Xiaolan Yin, Ke-jia Zhang, Huo-jun Zhang
    Technology in Cancer Research & Treatment.2023;[Epub]     CrossRef
  • Oncologic Outcomes Associated With MRI-detected Extramural Venous Invasion (mrEMVI) in Rectal Cancer
    François Rouleau Fournier, Mohammad Ali K. Motamedi, Carl J. Brown, Terry Phang, Manoj J. Raval, Cameron J. Hague, Ahmer A. Karimuddin
    Annals of Surgery.2022; 275(2): 303.     CrossRef
  • Watch and wait strategies for rectal cancer: A systematic review
    In Ja Park
    Precision and Future Medicine.2022; 6(2): 91.     CrossRef
  • Are oncological long-term outcomes equal after laproscopic completed and converted laparoscopic converted rectal resection for cancer?
    M. Finochi, B. Menahem, G. Lebreton, J. Lubrano, Y. Eid, A. Alves
    Techniques in Coloproctology.2021; 25(1): 91.     CrossRef
  • Sphincter‐saving surgery for ultra‐low rectal carcinoma initially indicated for abdominoperineal resection: Is it safe on a long‐term follow‐up?
    Philippe Rouanet, Michel Rivoire, Sophie Gourgou, Bernard Lelong, Eric Rullier, Merhdad Jafari, Laurent Mineur, Marc Pocard, Jean Luc Faucheron, François Dravet, Denis Pezet, Jean Michel Fabre, Laurent Bresler, Jacques Balosso, Christophe Taoum, Claire Le
    Journal of Surgical Oncology.2021; 123(1): 299.     CrossRef
  • The prognostic value of MRI-detected extramural vascular invasion (mrEMVI) for rectal cancer patients treated with neoadjuvant therapy: a meta-analysis
    Silin Chen, Ning Li, Yuan Tang, Jinming Shi, Ying Zhao, Huiying Ma, Shulian Wang, Ye-xiong Li, Jing Jin
    European Radiology.2021; 31(12): 8827.     CrossRef
  • Predictors of Positive Circumferential Resection Margin in Rectal Cancer: A Current Audit of the National Cancer Database
    Hillary L. Simon, Thais Reif de Paula, Magda M. Profeta da Luz, Ravi P. Kiran, Deborah S. Keller
    Diseases of the Colon & Rectum.2021; 64(9): 1096.     CrossRef
  • MRI-detected extramural venous invasion of rectal cancer: Multimodality performance and implications at baseline imaging and after neoadjuvant therapy
    Akitoshi Inoue, Shannon P. Sheedy, Jay P. Heiken, Payam Mohammadinejad, Rondell P. Graham, Hee Eun Lee, Scott R. Kelley, Stephanie L. Hansel, David H. Bruining, Jeff L. Fidler, Joel G. Fletcher
    Insights into Imaging.2021;[Epub]     CrossRef
  • Robotic Intersphincteric Resection for Low Rectal Cancer: Technical Controversies and a Systematic Review on the Perioperative, Oncological, and Functional Outcomes
    Guglielmo Niccolò Piozzi, Seon Hahn Kim
    Annals of Coloproctology.2021; 37(6): 351.     CrossRef
  • Surgical Treatment of Low-Lying Rectal Cancer: Updates
    Cristopher Varela, Nam Kyu Kim
    Annals of Coloproctology.2021; 37(6): 395.     CrossRef
  • Functional outcomes after sphincter-preserving surgeries for low-lying rectal cancer: A review
    Eun Jung Park, Seung Hyuk Baik
    Precision and Future Medicine.2021; 5(4): 164.     CrossRef
  • Reconsideration of the Safety of Laparoscopic Rectal Surgery for Cancer
    Gyung Mo Son, Bong-Hyeon Kye, Min Ki Kim, Jun-Gi Kim
    Annals of Coloproctology.2019; 35(5): 229.     CrossRef
Anastomotic Sinus That Developed From Leakage After a Rectal Cancer Resection: Should We Wait for Closure of the Stoma Until the Complete Resolution of the Sinus?
Chris Tae-Young Chung, Se-Jin Baek, Jung-Myun Kwak, Jin Kim, Seon-Hahn Kim
Ann Coloproctol. 2019;35(1):30-35.   Published online January 25, 2019
DOI: https://doi.org/10.3393/ac.2018.08.13
  • 8,747 View
  • 162 Download
  • 5 Web of Science
  • 5 Citations
AbstractAbstract PDF
Purpose
The aims of this study were to identify the clinical characteristics of an anastomotic sinus and to assess the validity of delaying stoma closure in patients until the complete resolution of an anastomotic sinus.
Methods
The subject patients are those who had undergone a resection of rectal cancer from 2011 to 2017, who had a diversion ileostomy protectively or therapeutically and who developed a sinus as a sequelae of anastomotic leakage. The primary outcomes that were measured were the incidence, management and outcomes of an anastomotic sinus.
Results
Of the 876 patients who had undergone a low anterior resection, 14 (1.6%) were found to have had an anastomotic sinus on sigmoidoscopy or a gastrografin enema before their ileostomy closure. In the 14 patients with a sinus, 7 underwent ileostomy closure as scheduled, with a mean closure time of 4.1 months. The remaining 7 patients underwent ileostomy repair, but it was delayed until after the follow-up for the widening of the sinus opening by using digital dilation, with a mean closure time of 6.9 months. Four of those remaining seven patients underwent stoma closure even though their sinus condition had not yet been completely resolved. No pelvic septic complications occurred after closure in any of the 14 patients with an anastomotic sinus, but 2 of the 14 needed a rediversion due to a severe anastomotic stricture.
Conclusion
Patients with an anastomotic sinus who had been carefully selected underwent successful ileostomy closure without delay.

Citations

Citations to this article as recorded by  
  • Management of Low-Rectal Anastomotic Sinus With Transanal Minimally Invasive Septotomy
    Nirvana B. Saraswat, Scott A. Brill, William E. Wise
    The American Surgeon™.2023; 89(2): 322.     CrossRef
  • The management of asymptomatic radiological anastomotic leakage following anterior resection
    Mohamed Rabie, Laura Parry, Iannish Sadien, Sandeep Kapur, Adam Stearns, Irshad Shaikh
    ANZ Journal of Surgery.2022; 92(4): 801.     CrossRef
  • Chronische Anastomoseninsuffizienz nach tiefer Rektumresektion – ein ungelöstes Problem?
    Peter Kienle, Jörn Richard Magdeburg
    Der Chirurg.2021; 92(7): 605.     CrossRef
  • Response to Dioscoridi et al.
    G. I. Popivanov, V. M. Mutafchiyski, R. Cirocchi, S. D. Chipeva, V. V. Vasilev, K. T. Kjossev, M. S. Tabakov
    Colorectal Disease.2020; 22(7): 841.     CrossRef
  • Anastomotic Sinus Developed From Leakage in Rectal Cancer Resection: When Can We Reverse the Defunctioning Stoma?
    Chang Hyun Kim
    Annals of Coloproctology.2019; 35(1): 1.     CrossRef
Review
Intersphincteric Resection for Patients With Low-Lying Rectal Cancer: Oncological and Functional Outcomes
In Ja Park, Jin Cheon Kim
Ann Coloproctol. 2018;34(4):167-174.   Published online August 31, 2018
DOI: https://doi.org/10.3393/ac.2018.08.02
  • 10,034 View
  • 339 Download
  • 29 Web of Science
  • 26 Citations
AbstractAbstract PDF
The aim of this review is to evaluate the outcomes after an intersphincteric resection (ISR) for patients with low-lying rectal cancer. Reports published in the literature regarding surgical, oncological, and functional outcomes of an ISR were reviewed. The morbidity after an ISR was 7.7%–32%, and anastomotic leakage was the most common adverse event. Local recurrence rates ranged from 0% to 12%, 5-year overall survival rates ranged from 62% to 92%, and rates of major incontinence ranged from 0% to 25.8% after an ISR. An ISR is a safe procedure for sphincter-saving rectal surgery in patients with very low rectal cancer; it does not compromise the oncological outcomes of the resection and is a valuable alternative to an abdominoperineal resection. While the functional outcomes after an ISR were found to be acceptable, the long-term functional outcome and quality of life still require careful investigation. ISRs have been performed with surgical and oncologic safety on patients with low-lying rectal cancer. However, patients must be selected very carefully for an ISR, considering the associated functional derangement and the limited extent of the resection.

Citations

Citations to this article as recorded by  
  • Long-term functional and prognostic outcomes of robotic intersphincteric resection for treating low rectal cancer: a single-center retrospective study
    Yang Bo, Wang Yigao, Zheng Mingye, Jian Zhao, Yongxiang Li
    International Journal of Colorectal Disease.2025;[Epub]     CrossRef
  • A randomized controlled trial of a digital lifestyle intervention involving postoperative patients with colorectal cancer
    Young Il Kim, In Ja Park, Jun-Soo Ro, Jong Lyul Lee, Chan Wook Kim, Yong Sik Yoon, Seok-Byung Lim, Chang Sik Yu, Yura Lee, Yae Won Tak, Seockhoon Chung, Kyung Won Kim, Yousun Ko, Sung-Cheol Yun, Min-Woo Jo, Jong Won Lee
    npj Digital Medicine.2025;[Epub]     CrossRef
  • Comparison of quality of life between intersphincteric and abdominoperineal resection in patients with low rectal cancer
    Adnan Abdulkadir Mohammed, Sara Shojaei-Zarghani, Zahra Ghanbarzadegan, Zahra Zabangirfard, Ahmed Mohammed Ali Hussein Alhurry, Khadije Gorgi, Seyed Vahid Hosseini
    coloproctology.2025; 47(5): 360.     CrossRef
  • Successful sphincter preservation and long-term survival in a patient with ultra-low locally advanced rectal cancer treated with photodynamic therapy combined with multimodal treatment: a case report and literature review
    Dan Zou, Baohong Gu, Yifan Li, Ying Yan, Huanhuan Ma, Kai Wang, Weiyi Chen, Bofang Wang, Hao Chen
    Therapeutic Advances in Medical Oncology.2025;[Epub]     CrossRef
  • Long-term efficacy and short-term outcomes of intersphincteric resection vs abdominoperineal resection in patients with ultra-low rectal cancer
    Guan-Cong Wang, Jun-Xing Chen, Hong-Feng Pan, Kai Ye, Yin-Cong Guo, Ying Huang
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Oncologic outcomes of intersphincteric resection versus abdominoperineal resection for lower rectal cancer: a systematic review and meta-analysis
    Qiang Du, Wenming Yang, Jianhao Zhang, Siyuan Qiu, Xueting Liu, Yong Wang, Lie Yang, Zongguang Zhou
    International Journal of Surgery.2024; 110(4): 2338.     CrossRef
  • Does anastomotic leakage after intersphincteric resection for ultralow rectal cancer influence long-term outcomes? A retrospective observational study
    Feifan Liu, Bin Zhang, Jianbin Xiang, Guangzuan Zhuo, Yujuan Zhao, Yiming Zhou, Jianhua Ding
    Langenbeck's Archives of Surgery.2023;[Epub]     CrossRef
  • Comparative study of functional outcomes between ultra‐low anterior resection and inter‐sphincteric resection: a propensity matched analysis
    Jayesh Gori, Mufaddal Kazi, Barath Rajkumar, Prajesh Bhuta, Suman Kumar Ankathi, Ashwin Desouza, Avanish Saklani
    ANZ Journal of Surgery.2022; 92(1-2): 151.     CrossRef
  • Current status and role of robotic approach in patients with low-lying rectal cancer
    Hyo Seon Ryu, Jin Kim
    Annals of Surgical Treatment and Research.2022; 103(1): 1.     CrossRef
  • Trans-Anastomotic Drainage Tube Placement After Hand-Sewn Anastomosis in Patients Undergoing Intersphincteric Resection for Low Rectal Cancer: An Alternative Drainage Method
    Xinjian Zhong, Xiaoyu Xie, Hang Hu, Yi Li, Shunhua Tian, Qun Qian, Congqing Jiang, Xianghai Ren
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Functional outcomes of intersphincteric resection in low rectal tumors
    Osman Bozbıyık, Cemil Çalışkan, Özgün Köse, Ozan Verendağ, Berk Göktepe, Tayfun Yoldaş, Erhan Akgün, Mustafa Ali Korkut
    Turkish Journal of Surgery.2022; 38(2): 180.     CrossRef
  • Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis for Low Rectal Cancers
    Diwakar Pandey, Vivek Sukumar, Avanish Saklani
    JAMA Surgery.2021; 156(2): 202.     CrossRef
  • Local recurrence with intersphincteric resection in adverse histology rectal cancers. A retrospective study with competing risk analysis
    Ashwin L. Desouza, Mufaddal Kazi, Kamlesh Verma, Pavan Sugoor, Balu K. Mahendra, Avanish P. Saklani
    ANZ Journal of Surgery.2021; 91(11): 2475.     CrossRef
  • A case of effective Delorme’s procedure for colonic mucosal prolapse after intersphincteric resection
    Akihiro Kohata, Wataru Shimizu, Masatoshi Kochi, Yuji Takakura, Hideki Ohdan
    Journal of Surgical Case Reports.2021;[Epub]     CrossRef
  • Oncologic and Functional Outcomes of Pelvic Perineal Reconstruction by Perineal Colostomy and Malone Procedure After Abdominoperineal Resection
    Anthony Marinho, Nicolas Zalay, Léonor Chaltiel, Sylvain Kirzin, Antoine Philis, Jannick Selves, Nicolas Carrère, Etienne Buscail, Laurent Ghouti
    Diseases of the Colon & Rectum.2021; 64(12): 1501.     CrossRef
  • Functional outcomes after sphincter-preserving surgeries for low-lying rectal cancer: A review
    Eun Jung Park, Seung Hyuk Baik
    Precision and Future Medicine.2021; 5(4): 164.     CrossRef
  • Robotic Intersphincteric Resection for Low Rectal Cancer: Technical Controversies and a Systematic Review on the Perioperative, Oncological, and Functional Outcomes
    Guglielmo Niccolò Piozzi, Seon Hahn Kim
    Annals of Coloproctology.2021; 37(6): 351.     CrossRef
  • Surgical Treatment of Low-Lying Rectal Cancer: Updates
    Cristopher Varela, Nam Kyu Kim
    Annals of Coloproctology.2021; 37(6): 395.     CrossRef
  • Oncologic safety and bowel function after ultralow anterior resection with or without intersphincteric resection for low lying rectal cancer: Comparative cross sectional study
    Ahmad Sakr, Seung Yoon Yang, Jae Hyun Kang, Min Soo Cho, Yoon Dae Han, Byung Soh Min, Waleed Thabet, Hosam Ghazy Elbanna, Mosaad Morshed, Nam Kyu Kim
    Journal of Surgical Oncology.2020; 121(2): 365.     CrossRef
  • Simplification or Accuracy: In Assessing Functional Outcomes After Intersphincteric Resection for Low Rectal Cancer
    Kyung Jong Kim
    Annals of Coloproctology.2020; 36(3): 129.     CrossRef
  • Avoidance of Overtreatment of Rectal Cancer by Selective Chemoradiotherapy: Results of the Optimized Surgery and MRI-Based Multimodal Therapy Trial
    Reinhard Ruppert, Rainer Kube, Joachim Strassburg, Andreas Lewin, Joerg Baral, Christoph A. Maurer, Joerg Sauer, Theodor Junginger, Paul Hermanek, Susanne Merkel, Martin E. Kreis, Guenther Winde, Rena Thomasmeyer, Sigmar Stelzner, Cornelius Bambauer, Soen
    Journal of the American College of Surgeons.2020; 231(4): 413.     CrossRef
  • Latest Advances in Intersphincteric Resection for Low Rectal Cancer
    Yifan Xv, Jiajun Fan, Yuan Ding, Yang Hu, Yingjie Hu, Zhengjie Jiang, Qingsong Tao
    Gastroenterology Research and Practice.2020; 2020: 1.     CrossRef
  • Nachsorge und Behandlung funktioneller Störungen nach operativer Therapie des Rektumkarzinoms
    C. Holmer
    Der Onkologe.2020; 26(12): 1154.     CrossRef
  • Factors influencing changing bowel habits in patients undergoing sphincter‐saving surgery for rectal cancer
    Hyeonju Jeong, JeongYun Park
    International Wound Journal.2019; 16(S1): 71.     CrossRef
  • Postoperative Bowel Function After Anal Sphincter-Preserving Rectal Cancer Surgery: Risks Factors, Diagnostic Modalities, and Management
    Chris George Cura Pales, Sanghyun An, Jan Paolo Cruz, Kwangmin Kim, Youngwan Kim
    Annals of Coloproctology.2019; 35(4): 160.     CrossRef
  • Long Term Results of Modified Intersphincteric Resections for Low Rectal Cancer: A Single Center Experience
    Vlad-Olimpiu Butiurca, Călin Molnar, Copotoiu Constantin, Marian Botoncea, Teodor Ioan Bud, Zsolt Kovacs, Cătălin Satala, Simona Gurzu
    Medicina.2019; 55(12): 764.     CrossRef
Case Reports
Rhabdomyolysis Following Colonoscopy: A Case Report
Jin Yong Jeong, Kap Tae Kim, Mi Jin Kim, Yea Jeong Kim
Ann Coloproctol. 2018;34(1):52-55.   Published online February 28, 2018
DOI: https://doi.org/10.3393/ac.2018.34.1.52
  • 7,198 View
  • 86 Download
  • 1 Web of Science
  • 1 Citations
AbstractAbstract PDF

We experienced a case of 1 patient who died from rhabdomyolysis-related complications after colonoscopy. A 60-year-old man had undergone an ‘uncomplicated’ colonoscopic polypectomy. Approximately 10 hours following this procedure, the patient complained of increasing left abdominal pain. His computed tomography image showed free gas, but his operative findings revealed no macroscopic perforation or abscess formation. Eight hours after the operation, the patient presented with myoglobulinuria, and we diagnosed the condition to be rhabdomyolysis. Based on this case, we recommend that rhabdomyolysis be added to the list of complications following a colonoscopic procedure. Moreover, for prevention and early treatment, endoscopists should be attentive to the risk factors and signs/symptoms of rhabdomyolysis.

Citations

Citations to this article as recorded by  
  • Rhabdomyolysis following colorectal endoscopic submucosal dissection: A case report
    Ying Chen, Wenxuan Zhang, Junqiang Cai, Min Zhong
    Clinical Case Reports.2024;[Epub]     CrossRef
Colorectal Perforation After Anorectal Manometry for Low Anterior Resection Syndrome
Kyung Ha Lee, Ji Yeon Kim, Young Hoon Sul
Ann Coloproctol. 2017;33(4):146-149.   Published online August 31, 2017
DOI: https://doi.org/10.3393/ac.2017.33.4.146
  • 6,318 View
  • 76 Download
  • 8 Web of Science
  • 7 Citations
AbstractAbstract PDF

We experienced 3 cases of manometry-induced colon perforation. A 75-year-old man (case 1) underwent anorectal manometry (ARM) 3 years after radiotherapy for prostate cancer and a laparoscopic intersphincteric resection for rectal cancer. A 70-year-old man (case 2) underwent ARM 3 months after conventional neoadjuvant chemoradiotherapy and a laparoscopic low anterior resection for rectal cancer. A 78-year-old man (case 3) underwent ARM 2 months after a laparoscopic intersphincteric resection for rectal cancer. In all cases, a colon perforation with fecal peritonitis occurred. All were treated successfully using prompt and active operations and were discharged without any complications. ARM with a balloon, as a measure of rectal compliance, should be performed 2 months or longer after surgery. If a perforation occurs, prompt and active surgical intervention is necessary due to the high possibility of extensive fecal peritonitis.

Citations

Citations to this article as recorded by  
  • The Japan Society of Coloproctology Practice Guidelines for Fecal Incontinence 2024 (Revised Second Edition)
    Keiji Koda, Toshiki Mimura, Tetsuo Yamana, Mitsuru Ishizuka, Tomoko Takahashi, Shota Takano, Tatsuya Abe, Yuji Nishizawa, Hidetoshi Katsuno, Masami Sato, Kaoru Nishimura, Masahiro Yoshida, Kotaro Maeda
    Journal of the Anus, Rectum and Colon.2026; 10(1): 64.     CrossRef
  • Colorectal perforation following anorectal manometry in a patient with anal stenosis post rectal prolapse repair: a rare complication
    Leanne Iorio, Monique Couto Matos, Benjamin Linkous, Marco Ferrara, Antonio Caycedo
    Journal of Surgical Case Reports.2025;[Epub]     CrossRef
  • Effect of low anterior resection syndrome on quality of life in colorectal cancer patients: A retrospective observational study
    Dong-Ai Jin, Fang-Ping Gu, Tao-Li Meng, Xuan-Xuan Zhang
    World Journal of Gastrointestinal Surgery.2023; 15(10): 2123.     CrossRef
  • Functional anorectal studies in patients with low anterior resection syndrome
    Ssu‐Chi Chen, Kaori Futaba, Wing Wa Leung, Cherry Wong, Tony Mak, Simon Ng, Hans Gregersen
    Neurogastroenterology & Motility.2022;[Epub]     CrossRef
  • Variation in rectoanal inhibitory reflex after laparoscopic intersphincteric resection for ultralow rectal cancer
    Bin Zhang, Ke Zhao, Yu‐Juan Zhao, Shu‐Hui Yin, Guang‐Zuan Zhuo, Yong Zhao, Jian‐Hua Ding
    Colorectal Disease.2021; 23(2): 424.     CrossRef
  • Broken beer bottle as a cause of sigmoid perforation
    Christian German Ospina-Pérez, Ana Milena Álvarez-Acuña, Lina María López-Álvarez, Rosa María Ospina-Pérez, Ivan David Lozada-Martínez, Sabrina Rahman
    International Journal of Surgery Case Reports.2021; 85(C): 106261.     CrossRef
  • Assessment of defecation function after sphincter-saving resection for mid to low rectal cancer: A cross-sectional study
    Bao-Jia Luo, Mei-Chun Zheng, Yang Xia, Zhu Ying, Jian-Hong Peng, Li-Ren Li, Zhi-Zhong Pan, Hui-Ying Qin
    European Journal of Oncology Nursing.2021; 55: 102059.     CrossRef
Original Articles
Usefulness of Anorectal Manometry for Diagnosing Continence Problems After a Low Anterior Resection
Audrius Dulskas, Narimantas E. Samalavicius
Ann Coloproctol. 2016;32(3):101-104.   Published online June 30, 2016
DOI: https://doi.org/10.3393/ac.2016.32.3.101
  • 6,275 View
  • 52 Download
  • 18 Web of Science
  • 21 Citations
AbstractAbstract PDF
Purpose

For several decades, the low anterior resection (LAR) with total mesorectal excision (TME) has been the gold standard for treating patients with rectal cancer. Up to 90% of patients undergoing sphincter-preserving surgery will have changes in bowel habits, so-called 'anterior resection syndrome.' This study examined patients' continence after a LAR for the treatment of rectal cancer.

Methods

This prospective study was performed between September 2014 and August 2015 at the National Cancer Institute and included 30 patients who underwent anorectal manometry preoperatively and at 3 and 4 months after a LAR, but 10 were excluded from further evaluation for various reasons. Wexner score was recorded preoperatively and 4 months after LAR (1 month after ileostomy repair).

Results

Postoperatively, 70% of patients complained of some degree of soiling (incontinence to liquid stool), and 30% experienced urgent defecation. Four months after surgery, these symptoms had somewhat abated. The anal resting pressure and the maximum squeezing pressure did not change significantly. Rectal capacity and compliance were reduced in all patients. The majority of patients demonstrated manometric anorectal changes and clinical anorectal function disorders during the first 4 months after surgery. The Wexner scores and the manometric findings showed no correlation.

Conclusion

Many patients undergoing a LAR with TME for the treatment of rectal cancer experience some degree of incontinence postoperatively. Anorectal manometry may be used as an additional tool for evaluating problems with continence after a LAR. No correlation between the Wexner score and the manometric findings was observed.

Citations

Citations to this article as recorded by  
  • Impact of timing of ileostomy reversal and anastomotic leakage on bowel function and health-related quality of life following rectal cancer surgery: a cross-sectional study
    Ditte Reitz Petersen, Pia Møller Faaborg, Issam Al-Najami, Maja Mi Thygesen, Anna Pilegaard Bjarnesen Mølstrøm, Sören Möller, Mark Bremholm Ellebæk
    Surgical Endoscopy.2026; 40(4): 2848.     CrossRef
  • Long-term Survival and Functional Outcomes of Laparoscopic Surgery for Clinical Stage I Ultra-low Rectal Cancers Located Within 5 cm of the Anal Verge
    Masaaki Ito, Yuichiro Tsukada, Jun Watanabe, Yosuke Fukunaga, Yasumitsu Hirano, Kazuhiro Sakamoto, Hiroki Hamamoto, Masanori Yoshimitsu, Hisanaga Horie, Nobuhisa Matsuhashi, Yoshiaki Kuriu, Shuntaro Nagai, Madoka Hamada, Shinichi Yoshioka, Shinobu Ohnuma,
    Annals of Surgery.2025; 281(2): 304.     CrossRef
  • Low Anterior Resection Syndrome (LARS): A Contemporary Surgical Review of Incidence, Pathophysiology, Risk Stratification and Functional Outcomes
    Supreet Kumar, Vivek Tandon, Deepak Govil
    Apollo Medicine.2025;[Epub]     CrossRef
  • Long term persistence and risk factors for anorectal symptoms following low anterior resection for rectal cancer
    E. Koifman, M. Armoni, Y. Gorelik, A. Harbi, Y. Streltsin, S. D. Duek, R. Brun, Y. Mazor
    BMC Gastroenterology.2024;[Epub]     CrossRef
  • Effect of neoadjuvant chemoradiation on anorectal function assessed with anorectal manometry: A systematic review and meta-analysis
    Pamela Milito, Guglielmo Niccolò Piozzi, Mohammad Iqbal Hussain, Tommaso A. Dragani, Luca Sorrentino, Maurizio Cosimelli, Marcello Guaglio, Luigi Battaglia
    Tumori Journal.2024; 110(4): 284.     CrossRef
  • Low anterior resection syndrome
    Matthew C. Hernandez, Paul Wong, Kurt Melstrom
    Journal of Surgical Oncology.2023; 127(8): 1271.     CrossRef
  • Effects of neoadjuvant radiochemotherapy for anorectal function in locally advanced rectal cancer patients: a study protocol for a prospective, observational, controlled, multicentre study
    Jie Shi, Yi-Kan Cheng, Fang He, Jian Zheng, Yun-Long Wang, Xiang-Bo Wan, Hong-Cheng Lin, Xin-Juan Fan
    BMC Cancer.2023;[Epub]     CrossRef
  • Should anorectal manometry be routine before stoma reversal in patients after an intersphincteric resection?
    Mufaddal Kazi, Bhushan Jajoo, Jitender Rohila, Sayali Dohale, Chaitali Nashikkar, Rajesh Sainani, Prajesh Bhuta, Ashwin Desouza, Avanish Saklani
    Colorectal Disease.2023; 25(8): 1638.     CrossRef
  • Optimizing the Utility of Anorectal Manometry for Diagnosis and Therapy: A Roundtable Review and Recommendations
    Satish S.C. Rao, Nitin K. Ahuja, Adil E. Bharucha, Darren M. Brenner, William D. Chey, Jill K. Deutsch, David C. Kunkel, Baharak Moshiree, Leila Neshatian, Robert M. Reveille, Gregory S. Sayuk, Jordan M. Shapiro, Eric D. Shah, Kyle Staller, Steven D. Wexn
    Clinical Gastroenterology and Hepatology.2023; 21(11): 2727.     CrossRef
  • Clinical impact of the triple‐layered circular stapler for reducing the anastomotic leakage in rectal cancer surgery: Porcine model and multicenter retrospective cohort analysis
    Ryota Nakanishi, Yoshiaki Fujimoto, Masahiko Sugiyama, Yuichi Hisamatsu, Tomonori Nakanoko, Koji Ando, Mitsuhiko Ota, Yasue Kimura, Eiji Oki, Tomoharu Yoshizumi
    Annals of Gastroenterological Surgery.2022; 6(2): 256.     CrossRef
  • Troubles de la motricité anorectale : troubles fonctionnels de la défécation et incontinence fécale
    C. Desprez, V. Bridoux, A.-M. Leroi
    Journal de Chirurgie Viscérale.2022; 159(1): S46.     CrossRef
  • Disorders of anorectal motility: Functional defecation disorders and fecal incontinence
    C. Desprez, V. Bridoux, A.-M. Leroi
    Journal of Visceral Surgery.2022; 159(1): S40.     CrossRef
  • Long-Term Anorectal Manometry Outcomes After Laparoscopic and Transanal Total Mesorectal Excision
    Ana López-Sánchez, Antonio Morandeira-Rivas, Carlos Moreno-Sanz, Francisco Javier Cortina-Oliva, Marina Manzanera-Díaz, Jhonny David Gonzales-Aguilar
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2021; 31(4): 395.     CrossRef
  • Assessment of defecation function after sphincter-saving resection for mid to low rectal cancer: A cross-sectional study
    Bao-Jia Luo, Mei-Chun Zheng, Yang Xia, Zhu Ying, Jian-Hong Peng, Li-Ren Li, Zhi-Zhong Pan, Hui-Ying Qin
    European Journal of Oncology Nursing.2021; 55: 102059.     CrossRef
  • Functional outcomes after sphincter-preserving surgeries for low-lying rectal cancer: A review
    Eun Jung Park, Seung Hyuk Baik
    Precision and Future Medicine.2021; 5(4): 164.     CrossRef
  • Predictors of permanent stoma creation in patients with mid or low rectal cancer: results of a multicentre cohort study with preoperative evaluation of anal function
    S. Kim, M. H. Kim, J. H. Oh, S.‐Y. Jeong, K. J. Park, H.‐K. Oh, D.‐W. Kim, S.‐B. Kang
    Colorectal Disease.2020; 22(4): 399.     CrossRef
  • Preoperative incremental maximum squeeze pressure as a predictor of fecal incontinence after very low anterior resection for low rectal cancer
    Masatoshi Kochi, Hiroyuki Egi, Tomohiro Adachi, Yuji Takakura, Shoichiro Mukai, Kazuhiro Taguchi, Ikki Nakashima, Yusuke Sumi, Shintaro Akabane, Koki Sato, Hisaaki Yoshinaka, Minoru Hattori, Hideki Ohdan
    Surgery Today.2020; 50(5): 516.     CrossRef
  • Manometric assessment of anorectal function after transanal total mesorectal excision
    M. X. Bjoern, S. K. Perdawood
    Techniques in Coloproctology.2020; 24(3): 231.     CrossRef
  • Assessments of Pudendal Motor and Sensory Nerves in Patients with or without Fecal Incontinence after Low Anterior Resection for Lower Rectal Cancer
    Ryouichi Tomita, Sakurai Kenichi, Shigeru Fujisaki
    Journal of Cancer Therapy.2020; 11(04): 220.     CrossRef
  • Postoperative Bowel Function After Anal Sphincter-Preserving Rectal Cancer Surgery: Risks Factors, Diagnostic Modalities, and Management
    Chris George Cura Pales, Sanghyun An, Jan Paolo Cruz, Kwangmin Kim, Youngwan Kim
    Annals of Coloproctology.2019; 35(4): 160.     CrossRef
  • Effectiveness of Pelvic Floor Rehabilitation for Bowel Dysfunction After Intersphincteric Resection for Lower Rectal Cancer
    Hideaki Nishigori, Masayuki Ishii, Yujiro Kokado, Kouji Fujimoto, Hiroshi Higashiyama
    World Journal of Surgery.2018; 42(10): 3415.     CrossRef
Short-term Outcomes of an Extralevator Abdominoperineal Resection in the Prone Position Compared With a Conventional Abdominoperineal Resection for Advanced Low Rectal Cancer: The Early Experience at a Single Institution
Seungwan Park, Hyuk Hur, Byung Soh Min, Nam Kyu Kim
Ann Coloproctol. 2016;32(1):12-19.   Published online February 29, 2016
DOI: https://doi.org/10.3393/ac.2016.32.1.12
  • 8,040 View
  • 47 Download
  • 11 Web of Science
  • 10 Citations
AbstractAbstract PDF
Purpose

This study compared the perioperative and pathologic outcomes between an extralevator abdominoperineal resection (APR) in the prone position and a conventional APR.

Methods

Between September 2011 and March 2014, an extralevator APR in the prone position was performed on 13 patients with rectal cancer and a conventional APR on 26 such patients. Patients' demographics and perioperative and pathologic outcomes were obtained from the colorectal cancer database and electronic medical charts.

Results

Age and preoperative carcinoembryonic antigen (CEA) level were significantly different between the conventional and the extralevator APR in the prone position (median age, 65 years vs. 55 years [P = 0.001]; median preoperative CEA level, 4.94 ng/mL vs. 1.81 ng/mL [P = 0.011]). For perioperative outcomes, 1 (3.8%) intraoperative bowel perforation occurred in the conventional APR group and 2 (15.3%) in the extralevator APR group. In the conventional and extralevator APR groups, 12 (46.2%) and 6 patients (46.2%) had postoperative complications, and 8 (66.7%) and 2 patients (33.4%) had major complications (Clavien-Dindo III/IV), respectively. The circumferential resection margin involvement rate was higher in the extralevator APR group compared with the conventional APR group (3 of 13 [23.1%] vs. 3 of 26 [11.5%]).

Conclusion

The extralevator APR in the prone position for patients with advanced low rectal cancer has no advantages in perioperative and pathologic outcomes over a conventional APR for such patients. However, through early experience with a new surgical technique, we identified various reasons for the lack of favorable outcomes and expect sufficient experience to produce better peri- or postoperative outcomes.

Citations

Citations to this article as recorded by  
  • Abdominoperineal Resection in Prone Versus Supine Position: A Systematic Review and Meta-Analysis
    Bernardo Fontel Pompeu, Eric Pasqualotto, Beatriz D'Andrea Pigossi, Matheus Reginato Araujo, Lucas Monteiro Delgado, Lucas Soares de Souza Pinto Guedes, Sergio Mazzola Poli de Figueiredo, Fernanda Bellotti Formiga
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2025; 35(3): 224.     CrossRef
  • Management of left-sided malignant colorectal obstructions with curative intent: a network meta-analysis
    Tyler McKechnie, Jeremy E. Springer, Zacharie Cloutier, Victoria Archer, Karim Alavi, Aristithes Doumouras, Dennis Hong, Cagla Eskicioglu
    Surgical Endoscopy.2023; 37(6): 4159.     CrossRef
  • Prone Versus Supine Position in Abdominoperineal Resection: Outcomes in the Laparoscopic Era
    Cecilia Ferrari, Carmen Martinez Sanchez, Jesus Bollo, Pilar Hernandez, Lorena Cambeiro, Claudia Codina, Eduardo Targarona
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2021; 31(4): 382.     CrossRef
  • Surgical Treatment of Low-Lying Rectal Cancer: Updates
    Cristopher Varela, Nam Kyu Kim
    Annals of Coloproctology.2021; 37(6): 395.     CrossRef
  • Perioperative and oncological outcomes of abdominoperineal resection in the prone position vs the classic lithotomy position: A systematic review with meta‐analysis
    Jose Wilson B. Mesquita‐Neto, Hassan Mouzaihem, Francisco Igor B. Macedo, Lance K. Heilbrun, Donald W. Weaver, Steve Kim
    Journal of Surgical Oncology.2019; 119(7): 979.     CrossRef
  • Prone Compared With Lithotomy for Abdominoperineal Resection: A Systematic Review and Meta-analysis
    Tyler McKechnie, Yung Lee, Jeremy E. Springer, Aristithes G. Doumouras, Dennis Hong, Cagla Eskicioglu
    Journal of Surgical Research.2019; 243: 469.     CrossRef
  • Perineal Wound Complications After Extralevator Abdominoperineal Excision for Low Rectal Cancer
    Jia Gang Han, Zhen Jun Wang, Zhi Gang Gao, Guang Hui Wei, Yong Yang, Zhi Wei Zhai, Bao Cheng Zhao, Bing Qiang Yi
    Diseases of the Colon & Rectum.2019; 62(12): 1477.     CrossRef
  • Critical and Challenging Issues in the Surgical Management of Low-Lying Rectal Cancer
    Aeris Jane D. Nacion, Youn Young Park, Seung Yoon Yang, Nam Kyu Kim
    Yonsei Medical Journal.2018; 59(6): 703.     CrossRef
  • EXTRALEVATOR ABDOMINOPERINEAL EXCISION OF THE RECTUM: SHORT-TERM OUTCOMES IN COMPARISON WITH CONVENTIONAL SURGERY
    R. A. Murashko, I. B. Uvarov, E. A. Ermakov, V. B. Kaushanskiy, R. V. Konkov, D. D. Sichinava, B. N. Sadikov
    Koloproktologia.2017; (4): 34.     CrossRef
  • Extralevator Abdominoperineal Resection in the Prone Position
    Young Jin Kim
    Annals of Coloproctology.2016; 32(1): 1.     CrossRef
Case Report
Mesh-Based Transperineal Repair of a Perineal Hernia After a Laparoscopic Abdominoperineal Resection
Taek-Gu Lee, Sang-Jeon Lee
Ann Coloproctol. 2014;30(4):197-200.   Published online August 26, 2014
DOI: https://doi.org/10.3393/ac.2014.30.4.197
  • 6,592 View
  • 60 Download
  • 12 Web of Science
  • 11 Citations
AbstractAbstract PDF

A perineal hernia (PH) is formed by a protrusion of intra-abdominal viscera through a defect in the pelvic floor. This is a rare complication after a conventional abdominoperineal resection (APR). However, the risk of a PH may be increased after a laparoscopic resection because this technique can cause fewer postoperative adhesions, predisposing the small bowel to sliding down toward the pelvis. However, only a few case reports describe the transperineal approach for the repair of a PH after a laparoscopic APR. We present a case of a PH after a laparoscopic APR; the PH was repaired with synthetic mesh by using a transperineal approach. A transperineal approach using a mesh to reconstruct the pelvic floor is less invasive and more effective. We suggest that this technique should probably be the first choice for treating an uncomplicated PH that occurs after a laparoscopic APR.

Citations

Citations to this article as recorded by  
  • Perineal Hernias: Diagnosis and surgical management
    Ahad Azimuddin, Saieesh A. Rao, Mohammad Ali Abbass
    Seminars in Colon and Rectal Surgery.2026; 37(1): 101162.     CrossRef
  • Perineal hernia repair with synthetic mesh and bivectorial gluteus maximus myocutaneous island flap
    Inês Carreira, Nelson Teixeira, Alexandra Rosa, José Guerreiro, Joana Pedro Marques
    JPRAS Open.2025; 46: 679.     CrossRef
  • Perineal hernia after abdominoperineal resection – a systematic review
    Sajad Ahmad Salati, Amr Y. Arkoubi
    Polish Journal of Surgery.2022; 94(6): 61.     CrossRef
  • The impact of laparoscopic technique on the rate of perineal hernia after abdominoperineal resection of the rectum
    Anna J. Black, Ahmer Karimuddin, Manoj Raval, Terry Phang, Carl J. Brown
    Surgical Endoscopy.2021; 35(6): 3014.     CrossRef
  • The Application of Extraperitoneal Ostomy Combined with Pelvic Peritoneal Reconstruction in Laparoscopic Abdominoperineal Resection for Rectal Cancer
    Sen Wang, Qingyang Meng, Jun Gao, Yuqin Huang, Jie Wang, Yang Chong, Youquan Shi, Huaicheng Zhou, Wei Wang, Dong Tang, Daorong Wang
    Gastroenterology Research and Practice.2019; 2019: 1.     CrossRef
  • Perineal hernia mesh repair: a fixation with glue, sutures and tacks. How to do it 
    L. Hassan, A. Beunis, M. Ruppert, V. Dhooghe, S. Van den Broeck, G. Hubens, N. Komen
    Acta Chirurgica Belgica.2019; 119(6): 406.     CrossRef
  • Case report of perineal hernia after laparoscopic abdominoperineal resection
    Kumpei Honjo, Kazuhiro Sakamoto, Shunsuke Motegi, Ryoichi Tsukamoto, Shinya Munakata, Kiichi Sugimoto, Hirohiko Kamiyama, Makoto Takahashi, Yutaka Kojima, Tetsu Fukunaga, Yoshiaki Kajiyama, Seiji Kawasaki
    Asian Journal of Endoscopic Surgery.2018; 11(2): 173.     CrossRef
  • Transvaginal Small Bowel Evisceration following Abdominoperineal Resection
    Enver Kunduz, Huseyin Bektasoglu, Samet Yigman, Huseyin Akbulut
    Case Reports in Surgery.2018; 2018: 1.     CrossRef
  • Composite mesh and gluteal fasciocutaneous rotation flap for perineal hernia repair after abdominoperineal resection: a novel technique
    Marios Papadakis, Gunnar Hübner, Marzena Bednarek, Mohamed Arafkas
    Updates in Surgery.2017; 69(1): 109.     CrossRef
  • Perineal hernia repair after abdominoperineal excision or extralevator abdominoperineal excision: a systematic review of the literature
    A. Balla, G. Batista Rodríguez, N. Buonomo, C. Martinez, P. Hernández, J. Bollo, E. M. Targarona
    Techniques in Coloproctology.2017; 21(5): 329.     CrossRef
  • Short-term Outcomes of an Extralevator Abdominoperineal Resection in the Prone Position Compared With a Conventional Abdominoperineal Resection for Advanced Low Rectal Cancer: The Early Experience at a Single Institution
    Seungwan Park, Hyuk Hur, Byung Soh Min, Nam Kyu Kim
    Annals of Coloproctology.2016; 32(1): 12.     CrossRef
Original Article
Association Between a Close Distal Resection Margin and Recurrence After a Sphincter-Saving Resection for T3 Mid- or Low-Rectal Cancer Without Radiotherapy
Jae Woong Han, Min Jae Lee, Ha Kyung Park, Jae Ho Shin, Min Sung An, Tae Kwun Ha, Kwang Hee Kim, Ki Beom Bae, Tae Hyun Kim, Chang Soo Choi, Sang Hoon Oh, Min Kyung Oh, Mi Seon Kang, Kwan Hee Hong
Ann Coloproctol. 2013;29(6):231-237.   Published online December 31, 2013
DOI: https://doi.org/10.3393/ac.2013.29.6.231
  • 5,816 View
  • 23 Download
  • 7 Citations
AbstractAbstract PDF
Purpose

To maintain the patient's quality of life, surgeons strive to preserve the sphincter during rectal cancer surgery. This study evaluated the oncologic safety of a sphincter-saving resection with a distal resection margin (DRM) <1 cm without radiotherapy in T3, mid- or low-rectal cancer.

Methods

This retrospective study enrolled 327 patients who underwent a sphincter-saving resection for proven T3 rectal cancer located <10 cm from the anal verge and without radiotherapy between January 1995 and December 2011. The oncologic outcomes included the 5-year cancer-specific survival, the local recurrence, and the systemic recurrence rates.

Results

In groups A (DRM ≤1 cm) and B (DRM >1 cm), the 5-year cancer-specific survival rates were 81.57% and 80.03% (P = 0.8543), the 5-year local recurrence rates were 6.69% and 9.52% (P = 0.3981), and the 5-year systemic recurrence rates were 19.46% and 23.11% (P = 0.5750), respectively.

Conclusion

This study showed that the close DRM itself should not be a contraindication for a sphincter-saving resection for T3 mid- or low-rectal cancer without radiotherapy. However, a prospective randomized controlled trial including the effect of adjuvant therapy will be needed.

Citations

Citations to this article as recorded by  
  • The Impact of Narrow and Infiltrated Distal Margin After Proctectomy for Rectal Cancer on Patients’ Outcomes: a Systematic Review and Meta-analysis
    Islam H. Metwally, Mohammad Zuhdy, Omar Hamdy, Ahmed M. Fareed, Saleh S. Elbalka
    Indian Journal of Surgical Oncology.2022; 13(4): 750.     CrossRef
  • Association of levels of metabolites with the safe margin of rectal cancer surgery: a metabolomics study
    Shaopeng Zhang, Guoqiang Pan, Zhifeng Liu, Yuan Kong, Daguang Wang
    BMC Cancer.2022;[Epub]     CrossRef
  • Distal resection margins in rectal cancer specimens: differences in assessment between surgeons and pathologists and the influence of neoadjuvant chemoradiation
    T. L. Ghezzi, C. Tarta, P. C. Contu, A. R. Lazzaron, B. M. Contin, L. M. Kliemann, D. C. Damin
    Updates in Surgery.2021; 73(5): 1787.     CrossRef
  • Surgical margins in squamous cell carcinoma, different for the vulva?
    Noortje Pleunis, Maria E.J. Leermakers, Anneke A. van der Wurff, Paul J.J.M. Klinkhamer, Nicole P.M. Ezendam, Dorry Boll, Joanne A. de Hullu, Johanna M.A. Pijnenborg
    European Journal of Surgical Oncology.2018; 44(10): 1555.     CrossRef
  • Continuous Effect of Radial Resection Margin on Recurrence and Survival in Rectal Cancer Patients Who Receive Preoperative Chemoradiation and Curative Surgery: A Multicenter Retrospective Analysis
    SooYoon Sung, Sung Hwan Kim, Joo Hwan Lee, Taek Keun Nam, Songmi Jeong, Hong Seok Jang, Jin Ho Song, Jeong Won Lee, Jung Min Bae, Jong Hoon Lee
    International Journal of Radiation Oncology*Biology*Physics.2017; 98(3): 647.     CrossRef
  • Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial
    Shapour Omidvari, Shadi Zohourinia, Mansour Ansari, Leila Ghahramani, Mohammad Zare-Bandamiri, Ahmad Mosalaei, Niloofar Ahmadloo, Saeedeh Pourahmad, Hamid Nasrolahi, Sayed Hasan Hamedi, Mohammad Mohammadianpanah
    Annals of Coloproctology.2015; 31(4): 123.     CrossRef
  • Safe Distal Resection Margin in Patients With T3 Mid and Distal Rectal Cancer Who Underwent a Sphincter-Saving Resection Without Preoperative Radiotherapy
    Bong Hwa Lee, Hyoung Chul Park, Min Jeong Kin, Mi Young Jang
    Annals of Coloproctology.2013; 29(6): 219.     CrossRef
Case Report
Intramural Recurrence Without Mucosal Lesions After an Endoscopic Mucosal Resection for Early Colorectal Cancer
Min Sung Kim, Nam Kyu Kim, Ji Hye Park
Ann Coloproctol. 2013;29(3):126-129.   Published online June 30, 2013
DOI: https://doi.org/10.3393/ac.2013.29.3.126
  • 5,244 View
  • 30 Download
  • 7 Citations
AbstractAbstract PDF

Advances in endoscopic instruments and techniques have enabled increased detection and removal of early colorectal cancer (ECC), which is defined as a tumor whose invasion is limited to the mucosa or submucosa. Some cases can be treated by endoscopic mucosal resection (EMR). However, local recurrence frequently occurs after an EMR for ECC. The recurrence pattern is usually intramural recurrence with a mucosal lesion at the EMR's site. We report the cases of two patients with intramural recurrence without mucosal lesions after an EMR for ECC. These cases indicate that a local recurrence after an EMR for ECC can appear as an intramural recurrence without mucosal lesions at a previous EMR site or another site, although this presentation is very unusual.

Citations

Citations to this article as recorded by  
  • Multidisciplinary Treatment Strategy for Early Colon Cancer: A Review-An English Version
    Gyung Mo Son, Su Bum Park, Tae Un Kim, Byung-Soo Park, In Young Lee, Joo-Young Na, Dong Hoon Shin, Sang Bo Oh, Sung Hwan Cho, Hyun Sung Kim, Hyung Wook Kim
    Journal of the Anus, Rectum and Colon.2022; 6(4): 203.     CrossRef
  • Growth-inhibition of S180 residual-tumor by combination of cyclophosphamide and chitosan oligosaccharides in vivo
    Xingchen Zhai, Shoujun Yuan, Xin Yang, Pan Zou, Yong Shao, A.M. Abd El-Aty, Ahmet Hacımüftüoğlu, Jing Wang
    Life Sciences.2018; 202: 21.     CrossRef
  • Handling and Pathology Reporting of Gastrointestinal Endoscopic Mucosal Resection
    Bita Geramizadeh, David A. Owen
    Middle East Journal of Digestive Diseases.2017; 9(1): 5.     CrossRef
  • Feasibility of mesorectal vascular invasion in predicting early distant metastasis in patients with stage T3 rectal cancer based on rectal MRI
    Young Chul Kim, Jai Keun Kim, Myeong-Jin Kim, Jei Hee Lee, Young Bae Kim, Sung Jae Shin
    European Radiology.2016; 26(2): 297.     CrossRef
  • Antitumor Effects of Orally and Intraperitoneally Administered Chitosan Oligosaccharides (COSs) on S180‐Bearing/Residual Mouse
    Pan Zou, Xin Yang, Yanxin Zhang, Pengfei Du, Shoujun Yuan, Dexuan Yang, Jing Wang
    Journal of Food Science.2016;[Epub]     CrossRef
  • Re-evaluation of indications and outcomes of endoscopic excision procedures for colorectal tumors: a review
    S. Cai, Y. Zhong, P. Zhou, J. Xu, L. Yao
    Gastroenterology Report.2014; 2(1): 27.     CrossRef
  • Anticancer activity of tuftsin-derived T peptide in postoperative residual tumors
    Yinghong An, Linna Li, Dexuan Yang, Na Jia, Chengwang Xu, Qiong Wang, Shanshan Wang, Shoujun Yuan
    Anti-Cancer Drugs.2014; 25(8): 857.     CrossRef
Review
The Role of Surgery for Asymptomatic Primary Tumors in Unresectable Stage IV Colorectal Cancer
Young Wan Kim, Ik Yong Kim
Ann Coloproctol. 2013;29(2):44-54.   Published online April 30, 2013
DOI: https://doi.org/10.3393/ac.2013.29.2.44
  • 7,810 View
  • 40 Download
  • 29 Citations
AbstractAbstract PDF

There are still debates regarding the appropriate primary treatment policy for asymptomatic primary colorectal lesions in cases of unresectable metastatic colorectal cancer. Even though there are patients with asymptomatic primary tumors when starting chemotherapy, those patients may still undergo surgery due to complications related to primary tumors in the middle of chemotherapy; therefore, controversy exists regarding surgical resection of primary colorectal lesions in cases where symptoms are absent when making a diagnosis. Thus, based on the published literature, we discuss opinions that prefer first-line surgery for primary tumors as well as opinions favoring first-line chemotherapy for treating unresectable synchronous metastatic colorectal cancer. Although the upfront chemotherapy including targeted agents is suggested as an effective treatment in recent years, the first line surgery has been a preferred treatment for decades. The first line surgery is beneficial to prolong the survival duration given the retrospective analysis of randomized trial data. So far, no prospective comparison study has only focused on the first-line treatment modality; thus, future clinical studies focusing on the survival duration and the quality of life should be performed as soon as possible. Furthermore, at this point, multidisciplinary team approaches would be helpful in finding the appropriate therapy. Regardless of symptoms, the performance status and the tumor burden should be taken into consideration as well. In case of surgical resection, minimally invasive surgery, such as laparoscopic surgery, is recommended.

Citations

Citations to this article as recorded by  
  • Self-Expanding Metal Stents as an Alternative to Palliative Surgery in Advanced Obstructive Colorectal Cancer—A Systematic Review and Meta-Analysis
    Vlad Rotaru, Elena Chitoran, Giuseppe Gullo, Daniela Viorica Mosoiu, Laurentiu Simion
    Journal of Clinical Medicine.2025; 14(12): 4339.     CrossRef
  • Randomized non-inferiority single-center prospective trial of malignant colonic obstruction therapy with Self-expandable metal stent (SEMS) endoscopic placement or stoma formation
    I.E. Gorovaia, P.V. Tsarkov, P.V. Pavlov, I.A. Tulina, V.I. Zhurkovskiy
    Endoscopic Surgery.2024; 30(2): 5.     CrossRef
  • Fístula anastomótica y reingreso no programado al quirófano en cirugía oncológica colorrectal electiva: experiencia de un centro de alta complejidad
    Diego Téllez, Daniela Yucuma, María Díaz, Saúl-Javier Rúgeles, Luis Jorge Lombana
    Revista Mexicana de Coloproctología Enfermedades del Ano, Recto y Colon.2024; 20(1): 19.     CrossRef
  • Palliative procedures for advanced obstructive colorectal cancer: a systematic review and meta-analysis
    Bingqing Ma, Tianxing Ren, Chengjun Cai, Biao Chen, Jinxiang Zhang
    International Journal of Colorectal Disease.2024;[Epub]     CrossRef
  • Impact of primary tumor resection on the survival of patients with unresectable colon cancer liver metastasis at different colonic subsites: a propensity score matching analysis
    Jiefeng Zhao, Jinfeng Zhu, Chao Huang, Rongfa Yuan, Zhengming Zhu
    Acta Chirurgica Belgica.2023; 123(2): 132.     CrossRef
  • Prognosis of patients with unresectable stage IV Colon cancer undergoing primary tumor resection: A multicenter study of minimally symptomatic or asymptomatic primary tumor
    Man Fung Ho, Victoria Cindy Lai, Dennis Chung Kei Ng, Simon Siu Man Ng
    Asian Journal of Surgery.2023; 46(9): 3710.     CrossRef
  • Asymptomatic Primary Tumor Resection in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
    Yefei Shu, Ling Xu, Wei Yang, Xiaofeng Xu, Song Zheng
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer
    Sanghyun An, Hongjin Shim, Kwangmin Kim, Bora Kim, Hui-Jae Bang, Hyejin Do, Hyang-Rae Lee, Youngwan Kim
    Annals of Coloproctology.2022; 38(2): 97.     CrossRef
  • Stenting as a bridge to surgery for obstructed stage IV colorectal cancers – long‐term outcomes of a 10‐year study
    Aik Yong Chok, Hui Jun Lim, Weng Kit Lye, Lasitha B Samarakoon, Jiwei Guo, Choong Leong Tang, Ronnie Mathew
    Asian Journal of Endoscopic Surgery.2020; 13(3): 343.     CrossRef
  • Frequency of unplanned surgery in patients with stage IV colorectal cancer receiving palliative chemotherapy with an intact primary: An analysis of SEER‐Medicare
    Patrick D. Lorimer, Benjamin M. Motz, Russell C. Kirks, Yimei Han, James T. Symanowski, Jimmy J. Hwang, Jonathan C. Salo, Joshua S. Hill
    Journal of Surgical Oncology.2019; 120(3): 407.     CrossRef
  • The American Society of Anesthesiologists score influences on postoperative complications and total hospital charges after laparoscopic colorectal cancer surgery
    Jae-Hyun Park, Dong-Hyun Kim, Bo-Ra Kim, Young-Wan Kim
    Medicine.2018; 97(18): e0653.     CrossRef
  • Identification of factors predictive of postoperative morbidity and short-term mortality in older patients after colorectal carcinoma resection: A single-center retrospective study
    Teresa Schreckenbach, Matthias Valentin Zeller, Hanan El Youzouri, Wolf Otto Bechstein, Guido Woeste
    Journal of Geriatric Oncology.2018; 9(6): 649.     CrossRef
  • The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor
    Qian-Kun Xie, Ping Chen, Wan-Ming Hu, Peng Sun, Wen-Zhuo He, Chang Jiang, Peng-Fei Kong, Shou-Sheng Liu, Hai-Tian Chen, Yuan-Zhong Yang, Dan Wang, Lin Yang, Liang-Ping Xia
    Journal of Translational Medicine.2018;[Epub]     CrossRef
  • Comparison of the Short-Term Outcomes of Laparoscopic and Open Resections for Colorectal Cancer in Patients with a History of Prior Median Laparotomy
    Young Wan Kim, Ik Yong Kim
    Indian Journal of Surgery.2017; 79(6): 527.     CrossRef
  • A Novel Derivation Predicting Survival After Primary Tumor Resection in Stage IV Colorectal Cancer: Validation of a Prognostic Scoring Model and an Online Calculator to Provide Individualized Survival Estimation
    Winson Jianhong Tan, Sreemanee Raaj Dorajoo, Madeline Yen Min Chee, Wah Siew Tan, Fung Joon Foo, Choong Leong Tang, Min Hoe Chew
    Diseases of the Colon & Rectum.2017; 60(9): 895.     CrossRef
  • Comparative effectiveness of chemotherapy vs resection of the primary tumour as the initial treatment in older patients with Stage IV colorectal cancer
    H. B. Mehta, G. M. Vargas, D. Adhikari, F. Dimou, T. S. Riall
    Colorectal Disease.2017;[Epub]     CrossRef
  • Primary tumor resection in stage IV unresectable colorectal cancer: what has changed?
    Michał Pędziwiatr, Magdalena Mizera, Jan Witowski, Piotr Major, Grzegorz Torbicz, Natalia Gajewska, Andrzej Budzyński
    Medical Oncology.2017;[Epub]     CrossRef
  • The influence of local therapy on the survival of patients with metastatic rectal cancer: a population-based, propensity-matched study
    Chi-Hao Zhang, Yuan-Bo Pan, Qing-Wei Zhang, Ou-Min Shi, Lei Zheng, Liang Gui, Meng Luo
    Journal of Cancer Research and Clinical Oncology.2017; 143(9): 1891.     CrossRef
  • Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis
    Rong-xin Zhang, Wen-juan Ma, Yu-ting Gu, Tian-qi Zhang, Zhi-mei Huang, Zhen-hai Lu, Yang-kui Gu
    World Journal of Surgical Oncology.2017;[Epub]     CrossRef
  • The impact of delayed commencement of adjuvant chemotherapy (eight or more weeks) on survival in stage II and III colon cancer: a national population-based cohort study
    Young Wan Kim, Eun Hee Choi, Bo Ra Kim, Woo-Ah Ko, Yeong-Mee Do, Ik Yong Kim
    Oncotarget.2017; 8(45): 80061.     CrossRef
  • Lymph node status as a prognostic factor after palliative resection of primary tumor for patients with metastatic colorectal cancer
    Qingguo Li, Changjian Wang, Yaqi Li, Xinxiang Li, Ye Xu, Guoxiang Cai, Peng Lian, Sanjun Cai
    Oncotarget.2017; 8(29): 48333.     CrossRef
  • Long-term outcomes of palliation for unresectable colorectal cancer obstruction in patients with good performance status: endoscopic stent versus surgery
    Hyo Jun Ahn, Sang Woo Kim, Sung Won Lee, Soon Wook Lee, Chul-Hyun Lim, Jin Su Kim, Yu Kyung Cho, Jae Myung Park, In Seok Lee, Myung-Gyu Choi
    Surgical Endoscopy.2016; 30(11): 4765.     CrossRef
  • Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal Cancer
    Hugh Colvin, Naohiro Nishida, Masamitsu Konno, Naotsugu Haraguchi, Hidekazu Takahashi, Junichi Nishimura, Taishi Hata, Koichi Kawamoto, Ayumu Asai, Kenta Tsunekuni, Jun Koseki, Tsunekazu Mizushima, Taroh Satoh, Yuichiro Doki, Masaki Mori, Hideshi Ishii
    Scientific Reports.2016;[Epub]     CrossRef
  • A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis
    S. R. Dorajoo, W. J. H. Tan, S. X. Koo, W. S. Tan, M. H. Chew, C. L. Tang, H. L. Wee, C. W. Yap
    International Journal of Colorectal Disease.2016; 31(2): 235.     CrossRef
  • Factors Affecting Use and Delay (≥8 Weeks) of Adjuvant Chemotherapy after Colorectal Cancer Surgery and the Impact of Chemotherapy-Use and Delay on Oncologic Outcomes
    Ik Yong Kim, Bo Ra Kim, Young Wan Kim, Ramon Andrade de Mello
    PLOS ONE.2015; 10(9): e0138720.     CrossRef
  • The Role of Palliative Resection for Asymptomatic Primary Tumor in Patients With Unresectable Stage IV Colorectal Cancer
    Jung-A Yun, Jung Wook Huh, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun
    Diseases of the Colon & Rectum.2014; 57(9): 1049.     CrossRef
  • A Meta-Analysis to Determine the Effect of Primary Tumor Resection for Stage IV Colorectal Cancer with Unresectable Metastases on Patient Survival
    Cillian Clancy, John P. Burke, Mitchel Barry, Matthew F. Kalady, J. Calvin Coffey
    Annals of Surgical Oncology.2014; 21(12): 3900.     CrossRef
  • Association Between Palliative Resection of the Primary Tumor and Overall Survival in a Population-Based Cohort of Metastatic Colorectal Cancer Patients
    Gillian Gresham, Daniel J. Renouf, Matthew Chan, Hagen F. Kennecke, Howard J. Lim, Carl Brown, Winson Y. Cheung
    Annals of Surgical Oncology.2014; 21(12): 3917.     CrossRef
  • Risk factors for the requirement of surgical or endoscopic interventions during chemotherapy in patients with uncomplicated colorectal cancer and unresectable synchronous metastases
    Jung-A Yun, Yoonah Park, Jung Wook Huh, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun
    Journal of Surgical Oncology.2014; 110(7): 839.     CrossRef
Original Articles
Feasibility of Hand-Assisted Laparoscopic Surgery as Compared to Open Surgery for Sigmoid Colon Cancer: A Case-Controlled Study
Sang Eun Nam, Eun-Joo Jung, Chun-Geun Ryu, Jin Hee Paik, Dae-Yong Hwang
Ann Coloproctol. 2013;29(1):17-21.   Published online February 28, 2013
DOI: https://doi.org/10.3393/ac.2013.29.1.17
  • 6,320 View
  • 18 Download
  • 5 Citations
AbstractAbstract PDF
Purpose

The aim of this study was to evaluate short-term clinical outcomes by comparing hand-assisted laparoscopic surgery (HALS) with open surgery for sigmoid colon cancer.

Methods

Twenty-six patients who underwent a hand-assisted laparoscopic anterior resection (HAL-AR group) and 52 patients who underwent a conventional open anterior resection during the same period were enrolled (open group) in this study with a case-controlled design.

Results

Pathologic parameters were similar between the two groups. The incidences of immediate postoperative leukocytosis were 38.5% in the HAL-AR group and 69.2% in the open group (P = 0.009). There were no significant differences between the two groups as to leukocyte count, hemoglobin, and hematocrits (P = 0.758, P = 0.383, and P = 0.285, respectively). Of the postoperative recovery indicators, first flatus, sips of water and soft diet started on postoperative days 3, 5, 7 in the HALS group and on days 4, 5, 6 in the open group showed statistical significance (P = 0.021, P = 0.259, and P = 0.174, respectively). Administration of additional pain killers was needed for 1.2 days in the HAL-AR group and 2.4 days in the open group (P = 0.002). No significant differences in the durations of hospital stay and the rates of postoperative complications were noted, and no postoperative mortality was encountered in either group.

Conclusion

The patients with sigmoid colon cancer who underwent a HAL-AR had a lower incidence of postoperative leukocytosis, less administration of pain killers, and faster first flatus than those who underwent open surgery. Clinical outcomes for patients' recovery and pathology status were similar between the two groups. Therefore, a HAL-AR for sigmoid colon cancer is feasible and has the same benefit as minimally invasive surgery.

Citations

Citations to this article as recorded by  
  • Hand-assisted laparoscopic surgery versus conventional open surgery in intraoperative and postoperative outcomes for colorectal cancer
    Xubing Zhang, Qingbin Wu, Chaoyang Gu, Tao Hu, Liang Bi, Ziqiang Wang
    Medicine.2017; 96(33): e7794.     CrossRef
  • Hand-Assisted Laparoscopic Surgery: A Versatile Tool for Colorectal Surgeons
    Ju Yong Cheong, Christopher J. Young
    Annals of Coloproctology.2017; 33(4): 125.     CrossRef
  • Hand-assisted laparoscopic vs open colectomy: an assessment from the American College of Surgeons National Surgical Quality Improvement Program procedure-targeted cohort
    Cigdem Benlice, Meagan Costedio, Luca Stocchi, Maher A. Abbas, Emre Gorgun
    The American Journal of Surgery.2016; 212(5): 808.     CrossRef
  • Learning curve for hand-assisted laparoscopic D2 radical gastrectomy
    Jia-Qing Gong
    World Journal of Gastroenterology.2015; 21(5): 1606.     CrossRef
  • Hand-assisted laparoscopic versus laparoscopy-assisted D2 radical gastrectomy: a prospective study
    JiaQing Gong, YongKuan Cao, YunMing Li, GuoHu Zhang, PeiHong Wang, GuoDe Luo
    Surgical Endoscopy.2014; 28(10): 2998.     CrossRef
Transanal Endoscopic Microsurgery for the Treatment of Well-Differentiated Rectal Neuroendocrine Tumors
Hyoung Ran Kim, Woo Yong Lee, Kyung Uk Jung, Hyuk Jun Chung, Chul Joong Kim, Hae-Ran Yun, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Ho-Kyung Chun
J Korean Soc Coloproctol. 2012;28(4):201-204.   Published online August 31, 2012
DOI: https://doi.org/10.3393/jksc.2012.28.4.201
  • 6,597 View
  • 35 Download
  • 11 Citations
AbstractAbstract PDF
Purpose

Recently, an increase in well-differentiated rectal neuroendocrine tumors (WRNETs) has been noted. We aimed to evaluate transanal endoscopic microsurgery (TEM) for the treatment of WRNETs.

Methods

Between December 1995 and August 2009, 109 patients with WRNETs underwent TEM. TEM was performed for patients with tumors sizes of up to 20 mm and without a lymphadenopathy. These patients had been referred from other clinics after having been diagnosed with WRNETs by using a colonoscopic biopsy; they had undergone a failed endoscopic submucosal dissection (ESD) or endoscopic mucosal resection (EMR) and exhibited an involved resection margin and remaining tumor after ESD or EMR, regardless of the distance from the anal verge. This study included 38 patients that had more than three years of follow-up.

Results

The mean age of the patients was 51.3 ± 11.9 years, the mean tumor size was 8.0 ± 3.9 mm, and no morbidity occurred. Thirty-five patients were asymptomatic. TEM was performed after a colonoscopic resection in 13 cases because of a positive resection margin, a residual tumor or a non-lifting lesion. Complete resections were performed in 37 patients; one patient with a positive margin was considered surgically complete. In one patient, liver metastasis and a recurrent mesorectal node occurred after five and 10 years, respectively.

Conclusion

TEM might provide an accessible and effective treatment either as an initial or as an adjunct after a colonoscopic resection for a WRNET.

Citations

Citations to this article as recorded by  
  • Rigid-platform transanal excision (TEM/TEO/TAMIS) for rectal neuroendocrine tumours: a single-centre TEM/TEO series and systematic review
    Alberto Arezzo, Carlo Alberto Ammirati, Giovanni Distefano, Michele Barbiero, Mario Morino
    Updates in Surgery.2026;[Epub]     CrossRef
  • Transanal endoscopic microsurgery in the treatment of rectal neuroendocrine tumors: a retrospective 10-year single-center experience
    Marek Szczepkowski, Piotr Witkowski, Alicja Przywózka-Suwała, Karolina Skonieczna-Żydecka, Teresa Starzyńska, Krzysztof Dąbkowski
    Langenbeck's Archives of Surgery.2025;[Epub]     CrossRef
  • Endoscopic Submucosal Dissection and Transanal Endoscopic Microsurgery in the Treatment of Rectal Neuroendocrine Tumors: Systematic Review and Meta-Analysis of the Observational Studies
    Krzysztof Dąbkowski, Karolina Skonieczna-Żydecka, Katarzyna Gaweł, Wojciech Marlicz, Piotr Szredzki, Andrzej Białek
    Clinical and Translational Gastroenterology.2025; 16(10): e00882.     CrossRef
  • Oncological outcomes according to the treatment modality based on the size of rectal neuroendocrine tumors: a single-center retrospective study
    Jimin Son, In Ja Park, Dong-Hoon Yang, Jisup Kim, Kyoung-Jo Kim, Jeong-Sik Byeon, Seung Mo Hong, Young Il Kim, Jong Beom Kim, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim
    Surgical Endoscopy.2022; 36(4): 2445.     CrossRef
  • Long-term outcomes of transanal endoscopic microsurgery for the treatment of rectal neuroendocrine tumors
    Wei-Kun Shi, Rui Hou, Yun-Hao Li, Xiao-Yuan Qiu, Yu-Xin Liu, Bin Wu, Yi Xiao, Jiao-Lin Zhou, Guo-Le Lin
    BMC Surgery.2022;[Epub]     CrossRef
  • Non-conventional applications for transanal endoscopic microsurgery. A single center experience and a systematic review of literature
    Rosita DE VINCENTI, Fabio CIANCHI, Francesco CORATTI
    Minerva Surgery.2022;[Epub]     CrossRef
  • Transanalis műtéti útmutató – második kiadás
    Kálmán Almási, Szabolcs Ábrahám, József Baracs, Attila Bursics, Zoltán Jánó, Tamás Sztipits, Áron Szűts, Dezső Tóth, Attila Zaránd, Balázs Bánky
    Orvosi Hetilap.2022; 163(Supplement): 3.     CrossRef
  • Endoscopic submucosal dissection versus transanal local excision for rectal carcinoid: a comparative study
    Fei-hu Yan, Zheng Lou, Shi-jie Hu, Xiao-dong Xu, Hao Wang, Han-tao Wang, Rong-gui Meng, Chuan-gang Fu, Wei Zhang, Jian He, En-da Yu
    World Journal of Surgical Oncology.2016;[Epub]     CrossRef
  • Efficacy and Safety of Endoscopic Resection Therapies for Rectal Carcinoid Tumors: A Meta-Analysis
    Lei He, Tao Deng, Hesheng Luo
    Yonsei Medical Journal.2015; 56(1): 72.     CrossRef
  • Full-thickness excision using transanal endoscopic microsurgery for treatment of rectal neuroendocrine tumors
    Wei-Jie Chen
    World Journal of Gastroenterology.2015; 21(30): 9142.     CrossRef
  • Current Issues Involving the Treatment of Small Rectal Carcinoid Tumors
    Dae Kyung Sohn
    Journal of the Korean Society of Coloproctology.2012; 28(4): 176.     CrossRef
Case Report
A Case of Endoscopic Resection of a Colonic Semipedunculated Leiomyoma
Seung Hwa Lee, Gun Yoong Huh, Yoo Seock Cheong
J Korean Soc Coloproctol. 2011;27(4):215-219.   Published online August 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.4.215
  • 6,439 View
  • 39 Download
  • 12 Citations
AbstractAbstract PDF

During colonoscopic examination, epithelial lesions, such as adenomatous polyps, are frequently encountered, unlike subepithelial lesions, such as leiomyomas, which are uncommon. A colonic leiomyoma is a rare tumor, originating either from the mucularis mucosa or from the proper muscle, and accounts for only 3% of all gastrointestinal leiomyomas. Colonic leiomyomas are usually benign and asymptomatic. However, they can sometimes cause symptoms, ie, abdominal pain, intestinal obstruction, hemorrhage, and perforation. The traditional management option for a colonic leiomyoma is surgical resection. Recently, with the development of endoscopy devices and techniques, the endoscopic resection has been considered as an alternative treatment option. We experienced a patient with a leiomyoma that was diagnosed during colonoscopy. The leiomyoma was resected endoscopically without complication. We report this case with a review of the literature.

Citations

Citations to this article as recorded by  
  • Rectal Leiomyoma on Routine Colonoscopy: Narrative Review and an Australian Case Report
    Joshua Sungho Hong, Radha Nair
    World Journal of Colorectal Surgery.2026; 15(1): 18.     CrossRef
  • Ascending Colon Leiomyoma: A Case Report of a Uncommon Case
    Abdulwahed A. Alotay
    Journal of Pharmacy and Bioallied Sciences.2024; 16(Suppl 3): S3002.     CrossRef
  • Descending Colon Leiomyoma: A Case Report and Literature Review
    Norah I Alabdulaaly , Bader D Alanazi , Khalid A Albassam , Nada N Binkhashlan , Saad T Alqahtani , Nahla S Arab, Fatima A Badahdah , Saeed S Albalawi
    Cureus.2024;[Epub]     CrossRef
  • An Unusual Diagnosis of Rectosigmoid Leiomyoma in an Adult: A Rare Case Report
    Karam Karam, Houssein Chebbo, Sarah Saleh, Sarah Jalloul, Johny Salem, Karim Al Halabi, Elias Fiani
    Clinical Medicine Insights: Case Reports.2024;[Epub]     CrossRef
  • Spontaneous Perforation of Maternal Small Bowel Leiomyoma during the Third Trimester of Pregnancy
    In Hye Kim, Hyeon Jin Kim, So Hee Kim, Eun Hee Yu, Sul Lee, Seung Chul Kim
    Perinatology.2023; 34(1): 41.     CrossRef
  • Colonic Leiomyoma: A Case Report of an Uncommon Endoscopic Finding
    Cristina Silva, José Mendes, Amélia Gaspar, Filipe Leal, Rui Almeida
    Cureus.2023;[Epub]     CrossRef
  • Leiomyoma in the Transverse Colon With Resection
    James R Pellegrini, Jose R Russe, Rezwan Munshi, Rebecca Smoller, Nausheer Khan
    Cureus.2021;[Epub]     CrossRef
  • Colon Leiomyoma Diagnosed and Treated with Endoscopy
    Ha Young Oh
    The Korean Journal of Medicine.2020; 95(5): 336.     CrossRef
  • A case of surgical complete transanal resection of rectal gastrointestinal stromal tumor diagnosed by endoscopic ultrasonography and endoscopic ultrasonography-guided fine needle aspiration
    Koichi SOGA, Kenji ITANI
    Choonpa Igaku.2019; 46(1): 71.     CrossRef
  • Rectal Leiomyoma, a Rare Entity
    Tagore Sunkara, Eric Omar Then, Andrea Culliford, Vinaya Gaduputi
    Clinics and Practice.2018; 8(2): 1053.     CrossRef
  • Incidental Subepithelial Sigmoid Colon Lesion
    Mohamed Naem, Peter P. Stanich, Samer El-Dika
    Clinical Gastroenterology and Hepatology.2015; 13(1): A32.     CrossRef
  • Colonoscopy procedural skills and training for new beginners
    Seung-Hwa Lee
    World Journal of Gastroenterology.2014; 20(45): 16984.     CrossRef
Original Article
Value and Interpretation of Resection Margin after a Colonoscopic Polypectomy for Malignant Polyps
Eun Jung Jang, Dae Dong Kim, Chang Ho Cho
J Korean Soc Coloproctol. 2011;27(4):194-201.   Published online August 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.4.194
  • 5,264 View
  • 22 Download
  • 5 Citations
AbstractAbstract PDF
Purpose

This study was designed to compare the clinicopathologic findings of an endoscopic polypectomy for malignant polyps with subsequent surgery and to evaluate the appropriateness of the pathologic finding criterion of the resection margin as an indicator for surgery in cases of malignant colorectal polyps.

Methods

We examined the clinicopathologic characteristics, complications and prognoses among the patients who underwent a colonoscopic polypectomy in both our hospitals and at other hospitals from April 2003 and April 2010. These patients were divided into two groups, the group (non-operation group) that only underwent a polypectomy (n = 37) and the group (operation group) that underwent a polypectomy with subsequent surgery (n = 33).

Results

There were no differences between two groups in the ratios of the number of men to the number of women, the ages or the comorbidities. In terms of endoscopic findings, we found no differences between the two groups in the locations of the polyps, the sizes of the polyps, or the presence of stalks. However, ulceration of polyps was higher in the non-operation group (51.5% vs. 21.6%; P = 0.009), as was the case with submucosal invasion (75.8% vs. 16.2%; P < 0.005). When an endoscopic polypectomy was performed, incomplete resection margins and specimens with margins involved occurred more frequently in the operation group (93.9% vs. 51.4%; P < 0.005), but no residual tumor was detected in 31 of 33 (93.9%) patients in that group. One pathologist reviewed the specimens of 54 patients (operation group, 19; non-operation group, 36). Six of the 19 polyps (31.6%) in the operation group and fifteen of the 36 polyps (41.7%) in the non-operation group had a margin without cancer cells.

Conclusion

We may accept the criterion of a safe margin, including a coagulation zone. A multidisciplinary approach has to be developed by surgeons, endoscopists and pathologists based on a discussion of the risk factors for the patient before making a decision on the treatment treatment.

Citations

Citations to this article as recorded by  
  • Additional colectomy after endoscopic excision of malignant polyps: is it always necessary?
    Mariana Marques, Mariana Peyroteo, Luís Lencastre, André Vale Guimarães, Maria João Madeira-Cardoso, Paula Ferreira Pinto, José Carlos Pereira, Flávio Videira, Joaquim Abreu de Sousa
    Surgical Oncology.2026; 65: 102361.     CrossRef
  • Frequency and clinicopathological correlation of gastrointestinal polyps: A six-year single center experience
    Goran Mohammed Raouf Abdulqader
    Open Medicine.2024;[Epub]     CrossRef
  • Factors Predicting Malignant Occurrence and Polyp Recurrence after the Endoscopic Resection of Large Colorectal Polyps: A Single Center Experience
    Olga Mandic, Igor Jovanovic, Mirjana Cvetkovic, Jasmina Maksimovic, Tijana Radonjic, Maja Popovic, Novica Nikolic, Marija Brankovic
    Medicina.2022; 58(10): 1440.     CrossRef
  • Near-infrared photoimmunotherapy is effective treatment for colorectal cancer in orthotopic nude-mouse models
    Hannah M. Hollandsworth, Siamak Amirfakhri, Filemoni Filemoni, Justin Molnar, Robert M. Hoffman, Paul Yazaki, Michael Bouvet, Irina V. Lebedeva
    PLOS ONE.2020; 15(6): e0234643.     CrossRef
  • Surgical treatment of malignant colon polyps
    Nuno Telo Preto Ramos, André Gonçalves, Pedro Correia da Silva, José Barbosa
    Journal of Coloproctology.2018; 38(04): 260.     CrossRef
Case Report
Efficacy of Imatinib Mesylate Neoadjuvant Treatment for a Locally Advanced Rectal Gastrointestinal Stromal Tumor
Kyu Jong Yoon, Nam Kyu Kim, Kang Young Lee, Byung Soh Min, Hyuk Hur, Jeonghyun Kang, Sarah Lee
J Korean Soc Coloproctol. 2011;27(3):147-152.   Published online June 30, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.3.147
  • 6,040 View
  • 38 Download
  • 10 Citations
AbstractAbstract PDF

Surgery is the standard treatment for a primary gastrointestinal stromal tumor (GIST); however, surgical resection is often not curative, particularly for large GISTs. In the past decade, with imatinib mesylate (IM), management strategies for GISTs have evolved significantly, and now IM is the standard care for patients with locally advanced, recurrent or metastatic GISTs. Adjuvant therapy with imatinib was recently approved for use, and preoperative imatinib is an emerging treatment option for patients who require cytoreductive therapy. IM neoadjuvant therapy for primary GISTs has been reported, but there is no consensus on the dose of the drug, the duration of treatment and the optimal time of surgery. These are critical because drug resistance or tumor progression can develop with a prolonged treatment. This report describes two cases of large rectal malignant GISTs, for which a abdominoperineal resection was initially anticipated. The two patients received IM preoperative treatment; we followed-up with CT or magnetic resonance imaging to access the response. After 9 months of treatment, a multi-disciplinary consensus that maximal benefit from imatinib had been achieved was reached. We determined the best time for surgical intervention and successfully performed sphincter-preserving surgery before resistance to imatinib or tumor progression occurred. We believe that a multidisciplinary team approach, considerating the optimal duration of therapy and the timing of surgery, is required to optimize treatment outcome.

Citations

Citations to this article as recorded by  
  • Safety, effectiveness and the optimal duration of preoperative imatinib in locally advanced gastric gastrointestinal stromal tumors: A retrospective cohort study
    Xiangfei Sun, Xiaohan Lin, Qiang Zhang, Chao Li, Ping Shu, Xiaodong Gao, Kuntang Shen
    Cancer Medicine.2024;[Epub]     CrossRef
  • Clinicopathological and Immunohistochemical Characterization of Gastrointestinal Stromal Tumour at Four Tertiary Health Centers in Nigeria Using CD117, DOG1, and Human Epidermal Growth Factor Receptor-2 Biomarkers
    Mumini Wemimo Rasheed, Afolayan Enoch Abiodun, Uchechukwu Brian Eziagu, Najeem Adedamola Idowu, Abdullahi Kabiru, Taiwo Adeyemi Adegboye, Waheed Akanni Oluogun, Adekunle Adebayo Ayoade
    Annals of African Medicine.2023; 22(4): 501.     CrossRef
  • Open transanal resection of low rectal stromal tumor following neoadjuvant therapy of imatinib mesylate: Report of 11 cases and review of literature
    Qiang Sun, Ning Su, Xinxing Li, Zhiqian Hu, Weijun Wang
    Asia-Pacific Journal of Clinical Oncology.2020; 16(3): 123.     CrossRef
  • Using endoscopy to minimize the extent of resection in the management of giant GISTs of the stomach
    Hishaam Ismael, Yury Ragoza, Steven Cox
    International Journal of Surgery Case Reports.2017; 36: 26.     CrossRef
  • Combined Therapy of Gastrointestinal Stromal Tumors
    Piotr Rutkowski, Daphne Hompes
    Surgical Oncology Clinics of North America.2016; 25(4): 735.     CrossRef
  • Indications for surgery in advanced/metastatic GIST
    Samuel J. Ford, Alessandro Gronchi
    European Journal of Cancer.2016; 63: 154.     CrossRef
  • Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib
    M J Wilkinson, J E F Fitzgerald, D C Strauss, A J Hayes, J M Thomas, C Messiou, C Fisher, C Benson, P P Tekkis, I Judson
    British Journal of Surgery.2015; 102(8): 965.     CrossRef
  • Intolerance to Imatinib in Gastrointestinal Stromal Tumors: A Case Report and a Review of Literature
    Yousra Akasbi, Samia Arifi, Sami Aziz Brahmi, Fatima Zahra El Mrabet, Nawfel Mellas, Fatima Zahra Mernisi, Omar El Mesbahi
    Journal of Gastrointestinal Cancer.2014; 45(S1): 71.     CrossRef
  • Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group
    Thanh-Khoa Huynh, Pierre Meeus, Philippe Cassier, Olivier Bouché, Sophie Lardière-Deguelte, Antoine Adenis, Thierry André, Julien Mancini, Olivier Collard, Michael Montemurro, Emmanuelle Bompas, Maria Rios, Nicolas Isambert, Didier Cupissol, Jean-Yves Bla
    BMC Cancer.2014;[Epub]     CrossRef
  • Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience
    Piotr Rutkowski, Alessandro Gronchi, Peter Hohenberger, Sylvie Bonvalot, Patrick Schöffski, Sebastian Bauer, Elena Fumagalli, Pawel Nyckowski, Buu-Phuc Nguyen, Jan Martijn Kerst, Marco Fiore, Elzbieta Bylina, Mathias Hoiczyk, Annemieke Cats, Paolo G. Casa
    Annals of Surgical Oncology.2013; 20(9): 2937.     CrossRef
Original Articles
Treatment Outcomes of Anorectal Melanoma
Byung Min Choi, Hyoung Ran Kim, Hae-Ran Yun, Seung Ho Choi, Yong Beom Cho, Hee Cheol Kim, Seong Hyeon Yun, Woo Yong Lee, Ho-Kyung Chun
J Korean Soc Coloproctol. 2011;27(1):27-30.   Published online February 28, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.1.27
  • 5,711 View
  • 43 Download
  • 20 Citations
AbstractAbstract PDF
Purpose

An anorectal melanoma (AM) is a very rare tumor. However, sufficient data supporting effective surgical options for the disease do not exist. This retrospective review aimed to analyze treatment outcomes for an AM.

Methods

From June 1999 to December 2008, we retrospectively reviewed a prospectively collected consecutive series of 19 patients who had undergone a surgical resection for an AM at a single institute. Surgical method and clinicopathological factors were analyzed.

Results

The median age was 61.4 years (range, 46 to79 years). Main symptoms were an anal mass, hematochezia, perianal pain, tenesmus, fecal incontinence, and bowel habit change. The average duration of symptoms before diagnosis was 7.8 months (range, 1 to 36 months). S-100 and HMB-45 were positive in all patients, even in non-melanin pigmentation. There were 12 abdominoperineal resections (APRs) and 7 wide local excisions (WEs). The APR showed longer overall survival when compared with the WE (64.1 months vs. 10.9 months, P < 0.001). No patients who underwent a WE survived more than 13 months.

Conclusion

A high index of suspicion is necessary to establish the diagnosis for an AM in patients with anal symptoms, and S-100 and HMB-45 can be useful markers for an AM. Even with the small number of cases and the short follow-up, our data suggest that an APR for an AM may provide longer survival than a WE.

Citations

Citations to this article as recorded by  
  • Prognostic Risk Factors and Construction of a Survival Prognostic Model for Anorectal Malignant Melanoma Based on the Surveillance, Epidemiology, and End Results Database
    Jingchao Wang, Yi Bai, Fengqin Xu, Bochao Zhao, Yuanfei Shan, Zhijun Tan, Yamin Zhang
    Indian Journal of Surgery.2026;[Epub]     CrossRef
  • Clinical and pathological characteristics and correlation analysis of anorectal malignant melanoma
    Lei Xi, Jinxing Zhou, Yan Wu, Boya Zhai, Rong Rong
    Medicine.2025; 104(51): e46741.     CrossRef
  • Optimal surgical management strategy for treatment of primary anorectal malignant melanoma—a systematic review and meta-analysis
    Hugo C. Temperley, Niall J. O’Sullivan, Alan Keyes, Dara O. Kavanagh, John O. Larkin, Brian J. Mehigan, Paul H. McCormick, Michael E. Kelly
    Langenbeck's Archives of Surgery.2022; 407(8): 3193.     CrossRef
  • Trends in the management of anorectal melanoma: A multi-institutional retrospective study and review of the world literature
    Josh Bleicher, Jessica N Cohan, Lyen C Huang, William Peche, T Bartley Pickron, Courtney L Scaife, Tawnya L Bowles, John R Hyngstrom, Elliot A Asare
    World Journal of Gastroenterology.2021; 27(3): 267.     CrossRef
  • Survival following surgical treatment for anorectal melanoma seems similar for local excision and extensive resection regardless of nodal involvement
    E. Jutten, S. Kruijff, A.B. Francken, H.L. van Westreenen, K.P. Wevers
    Surgical Oncology.2021; 37: 101558.     CrossRef
  • Response to Kahlke et al
    Audrius Dulskas
    Colorectal Disease.2021; 23(11): 3029.     CrossRef
  • Three Cases of Anorectal Malignant Melanoma Treated with Laparoscopic Abdominoperineal Resection
    Shin Yoshida, Nobuaki Suzuki, Shinobu Tomochika, Yoshitaro Shindo, Yukio Tokumitsu, Michihisa Iida, Shigeru Takeda, Tatsuya Ioka, Shoichi Hazama, Tsuzuri Shirahama, Hiroo Kawano, Eiji Ikeda, Hiroaki Nagano
    The Japanese Journal of Gastroenterological Surgery.2021; 54(9): 644.     CrossRef
  • Spectrum of presentation in primary anorectal malignant melanoma and its management
    Barun Kumar Singh, Samrat Ray, Shashi Dhawan, Samiran Nundy
    BMJ Case Reports.2021; 14(10): e245449.     CrossRef
  • Surgical treatment of anorectal melanoma: a systematic review and meta-analysis
    Esther Jutten, Schelto Kruijff, Anne Brecht Francken, Martijn F Lutke Holzik, Barbara L van Leeuwen, Henderik L van Westreenen, Kevin P Wevers
    BJS Open.2021;[Epub]     CrossRef
  • Long-term Oncologic Outcome and Its Relevant Factors in Anal Cancer in Korea: A Nationwide Data Analysis
    Hyuk Hur, Kyu-Won Jung, Byung-Woo Kim, Chang-Mo Oh, Young-Joo Won, Jae Hwan Oh, Nam Kyu Kim
    Annals of Coloproctology.2020; 36(1): 35.     CrossRef
  • Primary anorectal malignant melanoma with laparoscopic abdominoperineal resection: a case study and review of the relevant literature
    Kentaro Nonaka, Kensuke Kudou, Shun Sasaki, Tomoko Jogo, Kosuke Hirose, Yuta Kasagi, Qingjiang Hu, Yasuo Tsuda, Yuichi Hisamatsu, Koji Ando, Yuichiro Nakashima, Hiroshi Saeki, Eiji Oki, Mitsuo Kamori, Masaki Mori
    International Cancer Conference Journal.2020; 9(3): 116.     CrossRef
  • Less is more: A systematic review and meta-analysis of the outcomes of radical versus conservative primary resection in anorectal melanoma
    Henry G. Smith, Jessica Glen, Nancy Turnbull, Howard Peach, Ruth Board, Miranda Payne, Martin Gore, Karen Nugent, Myles J.F. Smith
    European Journal of Cancer.2020; 135: 113.     CrossRef
  • Anorectal Malignant Melanoma: Retrospective Analysis of Six Patients and Review of the Literature
    Ibrahim Atak
    Prague Medical Report.2018; 119(2-3): 97.     CrossRef
  • Extensive surgery and lymphadenectomy do not improve survival in primary melanoma of the anorectum: results from analysis of a large database (SEER)
    A. Ciarrocchi, R. Pietroletti, F. Carlei, G. Amicucci
    Colorectal Disease.2017; 19(2): 158.     CrossRef
  • Das anorektale maligne Melanom
    T. R. Glowka, M. D. Keyver-Paik, T. Thiesler, J. Landsberg, J. C. Kalff, D. Pantelis
    Der Chirurg.2016; 87(9): 768.     CrossRef
  • Abdominoperineal Resection Provides Better Local Control But Equivalent Overall Survival to Local Excision of Anorectal Malignant Melanoma
    Akihisa Matsuda, Masao Miyashita, Satoshi Matsumoto, Goro Takahashi, Takeshi Matsutani, Takeshi Yamada, Taro Kishi, Eiji Uchida
    Annals of Surgery.2015; 261(4): 670.     CrossRef
  • Anorectal malignant melanoma: retrospective analysis of management and outcome in a single Portuguese Institution
    Isália Miguel, João Freire, Maria José Passos, António Moreira
    Medical Oncology.2015;[Epub]     CrossRef
  • Characteristics and Survival of Korean Anal Cancer From the Korea Central Cancer Registry Data
    Hyoung-Chul Park, Kyu-Won Jung, Byung-Woo Kim, Aesun Shin, Young-Joo Won, Jae Hwan Oh, Seung-Yong Jeong, Chang Sik Yu, Bong Hwa Lee
    Annals of Coloproctology.2013; 29(5): 182.     CrossRef
  • Incidence and Survival Patterns of Rare Anal Canal Neoplasms Using the Surveillance Epidemiology and End Results Registry
    Cristina Metildi, Elisabeth C. McLemore, Thuy Tran, David Chang, Bard Cosman, Sonia L. Ramamoorthy, Sidney L. Saltzstein, Georgia Robins Sadler
    The American Surgeon™.2013; 79(10): 1068.     CrossRef
  • Rectal melanoma
    N. Patelis, P. Marselos, G. Sotiropoulou, S. Georgiou, A. Kominea
    Hellenic Journal of Surgery.2012; 84(3): 198.     CrossRef
Analysis of the Prognostic Effectiveness of a Multivisceral Resection for Locally Advanced Colorectal Cancer
Sejin Park, Yun Sik Lee
J Korean Soc Coloproctol. 2011;27(1):21-26.   Published online February 28, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.1.21
  • 5,722 View
  • 33 Download
  • 24 Citations
AbstractAbstract PDF
Purpose

The aim of this study was to evaluate the prognostic effectiveness of multivisceral resections of organs involved by locally advanced colorectal cancer.

Methods

A retrospective study was performed to analyze the data collected for 266 patients who underwent a curative resection for pT3-pT4 colorectal cancer without distant metastasis from January 2000 to December 2007. Of these 266 patients, 54 patients had macroscopically direct invasion of adjacent organs and underwent a multivisceral resection. We evaluated the short-term and the long-term outcomes of a multiviceral resection relative to that of standard surgery.

Results

The most common location for the primary lesion was the rectum, followed by the right colon and the sigmoid colon. Among the combined resected organs, common organs were the small bowel, ovary, and bladder. In the multivisceral resection group, tumor infiltration was confirmed histologically in 44.4% of the cases while in the remaining patients, a peritumorous adhesion had mimicked tumor invasion. Postoperative complications occurred in 17.5% of the patients who underwent standard surgery vs. 35.2% of those who underwent a multivisceral resection (P < 0.0001). But the survival rate of patients after a multivisceral resection was similar to that of patients after standard surgery (5-year survival rates: 61% vs. 58%; P = 0.36).

Conclusion

For locally advanced colorectal cancer, multivisceral resection was associated with higher postoperative morbidity, but the long-term survival after a curative resection is similar to that after a standard resection. Thus, a multivisceral resection can be recommended for most patients of locally advanced colorectal cancer.

Citations

Citations to this article as recorded by  
  • Multivisceral Resections in GI Oncology: Where to Draw the Line?
    Supreet Kumar, Sonam Gupta, Vivek Tandon, Deepak Govil
    Apollo Medicine.2025;[Epub]     CrossRef
  • Factors associated with one-year mortality after curative surgery for primary clinical T4 and locally recurrent rectal cancer in elderly patients
    Nikki C.M. van Ham, Sofie Glazemakers, Mirjam van der Ende-van Loon, Grard A.P. Nieuwenhuijzen, Harm J.T. Rutten, Jip L. Tolenaar, Anne Jacobs, Jacobus W.A. Burger, Stijn H.J. Ketelaers, Johanne G. Bloemen
    European Journal of Surgical Oncology.2024; 50(6): 108259.     CrossRef
  • A Novel Clinical Nomogram for Predicting Overall Survival in Patients with Emergency Surgery for Colorectal Cancer
    Georgiana Bianca Constantin, Dorel Firescu, Raul Mihailov, Iulian Constantin, Ioana Anca Ștefanopol, Daniel Andrei Iordan, Bogdan Ioan Ștefănescu, Rodica Bîrlă, Eugenia Panaitescu
    Journal of Personalized Medicine.2023; 13(4): 575.     CrossRef
  • Multivisceral resection of advanced colon and rectal cancer: a prospective multicenter observational study with propensity score analysis of the morbidity, mortality, and survival
    Michael Arndt, Hans Lippert, Roland S. Croner, Frank Meyer, Ronny Otto, Karsten Ridwelski
    Innovative Surgical Sciences.2023; 8(2): 61.     CrossRef
  • Extended Total Mesorectal Excision (e-TME) for Locally Advanced Rectal Cancer
    Narendra Pandit, Kunal Bikram Deo, Sujan Gautam, Tek Narayan Yadav, Awaj Kafle, Sudhir Kumar Singh, Laligen Awale
    Journal of Gastrointestinal Cancer.2022; 53(2): 253.     CrossRef
  • Predictors of undergoing multivisceral resection, margin status and survival in Dutch patients with locally advanced colorectal cancer
    L.C.F. de Nes, J.A.G. van der Heijden, M.G. Verstegen, L. Drager, P.J. Tanis, R.H.A. Verhoeven, J.H.W. de Wilt
    European Journal of Surgical Oncology.2022; 48(5): 1144.     CrossRef
  • Subclassification of Multivisceral Resections for T4b Colon Cancer with Relevance for Postoperative Complications and Oncological Risks
    Karin A.T.G.M. Wasmann, Charlotte E.L. Klaver, Jarmila D.W. van der Bilt, Iris D. Nagtegaal, Albert M. Wolthuis, Hjalmar C. van Santvoort, Bert Ramshorst, André D’Hoore, Johannes H.W. de Wilt, Pieter J. Tanis
    Journal of Gastrointestinal Surgery.2020; 24(9): 2113.     CrossRef
  • Outcomes of neoadjuvant chemoradiotherapy followed by radical resection for T4 colorectal cancer
    Chun-Ming Huang, Ching-Wen Huang, Cheng-Jen Ma, Hsiang-Lin Tsai, Wei-Chih Su, Tsung-Kun Chang, Ming-Yii Huang, Jaw Yuan Wang
    World Journal of Gastrointestinal Oncology.2020; 12(12): 1428.     CrossRef
  • Hospital volume and outcome in rectal cancer patients; results of a population-based study in the Netherlands
    J.A.W. Hagemans, W.J. Alberda, M. Verstegen, J.H.W. de Wilt, C. Verhoef, M.A. Elferink, J.W.A. Burger
    European Journal of Surgical Oncology.2019; 45(4): 613.     CrossRef
  • Significance of multivisceral resections in oncologic surgery: A systematic review of the literature
    Giorgi Nadiradze, Can Yurttas, Alfred Königsrainer, Philipp Horvath
    World Journal of Meta-Analysis.2019; 7(6): 269.     CrossRef
  • É o carcinoma colônico localmente avançado não metastático uma variante biológica distinta? Estudo baseado na avaliação histológica, painel imuno-histoquímico e sobrevida.
    René Aloisio da Costa Vieira, Ademar Lopes, Fernando Augusto Soares, Renata Almeida Coudry, Wilson Toshio Nakagawa, Maria do Rosário Dias de Oliveira Latore
    Revista do Colégio Brasileiro de Cirurgiões.2019;[Epub]     CrossRef
  • The short-term outcomes of laparoscopic multivisceral resection for locally advanced colorectal cancer: our experience of 39 cases
    Yuichiro Miyake, Junichi Nishimura, Hidekazu Takahashi, Naotsugu Haraguchi, Taishi Hata, Ichiro Takemasa, Tsunekazu Mizushima, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori
    Surgery Today.2017; 47(5): 575.     CrossRef
  • Safety and feasibility of laparoscopic multivisceral resection for surgical T4b colon cancers: Retrospective analyses
    Ryo Takahashi, Suguru Hasegawa, Kenjiro Hirai, Shigeo Hisamori, Koya Hida, Kenji Kawada, Yoshiharu Sakai
    Asian Journal of Endoscopic Surgery.2017; 10(2): 154.     CrossRef
  • The Feasibility of Hand-assisted Laparoscopic and Laparoscopic Multivisceral Resection Compared With Open Surgery for Locally Advanced Colorectal Cancer
    Guang-tan Zhang, Xue-dong Zhang
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2017; 27(4): e57.     CrossRef
  • Prognostic factors affecting outcomes in multivisceral en bloc resection for colorectal cancer
    Caio Sergio Rizkallah Nahas, Sergio Carlos Nahas, Ulysses Ribeiro-Junior, Leonardo Bustamante-Lopez, Carlos Frederico Sparapan Marques, Rodrigo Ambar Pinto, Antonio Rocco Imperiale, Guilherme Cutait Cotti, William Carlos Nahas, Daher Cezar Chade, Dariane
    Clinics.2017; 72(5): 258.     CrossRef
  • Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer
    Bo Qiu, Pei-Rong Ding, Ling Cai, Wei-Wei Xiao, Zhi-Fan Zeng, Gong Chen, Zhen-Hai Lu, Li-Ren Li, Xiao-Jun Wu, Rene-Olivier Mirimanoff, Zhi-Zhong Pan, Rui-Hua Xu, Yuan-Hong Gao
    Chinese Journal of Cancer.2016;[Epub]     CrossRef
  • Smaller tumor size is associated with poor survival in T4b colon cancer
    Ben Huang, Yang Feng, Shao-Bo Mo, San-Jun Cai, Li-Yong Huang
    World Journal of Gastroenterology.2016; 22(29): 6726.     CrossRef
  • Neo-adjuvant chemoradiotherapy and multivisceral resection to optimize R0 resection of locally recurrent adherent colon cancer
    J. Hallet, F.S. Zih, M. Lemke, L. Milot, A.J. Smith, C.S. Wong
    European Journal of Surgical Oncology (EJSO).2014; 40(6): 706.     CrossRef
  • Accuracy of Preoperative Urinary Symptoms, Urinalysis, Computed Tomography and Cystoscopic Findings for the Diagnosis of Urinary Bladder Invasion in Patients with Colorectal Cancer
    Varat Woranisarakul, Patkawat Ramart, Kittipong Phinthusophon, Ekkarin Chotikawanich, Siriluck Prapasrivorakul, Varut Lohsiriwat
    Asian Pacific Journal of Cancer Prevention.2014; 15(17): 7241.     CrossRef
  • Multivisceral Resection in Colorectal Cancer: A Systematic Review
    H. M. Mohan, M. D. Evans, J. O. Larkin, J. Beynon, D. C. Winter
    Annals of Surgical Oncology.2013; 20(9): 2929.     CrossRef
  • Laparoscopic Versus Open Multivisceral Resection for Primary Colorectal Cancer: Comparison of Perioperative Outcomes
    Yasutomo Nagasue, Takashi Akiyoshi, Masashi Ueno, Yosuke Fukunaga, Satoshi Nagayama, Yoshiya Fujimoto, Tsuyoshi Konishi, Toshiya Nagasaki, Jun Nagata, Toshiki Mukai, Atsushi Ikeda, Riki Ono, Toshiharu Yamaguchi
    Journal of Gastrointestinal Surgery.2013; 17(7): 1299.     CrossRef
  • En bloc Right Hemicolectomy/Pancreaticoduodenectomy for Cancer: One Institution's Experience
    Maria C. Mora-Pinzon, Amanda B. Francescatti, Minh B. Luu, Keith W. Millikan, Daniel J. Deziel, Dana M. Hayden, Theodore John Saclarides
    The American Surgeon™.2013; 79(6): 238.     CrossRef
  • Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: A single institution experience
    M. Cukier, A.J. Smith, L. Milot, W. Chu, H. Chung, D. Fenech, S. Herschorn, Y. Ko, C. Rowsell, H. Soliman, Y.C. Ung, C.S. Wong
    European Journal of Surgical Oncology (EJSO).2012; 38(8): 677.     CrossRef
  • A rectumtumorok sebészete
    Péter Metzger
    Magyar Sebészet.2012; 65(3): 129.     CrossRef
Risk Factors for Anastomotic Leakage after Laparoscopic Rectal Resection
Dong Hyun Choi, Jae Kwan Hwang, Yong Tak Ko, Han Jeong Jang, Hyeon Keun Shin, Young Chan Lee, Cheong Ho Lim, Seung Kyu Jeong, Hyung Kyu Yang
J Korean Soc Coloproctol. 2010;26(4):265-273.   Published online August 31, 2010
DOI: https://doi.org/10.3393/jksc.2010.26.4.265
  • 9,589 View
  • 71 Download
  • 60 Citations
AbstractAbstract PDF
Purpose

The anastomotic leakage rate after rectal resection has been reported to be approximately 2.5-21 percent, but most results were associated with open surgery. The aim of this study was to identify risk factors and their relationship to the experience of the surgeon for anastomotic leakage after laparoscopic rectal resection.

Methods

Between March 2003 and December 2008, 156 patients underwent a laparoscopic rectal resection without a diverting ileostomy. The patients' characteristics, the details of treatment, the intraoperative results, and the postoperative results were recorded prospectively. Univariate and multivariate analyses were applied to identify risk factors for anastomotic leakage.

Results

The majority of operations were performed for malignant disease (n = 150; 96.2%), and 96 patients (61.5%) were males. Conversion to open surgery occurred in 1 case (0.6%). The anastomotic leak rate was 10.3% (16/156), and there were no mortalities. In the univariate analysis, tumor location, anastomotic level, intraoperative events, and operation time were associated with increased anastomotic leakage rate. In the multivariate analysis, anastomotic level (odds ratio [OR], 6.855; 95% confidence interval [CI], 1.271 to 36.964) and operation time (OR, 8.115; 95% CI, 1.982 to 33.222) were significantly associated with anastomotic leakage.

Conclusion

The important risk factors for anastomotic leakage after laparoscopic rectal resection without a diverting ileostomy were low anastomosis and long operation time. An additional procedure, such as diverting stoma, may reduce the anastomotic leakage if it is selectively applied in cases with these risk factors.

Citations

Citations to this article as recorded by  
  • Anastomotic Leak Following Colorectal Surgery
    Olivia Ziegler, Audrey S. Kulaylat
    Clinics in Colon and Rectal Surgery.2026; 39(01): 024.     CrossRef
  • Clinical Safety and Effectiveness of COLO-BT™, an Intraluminal Fecal Diverting Device, as an Alternative to Defunctioning Ileostomy After Proctectomy
    Ho Yung Lee, Sung Il Kang, Sohyun Kim
    Surgical Innovation.2026; 33(2): 123.     CrossRef
  • Creating and validating an anastomotic leakage risk prediction model after laparoscopic low anterior resection for rectal cancer
    Wenqiang Li, Susu Zhou, Qikai Zhong, Luqiao Huang, Ning Li, Chengyu Sun, Liang Zhang, Zhengguo Zhang
    Clinics and Research in Hepatology and Gastroenterology.2026; 50(1): 102745.     CrossRef
  • Risk Factors for Anastomotic Leakage: A Comprehensive Single-Center Analysis of Colorectal Anastomoses for Ovarian and Gastrointestinal Cancers
    Francesco Santullo, Virginia Vargiu, Andrea Rosati, Barbara Costantini, Valerio Gallotta, Claudio Lodoli, Carlo Abatini, Miriam Attalla El Halabieh, Valentina Ghirardi, Federica Ferracci, Lorena Quagliozzi, Angelica Naldini, Fabio Pacelli, Giovanni Scambi
    Annals of Surgical Oncology.2025; 32(4): 2620.     CrossRef
  • Risk factors for anastomotic leakage in rectal cancer surgery reflecting current practices
    Tatsunosuke Harada, Masakatsu Numata, Yosuke Atsumi, Toshiyuki Fukuda, Shota Izukawa, Yusuke Suwa, Jun Watanabe, Tsutomu Sato, Aya Saito
    Surgery Today.2025; 55(8): 1043.     CrossRef
  • Laparoscopic versus open ileostomy closure: a systematic review and meta-analysis of postoperative outcomes
    Xiao-Qiang Zhang, Run-xi Tang, Dong-Hao Pan, Chao-Fu Zhang, Ming-Yang Xia, Lei-Yuan Shuai, Hua Tang, Guang-Yan Ji
    International Journal of Colorectal Disease.2025;[Epub]     CrossRef
  • Randomized Controlled Trial Comparative Study in Powered and Manual Stapler in Low Anterior Resection of Rectal Cancer
    Siripong Sirikurnpiboon
    Asian Journal of Endoscopic Surgery.2025;[Epub]     CrossRef
  • Comments on “Folic acid deficiency as a modifiable risk factor for anastomotic leak in patients undergoing colorectal cancer surgery”
    Eda Karapelit Agitoglu, Beliz Bahar Karaoglan, Kadriye Bir Yucel
    Updates in Surgery.2025; 77(8): 2371.     CrossRef
  • Risk factors for anastomotic fistula after total mesorectal excision: A monocentric retrospective study of 78 patients
    Amine Majdoubi, Anass El Aachi, Mohammed El Hammouti, Haïtam Aabalou, Ayoub Kharkhach, Tariq Bouhout, Badr Serji
    Clinical Surgical Oncology.2025; 4(3): 100096.     CrossRef
  • Extracellular Matrix Hydrogel Reduces Anastomotic Leaks in a Rodent Model of Rectal Anastomosis
    Vincent Antonelli, Charles Patterson, Catalina Pineda Molina, Scott A. Johnson, Michael Hu, George S. Hussey, David S. Medich, Stephen F. Badylak
    Journal of Surgical Research.2025; 315: 241.     CrossRef
  • Evaluation of risk factors for early complications following bowel anastomosis
    A. K. M. Zahedul Islam, M. Farhad Hossain, Masuma Sultana, M. Oliul Islam, Tanvir Ahmad, M. Jayer Haque
    International Surgery Journal.2025; 13(1): 19.     CrossRef
  • Colonic Anastomotic Leakage: Current State of the Problem and Prospects for Early Diagnosis
    M. A. Chernykh, A. M. Belousov, K. G. Shostka
    Innovative Medicine of Kuban.2024; (3): 131.     CrossRef
  • Vorhersagbarkeit von Anastomoseninsuffizienzen in der Viszeralchirurgie
    Jin-On Jung, Georg Dieplinger, Christiane Bruns
    Die Chirurgie.2024; 95(11): 901.     CrossRef
  • Anastomotic Leak Rate and Prolonged Postoperative Paralytic Ileus in Patients Undergoing Laparoscopic Surgery for Colo-Rectal Cancer After Placement of No-Coil Endoanal Tube
    Michele Ammendola, Giorgio Ammerata, Francesco Filice, Rosalinda Filippo, Michele Ruggiero, Roberto Romano, Riccardo Memeo, Patrick Pessaux, Giuseppe Navarra, Severino Montemurro, Giuseppe Currò
    Surgical Innovation.2023; 30(1): 20.     CrossRef
  • Potential short-term outcome advantage of low vs. high ligation of inferior mesenteric artery for sigmoid and rectal cancer: propensity score matching analysis
    Chia-Chen Hsu, Yu-Jen Hsu, Yih-Jong Chern, Bor-Kang Jong, Chun-Kai Liao, Pao-Shiu Hsieh, Wen-Sy Tsai, Jeng-Fu You
    BMC Surgery.2023;[Epub]     CrossRef
  • Predictive Factors for Anastomotic Leakage Following Colorectal Cancer Surgery: Where Are We and Where Are We Going?
    Christos Tsalikidis, Athanasia Mitsala, Vasileios I. Mentonis, Konstantinos Romanidis, George Pappas-Gogos, Alexandra K. Tsaroucha, Michail Pitiakoudis
    Current Oncology.2023; 30(3): 3111.     CrossRef
  • Impact of anastomotic leakage on long-term prognosis after colorectal cancer surgery
    Valeria Tonini, Manuel Zanni
    World Journal of Gastrointestinal Surgery.2023; 15(5): 745.     CrossRef
  • Efficacy and Safety of Transanal Drainage Tube for Prevention of Anastomotic Leakage after Surgery for Rectal Cancer
    Tatsunosuke Harada, Yasuhiro Ishiyama, Yume Minagawa, Shingo Ito, Masataka Oneyama, Kazuhiro Narita
    Nihon Daicho Komonbyo Gakkai Zasshi.2023; 76(6): 420.     CrossRef
  • Preservation of the left colic artery in modified laparoscopic anterior rectal resections without auxiliary abdominal incisions for transanal specimen retrieval
    Yulin Liu, Peng Yu, Han Li, Lijian Xia, Xiangmin Li, Meijuan Zhang, Zhonghui Cui, Jingbo Chen
    BMC Surgery.2022;[Epub]     CrossRef
  • The Role of Indocyanine Near-Infrared Fluorescence in Colorectal Surgery
    Francesco Maione, Michele Manigrasso, Alessia Chini, Sara Vertaldi, Pietro Anoldo, Anna D’Amore, Alessandra Marello, Carmen Sorrentino, Grazia Cantore, Rosa Maione, Nicola Gennarelli, Salvatore D’Angelo, Nicola D’Alesio, Giuseppe De Simone, Giuseppe Servi
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Risk factors for colorectal anastomotic leakage and preventive measures: a retrospective cohort study
    M. S. Lebedko, S. S. Gordeev, E. V. Alieva, M. D. Sivolob, Z. Z. Mamedli, S. G. Gaydarov, V. Yu. Kosyrev
    Surgery and Oncology.2022; 12(2): 17.     CrossRef
  • Intracorporeal reinforcement with barbed suture is associated with low anastomotic leakage rates after laparoscopic low anterior resection for rectal cancer: a retrospective study
    Haiping Lin, Minhao Yu, Guangyao Ye, Shaolan Qin, Hongsheng Fang, Ran Jing, Tingyue Gong, Yang Luo, Ming Zhong
    BMC Surgery.2022;[Epub]     CrossRef
  • Factors Contributing to Anastomotic Leakage Following Colorectal Surgery: Why, When, and Who Leaks?
    Shravani Sripathi, Mashal I Khan, Naomi Patel, Roja T Meda, Surya P Nuguru, Sriker Rachakonda
    Cureus.2022;[Epub]     CrossRef
  • Anastomotic Leak in Ovarian Cancer Cytoreduction Surgery: A Systematic Review and Meta-Analysis
    Massimiliano Fornasiero, Georgios Geropoulos, Konstantinos S. Kechagias, Kyriakos Psarras, Konstantinos Katsikas Triantafyllidis, Panagiotis Giannos, Georgios Koimtzis, Nikoletta A. Petrou, James Lucocq, Christos Kontovounisios, Dimitrios Giannis
    Cancers.2022; 14(21): 5464.     CrossRef
  • Association between circular stapler size and anastomotic leakage after laparoscopic low anterior resection for rectal cancer
    Yugang Jiang, Hongyuan Chen, Meng Kong, Dong Sun, Hongguang Sheng
    Journal of Cancer Research and Therapeutics.2022; 18(7): 1931.     CrossRef
  • Preliminary surgical outcomes of laparoscopic right hemicolectomy with transrectal specimen extraction: a propensity score matching study of 120 cases (with video)
    Mingguang Zhang, Zheng Liu, Peng Sun, Xiyue Hu, Haitao Zhou, Zheng Jiang, Jianqiang Tang, Qian Liu, Xishan Wang
    Gastroenterology Report.2022;[Epub]     CrossRef
  • Anastomotic Leak in Colorectal Surgery: Predictive Factors and Survival
    Swetha Prabhakaran, Sowmya Prabhakaran, Wei Mou Lim, Glen Guerra, Alexander G. Heriot, Joseph C. Kong
    Polish Journal of Surgery.2022; 95(5): 56.     CrossRef
  • Anastomotic Leakage After Laparoscopic Colectomy: Who Will Require Emergency Fecal Diversion?
    Alban Zarzavadjian Le Bian, Nicolas Tabchouri, Christine Denet, Théophile Guilbaud, Anaïs Laforest, Christophe Tresallet, Jean-Marc Ferraz, Brice Gayet, David Fuks
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2021; 31(9): 1040.     CrossRef
  • Postoperative morbidity and mortality after anterior resection with preventive diverting loop ileostomy versus loop colostomy for rectal cancer: A updated systematic review and meta-analysis
    Rui Du, Jiajie Zhou, Guifan Tong, Yue Chang, Dongliang Li, Feng Wang, Xu Ding, Qi Zhang, Wei Wang, Liuhua Wang, Daorong Wang
    European Journal of Surgical Oncology.2021; 47(7): 1514.     CrossRef
  • Risk factors of symptomatic anastomotic leakage and its impacts on a long-term survival after laparoscopic low anterior resection for rectal cancer: a retrospective single-center study
    Xinyu Qi, Maoxing Liu, Kai Xu, Pin Gao, Fei Tan, Zhendan Yao, Nan Zhang, Hong Yang, Chenghai Zhang, Jiadi Xing, Ming Cui, Xiangqian Su
    World Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • A Novel Nomogram for Prediction of Early Postoperative Complications of Total Gastrectomy for Gastric Cancer
    Jiawen Zhang, Linhua Jiang, Xinguo Zhu
    Cancer Management and Research.2021; Volume 13: 7579.     CrossRef
  • A Retrospective Study of Risk Factors for Symptomatic Anastomotic Leakage after Laparoscopic Anterior Resection of the Rectal Cancer without a Diverting Stoma
    Zhi-Jie Wang, Qian Liu
    Gastroenterology Research and Practice.2020; 2020: 1.     CrossRef
  • Impact of the number of stapler firings on anastomotic leakage in laparoscopic rectal surgery: a systematic review and meta-analysis
    Z. Balciscueta, N. Uribe, L. Caubet, M. López, I. Torrijo, J. Tabet, M. C. Martín
    Techniques in Coloproctology.2020; 24(9): 919.     CrossRef
  • Computed tomography based cross-sectional anatomy of the pelvis predicts surgical outcome after rectal cancer surgery
    Gyoung Tae Noh, Soon Sup Chung, Kwang Ho Kim, Ryung-Ah Lee
    Annals of Surgical Treatment and Research.2020; 99(2): 90.     CrossRef
  • Risk factors for anastomotic leakage and its impact on long-term survival in left-sided colorectal cancer surgery
    Marius Kryzauskas, Augustinas Bausys, Austeja Elzbieta Degutyte, Vilius Abeciunas, Eligijus Poskus, Rimantas Bausys, Audrius Dulskas, Kestutis Strupas, Tomas Poskus
    World Journal of Surgical Oncology.2020;[Epub]     CrossRef
  • Analysis of risk factors for anastomotic leakage after lower rectal Cancer resection, including drain type: a retrospective single-center study
    Tetsushi Kinugasa, Sachiko Nagasu, Kenta Murotani, Tomoaki Mizobe, Takafumi Ochi, Taro Isobe, Fumihiko Fujita, Yoshito Akagi
    BMC Gastroenterology.2020;[Epub]     CrossRef
  • Prediction model for anastomotic leakage after laparoscopic rectal cancer resection
    Enesh Shiwakoti, Jianning Song, Jun Li, Shanshan Wu, Zhongtao Zhang
    Journal of International Medical Research.2020;[Epub]     CrossRef
  • Drainage smell and peritonitis are efficient indicators of anastomotic leakage after laparoscopic rectal cancer resection
    Enesh Shiwakoti, Jianning Song, Jun Li, Shanshan Wu, Zhongtao Zhang
    Journal of International Medical Research.2020;[Epub]     CrossRef
  • Laparoscopic loop ileostomy reversal with intracorporeal anastomosis is associated with shorter length of stay without increased direct cost
    Sarath Sujatha-Bhaskar, Matthew Whealon, Colette S. Inaba, Christina Y. Koh, Mehraneh D. Jafari, Steven Mills, Alessio Pigazzi, Michael J. Stamos, Joseph C. Carmichael
    Surgical Endoscopy.2019; 33(2): 644.     CrossRef
  • Risk and early predictive factors of anastomotic leakage in laparoscopic low anterior resection for rectal cancer
    Masahiro Fukada, Nobuhisa Matsuhashi, Takao Takahashi, Hisashi Imai, Yoshihiro Tanaka, Kazuya Yamaguchi, Kazuhiro Yoshida
    World Journal of Surgical Oncology.2019;[Epub]     CrossRef
  • Male gender is associated with an increased risk of anastomotic leak in rectal cancer patients after total mesorectal excision
    Chi Zhou, Xian-rui Wu, Xuan-hui Liu, Yu-feng Chen, Jia Ke, Xiao-wen He, Xiao-sheng He, Tuo Hu, Yi-feng Zou, Xiao-bin Zheng, Hua-shan Liu, Jian-cong Hu, Xiao-jian Wu, Jian-ping Wang, Ping Lan
    Gastroenterology Report.2018; 6(2): 137.     CrossRef
  • Predictive factors for anastomotic leakage after laparoscopic colorectal surgery
    Antonio Sciuto, Giovanni Merola, Giovanni D De Palma, Maurizio Sodo, Felice Pirozzi, Umberto M Bracale, Umberto Bracale
    World Journal of Gastroenterology.2018; 24(21): 2247.     CrossRef
  • Predictive Factors for Small Intestinal and Colonic Anastomotic Leak: a Multivariate Analysis
    Ahmad Sakr, Sameh Hany Emile, Emad Abdallah, Waleed Thabet, Wael Khafagy
    Indian Journal of Surgery.2017; 79(6): 555.     CrossRef
  • Smoking and tumor obstruction are risk factors for anastomotic leakage after laparoscopic anterior resection during rectal cancer treatment
    Hiroyuki Matsuzaki, Soichiro Ishihara, Kazushige Kawai, Koji Murono, Kensuke Otani, Koji Yasuda, Takeshi Nishikawa, Toshiaki Tanaka, Tomomichi Kiyomatsu, Keisuke Hata, Hiroaki Nozawa, Toshiaki Watanabe
    Journal of the Anus, Rectum and Colon.2017; 1(1): 7.     CrossRef
  • De Prefectos a Mandatarios de la Nación. La violencia en la política peruana (1829-1836)
    Víctor Peralta Ruiz
    Revista de Indias.2016; 76(266): 173.     CrossRef
  • New technique of compression anastomosis in colorectal surgery – first results in 25 patients in Macedonia
    Svetozar Antovic, Aleksandar Mitevski, Aleksandar Karagozov, Biljana Kuzmanovska, Nikola Jankulovski
    PRILOZI.2016;[Epub]     CrossRef
  • Preoperative, intraoperative and postoperative risk factors for anastomotic leakage after laparoscopic low anterior resection with double stapling technique anastomosis
    Kenji Kawada, Yoshiharu Sakai
    World Journal of Gastroenterology.2016; 22(25): 5718.     CrossRef
  • Clinical risk factors for anastomotic leakage after laparoscopic anterior resection for rectal cancer: a systematic review and meta-analysis
    Hui Qu, Yao Liu, Dong-song Bi
    Surgical Endoscopy.2015; 29(12): 3608.     CrossRef
  • Safe anastomosis in laparoscopic and robotic low anterior resection for rectal cancer: A narrative review and outcomes study from an expert tertiary center
    S. AL Asari, M.S. Cho, N.K. Kim
    European Journal of Surgical Oncology (EJSO).2015; 41(2): 175.     CrossRef
  • Preoperative risk factors for anastomotic leakage after resection for colorectal cancer: a systematic review and meta‐analysis
    H.‐C. Pommergaard, B. Gessler, J. Burcharth, E. Angenete, E. Haglind, J. Rosenberg
    Colorectal Disease.2014; 16(9): 662.     CrossRef
  • Incidence and Mortality of Anastomotic Dehiscence Requiring Reoperation After Rectal Carcinoma Resection
    Zhi-jie Cong, Liang-hao Hu, Jun-jie Xing, Zheng-qian Bian, Chuan-gang Fu, En-da Yu, Zhao-shen Li, Ming Zhong
    International Surgery.2014; 99(2): 112.     CrossRef
  • Anastomotic leakage as an outcome measure for quality of colorectal cancer surgery
    H S Snijders, D Henneman, N L van Leersum, M ten Berge, M Fiocco, T M Karsten, K Havenga, T Wiggers, J W Dekker, R A E M Tollenaar, M W J M Wouters
    BMJ Quality & Safety.2013; 22(9): 759.     CrossRef
  • Systematic review of perioperative selective decontamination of the digestive tract in elective gastrointestinal surgery
    D Roos, L M Dijksman, J G Tijssen, D J Gouma, M F Gerhards, H M Oudemans-van Straaten
    British Journal of Surgery.2013; 100(12): 1579.     CrossRef
  • Systematic Review of Anastomotic Leakage Rate According to an International Grading System Following Anterior Resection for Rectal Cancer
    Zhi-Jie Cong, Liang-Hao Hu, Zheng-Qian Bian, Guang-Yao Ye, Min-Hao Yu, Yun-He Gao, Zhao-Shen Li, En-Da Yu, Ming Zhong, Georgina L Hold
    PLoS ONE.2013; 8(9): e75519.     CrossRef
  • A systematic review of outcome reporting in colorectal cancer surgery
    R. N. Whistance, R. O. Forsythe, A. G. K. McNair, S. T. Brookes, K. N. L. Avery, A. M. Pullyblank, P. A. Sylvester, D. G. Jayne, J. E. Jones, J. Brown, M. G. Coleman, S. J. Dutton, R. Hackett, R. Huxtable, R. H. Kennedy, D. Morton, A. Oliver, A. Russell,
    Colorectal Disease.2013;[Epub]     CrossRef
  • Compression anastomosis ring device in colorectal anastomosis: a review of 1,180 patients
    Hossein Masoomi, Ruihong Luo, Steven Mills, Joseph C. Carmichael, Anthony J. Senagore, Michael J. Stamos
    The American Journal of Surgery.2013; 205(4): 447.     CrossRef
  • Spontaneous Healing of a Rectovaginal Fistula Developing after Laparoscopic Segmental Bowel Resection for Intestinal Deep Infiltrating Endometriosis
    William Kondo, Reitan Ribeiro, Carlos Henrique Trippia, Monica Tessmann Zomer
    Case Reports in Obstetrics and Gynecology.2013; 2013: 1.     CrossRef
  • A Novel Rodent Model Modifying Perioperative Temperature and Humidity during Bowel Surgery and Mimicking Laparoscopic Conditions
    Torben Glatz, Gabriel Seifert, Philipp A. Holzner, S. Chikhladze, Birte Kulemann, Olivia Sick, Jens Höppner, Ulrich Theodor Hopt, Goran Marjanovic
    Surgical Science.2012; 03(07): 353.     CrossRef
  • Randomized clinical trial of perioperative selective decontamination of the digestive tract versus placebo in elective gastrointestinal surgery
    D Roos, L M Dijksman, H M Oudemans-van Straaten, L T de Wit, D J Gouma, M F Gerhards
    British Journal of Surgery.2011; 98(10): 1365.     CrossRef
  • Ghost Ileostomy with or without abdominal parietal split
    Michele Cerroni, Roberto Cirocchi, Umberto Morelli, Stefano Trastulli, Jacopo Desiderio, Mario Mezzacapo, Chiara Listorti, Luigi Esperti, Diego Milani, Nicola Avenia, Nino Gullà, Giuseppe Noya, Carlo Boselli
    World Journal of Surgical Oncology.2011;[Epub]     CrossRef
The Effects of a Standardized Postoperative Enhanced Recovery Program after a Laparoscopic Colorectal Resection in Regard to Patients' Recovery and Clinical Outcomes.
Joh, Yong Geul , Lee, Jeong Eun , Yoo, Sang Hwa , Kim, Seung Han , Jeong, Geu Young , Chung, Choon Sik , Lee, Dong Gun
J Korean Soc Coloproctol. 2010;26(3):225-232.
DOI: https://doi.org/10.3393/jksc.2010.26.3.225
  • 3,257 View
  • 18 Download
  • 3 Citations
AbstractAbstract PDF
PURPOSE
A multidisciplinary program for early recovery after colorectal surgery has been developed continuously since 2000. The purpose of this study was to evaluate the effects of the standardized postoperative enhanced recovery program (SPERP) after a colorectal resection.
METHODS
The patients undergoing laparoscopic colorectal resection for colorectal cancer were cared for by using the SPERP after surgery. The comparison group consisted of patients who had undergone similar surgery before establishment of the SPERP. The two groups were compared with respect to the patients' characteristics, operation methods, operation time, blood loss, amounts of intravenous fluid and intravenous antibiotics, complications, postoperative hospital stay, readmission rate, and reoperation rate.
RESULTS
The number of patients being treated with the standardized postoperative recovery program, the standardized group (SG), was 63, and that of the traditional group (TG) was 61. Even though the day of oral feeding (1.02 vs. 2.67 days) was faster in the SG, the day of flatus and defecation was not different between two groups. The postoperative hospital stay in the SG (6.76 days) was significantly shorter than that in the TG (10.43 days). The total amount of intravenous fluid after surgery in the SG was 8,574.75 mL, compared with 19,568.22 mL in the TG. The duration of intravenous antibiotics was 2.69 days in the SG and 7.38 days in the TG (P=0.0001). The rates of complication (27.0% in SG vs. 39.3% in TG), reoperation (3.17% vs. 9.84%), and readmission (7.94% vs. 6.56%) did not increase after implementation of this program.
CONCLUSION
The standardized postoperative recovery program reduced the amounts of postoperative intravenous fluid and antibiotics and the postoperative hospital stay without increasing either complications or the readmission rate. A prospective multi-center study of this program is needed.

Citations

Citations to this article as recorded by  
  • Effectiveness of comprehensive interventions including exercise and exercise-only interventions on postoperative ileus and recovery of intestinal function in patients with colorectal cancer: a systematic review and meta-analysis
    Takuya Yanagisawa, Naohiro Furuya, Noriatsu Tatematsu, Kazuhiro Hayashi
    Supportive Care in Cancer.2026;[Epub]     CrossRef
  • Perioperative surgical home: a new scope for future anesthesiology
    Min A Kwon
    Korean Journal of Anesthesiology.2018; 71(3): 175.     CrossRef
  • The Effects and Variances of the Critical Pathway of Laparoscopic Colon Resection in Colon Cancer Patients
    Hye Jeong Jung, Mona Choi, So Sun Kim, Nam Kyu Kim, Kang Young Lee
    Asian Oncology Nursing.2012; 12(3): 204.     CrossRef
Prognostic Analysis According to N Stage and Circumferential Resection Margin in Patients with Locally Advanced Rectal Cancer.
Sohn, Yong Ki , Shin, Jin Yong , Hong, Kwan Hee
J Korean Soc Coloproctol. 2010;26(3):217-224.
DOI: https://doi.org/10.3393/jksc.2010.26.3.217
  • 2,150 View
  • 10 Download
AbstractAbstract PDF
PURPOSE
Efforts must be made to clarify the contribution of lymph node metastasis (NM) to adjuvant (chemo) radiotherapy following a curative resection for rectal cancer as the circumferential resection margin (CRM) has increasingly become a more reliable prognosticator for rectal cancer. This study examined the prognostic impact of NM on local recurrence, disease-free survival. and overall survival rates in curatively resected patients with locally advanced rectal cancer.
METHODS
Two hundred two patients with locally advanced rectal cancer curatively resected in Pusan Paik Hospital from January 1995 to December 2003 were enrolled. These patients were divided into three groups according to lymph node (N) disease (N0: node negative, n=79; N1: 1-3 nodes positive, n=70; N2: > or =4 nodes positive, n=53). The potential prognostic factors, for example, T and N stage, preoperative carcinoembryonic antigen (CEA), postoperative (chemo) radiotherapy, operative methods, and several pathologic variables, were assessed among the three groups. The potential clinicopathologic factors were analyzed by using the Kaplan-Meier method, and the prognostic factors were compared in a Cox regression model. Also, we compared the oncologic results of 26 patients with a positive CRM (CMI) with those of the N1 and the N2 subgroups.
RESULTS
N2 patients had an impaired 5-yr local control rate (19.1%) compared with N0 (6.8%) and N1 (11.6%, P=0.029) patients after a median follow up of 60 months (range, 6 to 156 mo). Differences in disease-free and overall survival were also significantly different statistically among the three groups (84.0% and 85.2% for N0; 54.9% and 65.1% for N1; 37.3% and 49.8% for N2; P<0.001 both). The impact of NM on the local recurrence, disease-free survival and overall survival was confirmed in the regression model for the curatively resected patients. There were no significant differences in the recurrence and the survival rates between CMI and N2 stage.
CONCLUSION
NM has an independent prognostic impact on local failure and on disease-free survival and overall survival. Based on these findings, NM should be considered as an indicatior for adjuvant therapy. Although the prognostic impact of CMI is similar to that of N2, a larger prospective study is needed to clarify the prognostic association of CMI and N2.
Outcomes of a Hepatic Resection for Colorectal-Carcinoma Liver Metastases.
Lee, Woo Koung , Kim, Sang Bum , Cho, Eung Ho , Hwang, Dae Yong , Moon, Sun Mi
J Korean Soc Coloproctol. 2010;26(3):204-210.
DOI: https://doi.org/10.3393/jksc.2010.26.3.204
  • 2,569 View
  • 14 Download
  • 1 Citations
AbstractAbstract PDF
PURPOSE
Recent managements of liver metastasis from colorectal cancer consist of multi-disciplinary treatments. Although hepatic resection is the only curative treatment, for which long-term survival is expected, the recurrence rates is still high. Recently, liver resections, combined with chemotherapy and other additional therapy, have produced promising outcomes. We analyzed the outcomes of hepatic resection for liver metastasis from colorectal cancer.
METHODS
From 1993 to 2007, we performed 116 hepatic resections for the treatment of liver metastasis from colorectal cancer. All patients received adjuvant chemotherapy. We reviewed their medical records and investigated the clinico-pathologic data retrospectively.
RESULTS
One in hospital mortality occurred, and the postoperative morbidity rate was 37.5%, including major complication (11.7%). Five-yr overall survival rate and disease free survival rate were 33.2% and 25.0%, respectively. T stage and postoperative morbidity were independent prognostic factors for survival whereas metachronous metastases and postoperative morbidity were independent prognostic factors for recurrence. During the follow-up periods, 67 recurrences occurred.
CONCLUSION
Hepatic resections for liver metastasis from colorectal cancer were safe and effective. The surgical T stage, complications, and metastasis type (metachronous or synchronous) may determine the results in patients with surgically-curable liver metastasis from colorectal cancer.

Citations

Citations to this article as recorded by  
  • Scoring of prognostic factors that influence long-term survival in patients with hepatic metastasis of colorectal cancer
    Sung Woo Ahn, Ahn Soo Na, Jae Do Yang, Hong Pil Hwang, Hee Chul Yu, Baik Hwan Cho
    Korean Journal of Hepato-Biliary-Pancreatic Surgery.2011; 15(3): 146.     CrossRef
Trans-Sacral Local Resection as a Posterior Approach.
Lee, Bong Hwa , Park, Hyoung Chul , Lee, Hae Wan , An, Chang Nam , Um, Taeik , Lim, Young A , Kim, Byoung Sup , Chang, Mi Young , Kim, Soo Hyoung , Cho, Sung Wook
J Korean Soc Coloproctol. 2010;26(3):197-203.
DOI: https://doi.org/10.3393/jksc.2010.26.3.197
  • 3,167 View
  • 28 Download
  • 1 Citations
AbstractAbstract PDF
PURPOSE
Surgical removal for a mass in the pre-sacral space or mid rectum through a posterior approach is not frequent. We would like to present the technique of trans-sacral local resection as a posterior approach. We analyzed the follow up of patients who underwent surgery using the proposed technique.
METHODS
A total of 21 patients who had undergone a trans-sacral local resection with lower sacrectomy between January 1997 and December 2006 were enrolled in this study. The diagnoses were large epidermal cyst, gastrointestinal stromal tumor, high grade adenoma, and early cancers in the mid rectum. We analyzed the surgical complications and disease recurrences. The mean follow up for tumors of the rectum was 53+/-35 mo.
RESULTS
Epidural anesthesia was appropriate for all whole procedures. Among the 21 cases, there was one case of a rectocutaneous fistula as a postoperative complication (4.9%). In one case among the submucosal cancers, there was a systemic metastasis at 24 mo without local recurrence.
CONCLUSION
In our experience, a trans-sacral resection with a lower sacrectomy is a good option and provides a wide and direct surgical exposure for the removal of a pre-sacral or a mid-rectal mass. Good bowel preparation is mandatory.

Citations

Citations to this article as recorded by  
  • How to Treat Retrorectal Cysts or Tumors in Adult
    Bong Hwa Lee, Hyoung Chul Park, Byung Seup Kim
    Journal of the Korean Society of Coloproctology.2011; 27(6): 276.     CrossRef
Abdominoperineal Resection in the Treatment of Locally-advanced Low Rectal Cancer: Is Preoperative Chemoradiation Advantageous?.
Kim, Jeong Yeon , Kim, Jin Soo , Kim, Young Wan , Hur, Hyuk , Min, Byung Soh , Kim, Nam Kyu
J Korean Soc Coloproctol. 2010;26(2):129-136.
DOI: https://doi.org/10.3393/jksc.2010.26.2.129
  • 7,849 View
  • 9 Download
AbstractAbstract PDF
PURPOSE
An abdominoperineal resection (APR) has a poor prognosis. However, limited studies about the prognostic factors in APR and the role of preoperative chemoradiotherapy (CRT) have been performed even though in rectal cancer, the application of preoperative CRT provides better local control compared to postoperative CRT. The aim of this study was to identify the prognostic factors and the impact of preoperative CRT in patients who undergo an APR.
METHODS
A retrospective analysis was conducted with a total of 133 patients who underwent an APR, cT3, cT4, or cN(+) patients, for rectal cancer between January 1995 and October 2004. Fifty-one patients treated with preoperative CRT (Group 1) were compared with 82 APR patients treated with postoperative CRT (Group 2). Oncologic outcomes were compared between the two groups, and the clinicopathologic factors affecting the treatment outcomes were evaluated.
RESULTS
The median follow-up period was 61.2 mo (range 6 to 194 mo). Circumferential margin (CRM) involvement was significantly associated with local recurrence (LR) and with disease-free survival in APR patients (P<0.001, P=0.011). The 5-yr LR rate was significantly lower in Group 1 than in Group 2 (P=0.013) in the univariate analysis, but no difference was noted in multivariate analysis (P=0.315). In Group 1, CRM involvement, tumor size, and lymph node metastasis were significantly lower than they were in Group 2 (P=0.043, P=0.003, P<0.001).
CONCLUSION
For achieving adequate oncologic outcomes in APR patients, an adequate CRM should be acquired with an optimal operation. In addition, preoperative CRT would be helpful for high-risk APR patients with a threatening CRM margin, providing the benefit of tumor downstaging.
Safety of Early Chemotherapy after a Laparoscopic Colorectal Cancer Resection: A Case-Control Study.
Shin, Seung Ho , Lee, Sun Il , Choi, Dong Jin , Woo, Si Uk , Kim, Jin , Min, Byung Wook , Moon, Hong Young , Kim, Seon Hahn
J Korean Soc Coloproctol. 2009;25(6):429-436.
DOI: https://doi.org/10.3393/jksc.2009.25.6.429
  • 2,514 View
  • 11 Download
AbstractAbstract PDF
PURPOSE
Since micrometastasis is generally inhibited by primary cancer, surgical ablation of the tumor may stimulate the growth of residual cancer cells, if they exist. This supports the importance of early administration of postoperative chemotherapy. METHODS: We reviewed the cases of patients who underwent a laparoscopic resection and then received chemotherapy (5 fluorouracil+leucovorin or FOLFOX4) between September 2006 and May 2008. The chemotherapy was scheduled on the 7th or the 8th postoperative day, but was postponed when a final pathologic report was delayed or patients were discharged early. The safety of chemotherapy was evaluated in two ways. Early safety, such as the presence of surgical complications and medical toxicity, was prospectively assessed just before the beginning of the second cycle of chemotherapy. Late safety, such as medical toxicity, was retrospectively estimated from the 2nd to the last cycle. These safeties were compared between the two groups: the early chemotherapy group (n=50) for which chemotherapy started on the 7th or 8th postoperative day as scheduled and the delayed chemotherapy group (n=31) for which chemotherapy started after the 14th postoperative day.
RESULTS
Patient demographics were not different between the two groups. With regards to early safety, no differences in surgical complications existed between the two groups. In medical toxicities, there were no differences, except for a higher rate of nausea in the early chemotherapy group (20 percent vs. 10 percent, P=0.01). With regards to late safety, the two groups were not different in the development of medical toxicities. CONCLUSION: Because nausea is an easily controllable toxicity, we conclude that chemotherapy is safely started on the 7th or the 8th day after a laparoscopic colorectal cancer resection.
Short-Term Outcome of Curative One-Stage Laparoscopic Resection for Obstructive Left-Sided Colon Cancers Followed by Stent Insertion: Comparative Study with Non-Obstructive Left-Sided Colon Cancers.
Kim, Hyun Sil , Kim, Sung Geun , Ahn, Chang Hyuk , Kang, Won Kyung , Lee, Yun Seok , Lee, In Kyu , Kim, Hyung Jin , Lee, Sang Cheol , Cho, Hyeon Min , Park, Jong Kyung , Oh, Seong Taek , Kim, Jun Gi
J Korean Soc Coloproctol. 2009;25(6):417-422.
DOI: https://doi.org/10.3393/jksc.2009.25.6.417
  • 2,366 View
  • 9 Download
AbstractAbstract PDF
PURPOSE
Laparoscopic surgery has been considered to be contraindicated for treating malignant colorectal obstruction. Stent insertion for obstructive colorectal cancer has recently allowed laparoscopic surgery to be performed by means of preoperative bowel decompression and bowel preparation. The aim of this study is to evaluate the safety and the feasibility of a one-stage laparoscopic resection for obstructive left-sided colon cancer after stent insertion by comparing the results to those for non-obstructive left-sided colon cancer. METHODS: Between May 2006 and January 2009, a laparoscopic colorectal operation was performed on 18 consecutive patients with obstructive left-sided colon cancer after placement of a self-expandable stent by one colorectal surgeon, and the results were compared retrospectively to those for 43 patients with non-obstructive left-sided colon cancer who had undergone a laparoscopic procedure with the same surgeon. The collected data were the clinicopathologic characteristics, the perioperative complications, the oncologic outcomes, the postoperative recovery results, and the survival rate. RESULTS: The obstructive left-sided colon cancer group had significant benefits in retrieved lymph nodes (18.8+/-5.3 vs. 14.0+/-8.7, P=0.036), and distal resection margin (5.5+/-3.0 cm vs. 3.6+/-2.4 cm, P=0.011). There were no significant differences in other clinicopathological characteristics and oncologic outcomes, including the overall 3-yr survival rate, between the two groups. CONCLUSION: Preoperative stent decompression followed by a laparoscopic colorectal resection is a safe and feasible option for treating obstructive left-sided colon cancer. A further large-scale prospective study should be performed to evaluate the long-term outcome of a one-stage laparoscopic resection using stent insertion in cases of obstructive left-sided colon cancer.

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP